0001213900-21-026400.txt : 20210514 0001213900-21-026400.hdr.sgml : 20210514 20210514160042 ACCESSION NUMBER: 0001213900-21-026400 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 67 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210514 DATE AS OF CHANGE: 20210514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SenesTech, Inc. CENTRAL INDEX KEY: 0001680378 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 202079805 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37941 FILM NUMBER: 21924368 BUSINESS ADDRESS: STREET 1: 3140 N. CADEN COURT STREET 2: SUITE 1 CITY: FLAGSTAFF STATE: AZ ZIP: 86004 BUSINESS PHONE: (928) 779 - 4143 MAIL ADDRESS: STREET 1: 3140 N. CADEN COURT STREET 2: SUITE 1 CITY: FLAGSTAFF STATE: AZ ZIP: 86004 10-Q 1 f10q0321_senestechinc.htm QUARTERLY REPORT

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 10-Q

 

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2021

 

OR

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

Commission File Number: 001-37941

 

SENESTECH, INC. 

(Exact name of registrant as specified in its charter)

 

Delaware   20-2079805
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)
     
23460 N. 19th Avenue, Suite 110
Phoenix, AZ
  85027
(Address of principal executive offices)   (Zip Code)

 

(928) 779-4143

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
Common Stock, $0.001 par value   SNES   The NASDAQ Stock Market LLC
(NASDAQ Capital Market)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes    No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes    No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes    No

 

The number of shares of common stock outstanding as of May 14, 2021: 12,184,997

 

 

 

 

 

SENESTECH, INC.
FORM 10-Q
For the Quarterly Period Ended March 31, 2021

 

TABLE OF CONTENTS

 

    Page
  PART I. FINANCIAL INFORMATION 1
     
Item 1 Financial Statements 1
Item 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations 25
Item 3 Quantitative and Qualitative Disclosures About Market Risk 35
Item 4 Controls and Procedures 35
     
  PART II. OTHER INFORMATION 36
     
Item 1 Legal Proceedings 36
Item 1A Risk Factors 36
Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 36
Item 3 Defaults Upon Senior Securities 36
Item 4 Mine Safety Disclosures 36

 

i

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

SENESTECH, INC.
CONDENSED BALANCE SHEETS
(In thousands, except shares and per share data)

 

   March 31,   December 31, 
   2021   2020 
   (Unaudited)     
ASSETS        
         
Current assets:        
Cash  $15,165   $3,643 
Accounts receivable trade, net   27    25 
Prepaid expenses   360    178 
Inventory   905    945 
Deposits   26    28 
Total current assets   16,483    4,819 
           
Right to use asset-operating leases   627    665 
Property and equipment, net   528    538 
Total assets  $17,638   $6,022 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
           
Current liabilities:          
Short-term debt  $79   $98 
Accounts payable   175    404 
Accrued expenses   238    292 
Total current liabilities   492    794 
           
Long-term debt, net   662    673 
Operating lease liability   636    671 
Total liabilities   1,790    2,138 
           
Commitments and contingencies (See note 12)   -    - 
           
Stockholders’ equity:          
Common stock, $0.001 par value, 100,000,000 shares authorized, 12,164,046 and 5,099,512 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively   12    5 
Additional paid-in capital   121,897    108,119 
Accumulated deficit   (106,061)   (104,240)
Total stockholders’ equity   15,848    3,884 
           
Total liabilities and stockholders’ equity  $17,638   $6,022 

 

See accompanying notes to financial statements.

 

1

 

SENESTECH, INC.
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(In thousands, except shares and per share data)
(Unaudited)

 

   For the Three Months
Ended March 31,
 
   2021   2020 
         
Revenue:        
Sales  $88   $37 
Cost of sales   50    22 
Gross profit   38    15 
           
Operating expenses:          
Research and development   455    296 
Selling, general and administrative   1,422    2,045 
Total operating expenses   1,877    2,341 
           
Net operating loss   (1,839)   (2,326)
           
Other income (expense):          
Interest income   2    2 
Interest expense   (5)   (8)
Other income   21    15 
Total other income   18    9 
           
Net loss and comprehensive loss   (1,821)   (2,317)
Deemed dividend-warrant price protection-revaluation adjustment   -    414 
Net loss attributable to common shareholders  $(1,821)  $(2,731)
           
Weighted average common shares outstanding - basic and fully diluted   8,137,038    1,611,304 
           
Net loss per common share - basic and fully diluted  $(0.22)  $(1.69)

 

See accompanying notes to financial statements.

 

2

 

SENESTECH, INC.
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)
(In thousands, except shares and per share data)
(Unaudited) 

 

For The Three Months Ended March 31, 2020 and 2021

 

   Common Stock   Additional
Paid-In
   Accumulated   Total
Stockholders’
 
   Shares   Amount   Capital   Deficit   Equity (Deficit) 
Balance, December 31, 2019   1,414,671   $1   $98,433   $(95,867)  $2,567 
                          
Stock based compensation   -    -    151    -    151 
Issuance of common stock, sold for cash, net   353,872    1    1,707    -    1,708 
Issuance of common stock upon exercise of warrants   51,414    -    238    -    238 
Issuance costs of common stock issuances             (273)        (273)
Issuance of common stock for fractional shares-20-1 reverse split   24    -    -    -    - 
Warrant antidilution price protection adjustment             414         414 
Net loss for the three months ended March 31, 2020   -    -    -    (2,731)   (2,731)
                          
Balance, March 31, 2020   1,819,981   $2   $100,670   $(98,598)  $2,074 
                          
Balance, December 31, 2020   5,099,512   $5   $108,119   $(104,240)  $3,884 
                          
Stock based compensation   -    -    155    -    155 
Issuance of common stock, sold for cash, net   6,163,854    6    12,586    -    12,592 
Issuance of common stock upon exercise of warrants   900,680    1    1,208    -    1,209 
Issuance costs of common stock issuances             (171)        (171)
Net loss for the three months ended March 31, 2021   -    -    -    (1,821)   (1,821)
                          
Balance, March 31, 2021   12,164,046   $12   $121,897   $(106,061)  $15,848 

 

See accompanying notes to financial statements.

 

3

 

SENESTECH, INC.
CONDENSED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

 

   For the Three Months
Ended March 31,
 
   2021   2020 
CASH FLOWS FROM OPERATING ACTIVITIES        
Net loss  $(1,821)  $(2,317)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   73    77 
Stock-based compensation   155    151 
Gain on sale of equipment   -    (15)
(Increase) decrease in current assets:          
Accounts receivable - trade   (2)   4 
Accounts receivable - other   -    123 
Other assets   5    9 
Prepaid expenses   (182)   (40)
Inventory   40    18 
Increase (decrease) in current liabilities:          
Accounts payable   (229)   474 
Accrued expenses   (54)   (355)
Net cash used in operating activities   (2,015)   (1,871)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Cash received on sale of property and equipment   -    40 
Purchase of property and equipment   (63)   - 
Net cash provided by (used in) investing activities   (63)   40 
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Proceeds from the issuance of common stock, net   12,421    1,435 
Repayments of notes payable   (17)   (14)
Repayments of finance lease obligations   (13)   (34)
Proceeds from the exercise of warrants   1,209    - 
Net cash provided by financing activities   13,600    1,387 
           
NET CHANGE IN CASH   11,522    (444)
CASH AT BEGINNING OF PERIOD   3,643    1,936 
CASH AT END OF PERIOD  $15,165   $1,492 
           
SUPPLEMENTAL INFORMATION:          
Interest paid  $5   $8 
Income taxes paid  $-   $- 
           
NON-CASH INVESTING AND FINANCING ACTIVITIES:          
Forgiveness of accrual in warrant exercise   -   $238 
Deemed dividend   -   $414 

 

See accompanying notes to financial statements.

 

4

 

SENESTECH, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(Unaudited)

 

Note 1 - Organization and Description of Business

 

SenesTech, Inc. (referred to in this report as “SenesTech,” the “Company,” “we” or “us”) has developed and is commercializing a global, proprietary technology for managing animal pest populations, initially rat populations, through fertility control.

 

Although there are myriad tools available to control rat populations, most rely on some form of lethal method to achieve effectiveness. Each of these solutions is inherently limited by rat species’ resilience and survival mechanisms as well as their extraordinary rate of reproduction. ContraPest®, our initial product, is unique in the pest control industry in attacking the reproductive systems of both male and female rats, which our field data shows results in a sustained reduction of the rat population.

 

Rats have plagued humanity throughout history. They pose significant threats to the environment and to the health and food security of many communities. In addition, rodents cause extensive product loss and damage through consumption and contamination. Rats also cause significant damage to critical infrastructure by burrowing beneath foundations and gnawing on electrical wiring, insulation, fire proofing systems, electronics and computer equipment.

 

The most prevalent solution to rat infestations is the use of increasingly powerful rodenticides. Although these solutions provide short term results, there are growing concerns about secondary exposure and bioaccumulation of rodenticides in the environment, as well as concerns about rodenticides that have no antidotes. The pest management industry and Pest Management Professionals (“PMPs”) are being asked for new solutions that are both effective and less toxic. Our goal is to provide customers with not only a solution to combat their most difficult rat problems, but also offer an effective, non-lethal option to serve customers that are looking to decrease or remove the amount of rodenticide used in their pest control programs.

 

ContraPest is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (“VCD”) and triptolide. ContraPest limits reproduction of male and female rats beginning with the first breeding cycle following consumption. ContraPest is being marketed for use in controlling Norway and roof rat populations.

 

SenesTech began the registration process with the United States Environmental Protection Agency (the “EPA”) for ContraPest on August 23, 2015. On August 2, 2016, the EPA granted an unconditional registration for ContraPest as a Restricted Use Product (“RUP”), due to the need for applicator expertise for deployment. On October 18, 2018, the EPA approved the removal of the RUP designation. We believe ContraPest is the first and only non-lethal, fertility control product approved by the EPA for the management of rodent populations.

 

In addition to the EPA registration of ContraPest in the United States, ContraPest must obtain registration from the various state regulatory agencies prior to selling in each state. We have received registration for ContraPest in all 50 states and the District of Columbia, 48 of which have approved the removal of the RUP designation.

 

We expect to continue to pursue regulatory approvals and amendments to the existing U.S. registration for ContraPest to broaden the marketability and use of ContraPest, and if ContraPest begins to generate sufficient revenue, regulatory approvals for additional jurisdictions beyond the United States. In certain cases, our EPA and state registrations require completion of testing and certifications even though we have received approval for the product or its labelling. We continue to seek to comply with these requirements.

 

The Company also continues to research and develop enhancements to ContraPest that align with our target verticals and other potential fertility control options for additional species. 

 

We were formed in July 2004 and incorporated in the state of Nevada. The Company subsequently reincorporated in the state of Delaware in November 2015. Our corporate headquarters and manufacturing site are in Phoenix, Arizona. On December 8, 2016, we went public and are currently traded on Nasdaq under the symbol SNES.

 

On February 4, 2020, we amended our amended and restated certificate of incorporation to effect a 1-for-20 reverse split of our issued and outstanding shares of our common stock. The accompanying condensed financial statements and notes thereto give retrospective effect to the reverse stock split for all periods presented. All issued and outstanding common stock, options and warrants exercisable for common stock, restricted stock units, preferred stock conversions to common stock and per share amounts contained in our condensed financial statements have been retrospectively adjusted.

 

5

 

SENESTECH, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)

 

Note 1 - Organization and Description of Business – (continued)

 

Going Concern

 

Our financial statements as of March 31, 2021, December 31, 2020 and March 31, 2020 have been prepared under the assumption that we will continue as a going concern. Our independent registered public accounting firm included in its opinion for the years ended December 31, 2020 and 2019 an explanatory paragraph referring to our net loss from operations and net capital deficiency and expressing substantial doubt in our ability to continue as a going concern without additional capital becoming available. If we encounter continued issues or delays in the commercialization of ContraPest, our prior losses and expected future losses could have an adverse effect on our financial condition and negatively impact our ability to fund continued operations, obtain additional financing in the future and continue as a going concern. There are no assurances that such financing, if necessary, will be available to us at all or will be available in sufficient amounts or on reasonable terms. Our financial statements do not include any adjustments that may result from the outcome of this uncertainty. If we are unable to generate additional funds in the future through additional financings, sales of our products, licensing fees, royalty payments or from other sources or transactions, we will exhaust our resources and will be unable to continue operations.

 

Liquidity and Capital Resources

 

Since our inception, we have sustained significant operating losses in the course of our research and development and commercialization activities and expect such losses to continue for the near future. We have generated limited revenue to date from product sales, research grants and licensing fees received under our former license agreement. We have primarily funded our operations to date through the sale of equity securities, including convertible preferred stock, common stock and warrants to purchase common stock. See Note 10 for a description of our public equity sales.

 

We have also raised capital through debt financing, consisting primarily of convertible notes and government loan programs, and, to a lesser extent, payments received in connection with product sales, research grants and licensing fees.

 

Through March 31, 2021, we received net proceeds of $89.3 million from our sales of common stock, preferred stock and warrant exercises and issuance of convertible and other promissory notes, an aggregate of $1.7 million from licensing fees and an aggregate of $1.0 million in net product sales. As of March 31, 2021, we had an accumulated deficit of $106.1 million and cash and cash equivalents of $15.2 million.

 

Our ultimate success depends upon the outcome of a combination of factors, including: (i) successful commercialization of ContraPest and maintaining and obtaining regulatory approval of our products and product candidates; (ii) market acceptance, commercial viability and profitability of ContraPest and other products; (iii) the ability to market our products and establish an effective sales force and marketing infrastructure to generate significant revenue; (iv) the success of our research and development; (v) the ability to retain and attract key personnel to develop, operate and grow our business; and (vi) our ability to meet our working capital needs.

 

Based upon our current operating plan, we expect that cash and cash equivalents at March 31, 2021, in combination with anticipated revenue and any additional sales of our equity securities, will be sufficient to fund our current operations for at least the next 12 months. We have evaluated and will continue to evaluate our operating expenses and will concentrate our resources toward the successful commercialization of ContraPest in the United States. However, if anticipated revenue targets and margin targets are not achieved or expenses are more than we have budgeted, we may need to raise additional financing before that time. If we need more financing and we are unable to raise necessary capital through the sale of our securities, we may be required to take other measures that could impair our ability to be successful and operate as a going concern. In any event, we may require additional capital in order to fund our operating losses and research and development activities before we become profitable and may opportunistically raise capital. We may never achieve profitability or generate positive cash flows, and unless and until we do, we will continue to need to raise capital through equity or debt financing. If such equity or debt financing is not available at adequate levels or on acceptable terms, we may need to delay, limit or terminate commercialization and development efforts or discontinue operations.

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. In the Company’s opinion, the unaudited condensed financial statements include all material adjustments, all of which are of a normal and recurring nature, necessary to present fairly the Company’s financial position as of March 31, 2021, the Company’s operating results for the three months ended March 31, 2021 and 2020, and the Company’s cash flows for the three months ended March 31, 2021 and 2020. The accompanying financial information as of December 31, 2020 is derived from audited financial statements. Interim results are not necessarily indicative of results for a full year. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 29, 2021. All amounts shown in these financial statements and accompanying notes are in thousands, except percentages and per share and share amounts. 

 

6

 

SENESTECH, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)

 

Note 2 - Summary of Significant Accounting Policies

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and classification of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The significant estimates in the Company’s financial statements include the valuation of preferred stock, if issued, common stock and related warrants, and other stock-based awards. Actual results could differ from such estimates.

 

Reclassifications

 

Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no material impact on net earnings, financial position or cash flows.

 

Cash and Cash Equivalents

 

The Company considers money market fund investments to be cash equivalents. The Company had cash equivalents in the form of money market fund investment of $7,000 and $1,500 at March 31, 2021 and December 31, 2020, respectively, included in cash as reported.

 

Accounts Receivable-Trade

 

Accounts receivable-trade consist primarily of receivables from customers. The Company provides an allowance for doubtful trade receivables equal to the estimated uncollectible amounts. That estimate is based on historical collection experience, current economic and market conditions and a review of the current status of each customer’s trade accounts receivable. The allowance for doubtful trade receivables was $0 at March 31, 2021 and December 31, 2020.

 

Inventories

 

Inventories are stated at the lower of cost or market value, using the first-in, first-out convention. Inventories consist of raw materials, work in progress and finished goods. Raw materials are stocked to reduce the risk of impact on manufacturing for potential supply interruptions due to the COVID-19 pandemic or long lead times on certain ingredients.

 

Components of inventory are:

 

   March 31,   December 31, 
   2021   2020 
Raw materials  $935   $950 
Work in progress   4    24 
Finished goods   89    94 
Total inventory   1,028    1,068 
Less:          
Reserve for obsolete   (123)   (123)
Total net inventory  $905   $945 

 

Prepaid Expenses

 

Prepaid expenses consist primarily of payments made for director and officer insurance, director compensation, rent, legal and inventory purchase deposits and seminar fees to be expensed in the current year.

 

7

 

SENESTECH, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)

 

Note 2 - Summary of Significant Accounting Policies – (continued)

 

Property and Equipment

 

Property and equipment are stated at cost less accumulated depreciation. Equipment held under finance leases are stated at the present value of minimum lease payments less accumulated amortization.

 

Depreciation on property and equipment is computed using the straight-line method over the estimated useful lives of the respective assets. The cost of leasehold improvements is amortized over the life of the improvement or the term of the lease, whichever is shorter. Equipment held under finance leases is amortized over the shorter of the lease term or estimated useful life of the asset. The Company incurs repair and maintenance costs on its major equipment, which are expensed as incurred.

 

Impairment of Long-Lived Assets

 

Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require long-lived assets or asset groups to be tested for possible impairment, the Company compares the undiscounted cash flows expected to be generated from the use of the asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment charge is recognized to the extent that the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques, such as discounted cash flow models and the use of third-party independent appraisals. The Company has not recorded an impairment of long-lived assets since its inception.

 

Revenue Recognition

 

Effective January 1, 2018, the Company adopted Accounting Standards Codification (“ASC”) 606 — Revenue from Contracts with Customers (“ASC 606”). Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.

 

The Company recognizes revenue when product is shipped at a fixed selling price on payment terms of 30 to 120 days from invoicing. The Company recognizes other revenue earned from pilot studies, consulting and implementation services upon the performance of specific services under the respective service contract.

 

The Company derives revenue primarily from commercial sales of products, net of discounts and promotions, as well as consulting and implementation services provided in conjunction with our product deployments. 

 

Research and Development

 

Research and development costs are expensed as incurred. Research and development expenses primarily consist of salaries and benefits for research and development employees, stock-based compensation, consulting fees, lab supplies, costs incurred related to conducting scientific trials and field studies, regulatory compliance costs, and manufacturing costs associated with process improvement. Research and development expenses include an allocation of facilities related costs, including depreciation of research and development equipment.

 

Stock-based Compensation

 

Stock based awards, consisting of stock options and restricted stock units expected to be settled in shares of the Company’s common stock, are recorded as equity awards. The grant date fair value of these awards is measured using the Black-Scholes option pricing model for stock options and grant date market value for restricted stock units. The Company expenses the grant date fair value of its stock options on a straight-line basis over their respective vesting periods.

 

8

 

SENESTECH, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)

 

Note 2 - Summary of Significant Accounting Policies – (continued)

 

The stock-based compensation expense recorded for the three months ended March 31, 2021 and 2020, is as follows:

 

   Three Months Ended
March 31,
 
   2021   2020 
Research and development  $2   $3 
Selling, general and administrative   153    148 
Total stock-based compensation expense  $155   $151 

 

See Note 11 for additional discussion on stock-based compensation.

 

Income Taxes

 

The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements and tax bases of assets and liabilities and net operating loss carryforwards using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period that includes the enactment date.

 

The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized. These deferred tax assets are subject to periodic assessments as to recoverability and if it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recorded which would increase the provision for income taxes. In making such determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations.

 

The Company applies a more-likely-than-not recognition threshold for all tax uncertainties. Only those benefits that have a greater than fifty percent likelihood of being sustained upon examination by the taxing authorities are recognized. Based on its evaluation, the Company has concluded there are no significant uncertain tax positions requiring recognition in its financial statements.

 

The Company recognizes interest and/or penalties related to uncertain tax positions in income tax expense. There are no uncertain tax positions as of March 31, 2021 or December 31, 2020 and as such, no interest or penalties were recorded in income tax expense.

 

Comprehensive Loss

 

Net loss and comprehensive loss were the same for all periods presented; therefore, a separate statement of comprehensive loss is not included in the accompanying financial statements.

 

Loss Per Share Attributable to Common Stockholders

 

Basic loss per share attributable to common stockholders is calculated by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share attributable to common stockholders is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury stock and if-converted methods. For purposes of the computation of diluted loss per share attributable to common stockholders, common stock purchase warrants, and common stock options are considered to be potentially dilutive securities but have been excluded from the calculation of diluted loss per share attributable to common stockholders because their effect would be anti-dilutive given the net loss reported for the three months ended March 31, 2021 and 2020. Therefore, basic and diluted loss per share attributable to common stockholders are the same for each period presented.

 

9

 

SENESTECH, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)

 

Note 2 - Summary of Significant Accounting Policies – (continued)

 

The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted loss per share attributable to common stockholders (in common stock equivalent shares):

 

   March 31, 
   2021   2020 
Common stock purchase warrants   4,553,733    812,963 
Restricted stock units   31,405    5,877 
Common stock options   506,852    136,239 
Total   5,091,990    955,079 

 

Adoption of New Accounting Standard:

 

In August 2018, the FASB issued ASU 2018-15 Accounting for Implementation Costs Related to Cloud Computing or Hosting Arrangements, authoritative guidance intended to address a customer’s accounting for implementation costs incurred in a cloud computing arrangement that is a service contract. This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires presentation of the capitalized implementation costs in the statement of financial position and in the statement of cash flows in the same line item that a prepayment for the fees of the associated hosting arrangement would be presented, and the expense related to the capitalized implementation costs to be presented in the same line item in the statement of operations as the fees associated with the hosting element (service) of the arrangement. This guidance was effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods, with early adoption permitted. Effective January 1, 2020, the Company adopted the guidance and determined there was no applicability to the Company at this time and as such, there was no impact on our financial position, results of operations, or cash flows.

 

Other than the item noted above, there have been no new accounting pronouncements not yet effective or adopted in the current year that we believe have a significant impact, or potential significant impact, to our unaudited condensed interim financial statements.

 

Note 3 - Fair Value Measurements

 

The Company issued common stock warrants to purchase shares of common stock in June of 2015 (see Note 9 - Common Stock Warrants and Common Stock Warrant Liability) that expired in June of 2020. These warrants contained a cash settlement provision that resulted in a common stock warrant liability that was revalued at the end of each reporting period.

 

10

 

SENESTECH, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)

 

Note 3 - Fair Value Measurements – (continued)

 

We valued these warrant derivatives at fair value. The accounting guidance for fair value, among other things, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The framework for measuring fair value consists of a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows: 

 

Level 1—Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;

 

Level 2—Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and

 

Level 3—Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.

 

An asset’s or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

 

Assets and liabilities measured at fair value are based on one or more of the following three valuation techniques:

 

  A. Market approach: Prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.
     
  B. Cost approach: Amount that would be required to replace the service capacity of an asset (replacement cost).
     
  C. Income approach: Techniques to convert future amounts to a single present amount based upon market expectations, including present value techniques, option-pricing and excess earnings models.

 

The Company’s common stock warrant liabilities are classified as Level 3 because there is limited activity or less transparency around the inputs to valuation.

 

Financial Instruments Not Carried at Fair Value

 

The carrying amounts of the Company’s financial instruments, including accounts payable and accrued liabilities, approximate fair value due to their short maturities. The estimated fair value of the convertible notes and other notes, not recorded at fair value, are recorded at cost or amortized cost which was deemed to estimate fair value.

 

Note 4 - Credit Risk

 

The Company is potentially subject to concentrations of credit risk in its accounts receivable. Credit risk with respect to receivables is limited due to the number of companies comprising the Company’s customer base, however the Company did identify a potentially uncollectable account and at December 31, 2019 and maintained a reserve for this receivable balance of $123. At December 31, 2020, the account was deemed uncollectable and offset against the reserve. The Company did not have any potentially uncollectable account at March 31, 2021 or December 31, 2020 and therefore, did not record a reserve for uncollectable accounts at March 31, 2021 or December 31, 2020. The Company does not require collateral or other securities to support its accounts receivable.

 

11

 

SENESTECH, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)

 

Note 5 - Prepaid Expenses

 

Prepaid expenses consist of the following:

 

   March 31,   December 31, 
   2021   2020 
Director, officer and other insurance  $181   $18 
NASDAQ fees   33    - 
Legal retainer   25    25 
Marketing programs and conferences   73    106 
Professional services retainer   12    8 
Rent   18    18 
Engineering, software licenses and other   18    3 
Total prepaid expenses  $360   $178 

 

Note 6 - Property and Equipment

 

Property and equipment, net consist of the following:

 

   Useful  March 31,   December 31, 
   Life  2021   2020 
Research and development equipment  5 years  $1,420   $1,397 
Office and computer equipment (1)  3 years   749    733 
Autos  5 years   54    54 
Furniture and fixtures  7 years   41    41 
Leasehold improvements  *   102    283 
Construction in progress      36    115 
       2,402    2,623 
Less accumulated depreciation and amortization      (1,874)   (2,085)
Total     $528   $538 

 

* Shorter of lease term or estimated useful life
   
(1)

In the three months ended March 31, 2021, the Company received net proceeds of less than $1 in the sale of research and development equipment resulting in gains on the sale of these assets of less than $1. In the three months ended March 31, 2020, the Company received net proceeds of $40 in the sale of research and development equipment and office and computer equipment, resulting in a gain on the sale of these assets of $15.

 

Depreciation and amortization expense was approximately $73 and $77 for the three months ended March 31, 2021 and 2020, respectively.

 

Note 7 - Accrued Expenses

 

Accrued expenses consist of the following:

 

   March 31,   December 31, 
   2021   2020 
Compensation and related benefits  $209   $218 
Board Compensation   5    3 
Personal property and franchise tax   8    57 
Other   16    14 
Total accrued expenses  $238   $292 

 

12

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 8 - Borrowings

 

A summary of the Company’s borrowings, including finance lease obligations, is as follows:

 

   March 31,   December 31, 
   2021   2020 
Short-term debt:        
Current portion of long-term debt   79    98 
Total short-term debt  $79   $98 
Long-term debt:          
Finance lease obligations  $66   $79 
Other promissory notes   675    692 
Total   741    771 
Less: current portion of long-term debt   (79)   (98)
Total long-term debt  $662   $673 

 

Finance Lease Obligations 

 

Finance lease obligations at March 31, 2021 are for computer and lab equipment leased through GreatAmerica Financial Services and ENGS Commercial Finance Co. These finance leases expire at various dates through April 2022 and carry interest rates ranging from 11.4% to 18.3%.

 

Other Promissory Notes

 

Also included in the table above are notes payable to Direct Capital, M2 Financing and Fidelity Capital, all for the financing of fixed assets. These notes expire at various dates through June 2022 and carry interest rates ranging from 13.1% to 13.3%.

 

Also included in the table above is a loan agreement payable to BMO Harris Bank National Association as the lender in an aggregate principal amount of $645,700 pursuant to the Paycheck Protection Program (the “PPP”) under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The loan is evidenced by a promissory note dated April 15, 2020 and matures April 15, 2022. The loan bears interest at a rate of 1.00% per annum and contains customary events of default including, among other things, payment defaults. The loan closed and was funded April 20, 2020. Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of loans granted under the PPP. The loan is subject to forgiveness to the extent proceeds are used for qualifying expenses, including certain payroll, utility, rent and mortgage interest expenses. No assurance is provided that the Company will obtain forgiveness of the loan in whole or in part.

 

Pursuant to amendments to the CARES Act, as long as the Company submits its application for loan forgiveness within ten months after the expiration of the applicable covered period, the Company will not be required to make any payments until the forgiveness amount is remitted to the lender by the SBA. The Company applied for forgiveness in February 2021. We cannot guarantee that the PPP loan will be forgiven. In the event the PPP loan is not forgiven in whole or in part, the lender is responsible for notifying the Company of the date on which the Company’s first repayment is due.

 

13

 

SENESTECH, INC.
NOTES TO CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)

 

Note 9 - Common Stock Warrants and Common Stock Warrant Liability

 

The table summarizes the common stock warrant activity as of March 31, 2021 as follows:

 

      Term  Exercise   Balance               Balance               Balance 
Issue Date  Warrant Type  Date  Price   December 31, 2019   Issued   Exercised   Expired   December 31, 2020   Issued   Exercised   Expired   March 31, 2021 
                                               
2016 and prior  Various  Various-2020/2021   Various    17,059    -    (9,375)   (7,684)   -    -    -    -    - 
                                                         
November 21,2017  Common Stock Offering Warrants  November 21, 2022  $1.3659(1)   143,501    -         -    143,501    -    -    -    143,501 
                                                         
November 21,2017  Dealer Manager Warrants  November 21, 2022  $30.00    47,250    -    (47,250)   -    -    -    -    -    - 
                                                         
June 20,2018  Warrant Reissue  December 20, 2023  $36.40    56,696    -    -    -    56,696    -    -    -    56,696 
                                                         
August 13,2018  Rights Offering Warrants  July 25, 2023  $23.00    202,943    -    -    -    202,943    -    -    -    202,943 
                                                         
August 13,2018  Dealer Manager Warrants  August 13, 2023  $34.50    13,393    -    -    -    13,393    -    -    -    13,393 
                                                         
July 16,2019  Dealer Manager Warrants  July 11, 2024  $33.75    8,334    -    -    -    8,334    -    -    -    8,334 
                                                         
January 28,2020  Registered Direct Offering  July 28,2025  $9.00    -    177,500    -    -    177,500    -    -    -    177,500 
                                                         
January 28,2020  Dealer Manager Warrants  July 28,2025  $10.00    -    13,315    -    -    13,315    -    -    -    13,315 
                                                         
March 6,2020  Registered Direct Offering  September 8,2025  $2.88    -    176,372    (176,372)   -    -    -    -    -    - 
                                                         
March 6,2020  Dealer Manager Warrants  March 4,2025  $3.76    -    13,228    -    -    13,228    -    -    -    13,228 
                                                         
April 21,2020  Dealer Manager Warrants  April 21,2025  $3.97    -    118,073    -    -    118,073    -    -    -    118,073 
                                                         
April 24,2020  Registered Direct Offering  April 24,2025  $3.05    -    1,574,308    (1,524,308)   -    50,000    -    -    -    50,000 
                                                         
October 26, 2020  Private Warrant Inducement  April 27,2026  $1.73    -    1,700,680              1,700,680    -    (700,680)   -    1,000,000 
                                                         
October 26, 2020  Dealer Manager Warrants  April 27,2026  $2.16    -    85,034              85,034    -    -    -    85,034 
                                                         
February 2, 2021  Private Placement Agreement  August 2,2026  $2.216    -    -    -    -    -    2,194,427              2,194,427 
                                                         
February 2, 2021  Dealer Manager Warrants  August 2,2026  $2.848    -    -    -    -    -    329,164              329,164 
                                                         
March 23, 2021  Dealer Manager Warrants  March 23, 2026  $2.50    -    -    -    -    -    148,125              148,125 
                                                         
               489,176                   2,582,697                   4,553,733 

 

(1) The initial exercise price of these warrants was $30.00 per share. Pursuant to antidilution price adjustment protection contained within these warrants, the initial exercise price of these warrants was adjusted downward to $29.40 on July 24, 2018, the record date of the Right’s Offering and downward to $19.00 per share on August 13, 2018. These warrants were further adjusted downward from $19.00 to $7.13 and to $2.1122 on January 28, 2020 and March 4, 2020, respectively, in connection with separate Registered Direct Offerings. These warrants were further adjusted downward from $2.1122 to $1.3659 on October 26, 2020 in connection with a Registered Direct Offering.  These warrants are subject to further adjustment pursuant to antidilution price adjustment protection.

 

14

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 9 - Common Stock Warrants and Common Stock Warrant Liability – (continued)

 

Outstanding Warrants

 

As of March 31, 2021, we had 4,553,733 shares of common stock issuable upon exercise of outstanding common stock warrants, at a weighted-average exercise price of $3.98603 per share.

 

On November 21, 2017, the Company issued a total of 232,875 detachable common stock warrants issued with the second public offering of 293,000 shares of its common stock at $20.00 per share. The common stock warrant is exercisable until five years from the date of grant. The common shares of the Company’s stock and detachable warrants exist independently as separate securities. As such, the Company estimated the fair value of the common stock warrants, exercisable at $30.00 per share, to be $661 using a lattice model based on the following significant inputs: common stock price of $20.00; comparable company volatility of 73.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 1.87%. The initial exercise price of these warrants was $30.00 per share, which adjusted downward to $29.40 on July 24, 2018, the record date of the Right’s Offering and downward to $19.00 per share on August 13, 2018, the date of the Rights Offering, pursuant to antidilution price adjustment protection contained within these warrants. The exercise price of the warrants was adjusted downward to $7.13 on January 28, 2020 in connection with a private placement of common stock. Per guidance of ASC 260, the Company recorded a deemed dividend of $285 on the 143,501 unexercised warrants that contained this antidilution price adjustment protection provision and was calculated as the difference between the fair value of the warrants immediately prior to downward exercise price adjustment and immediately after the adjustment using a Black Scholes model based on the following significant inputs: on January 28, 2020, common stock price of $7.90; comparable company volatility of 73.8%; remaining term 2.82 years; dividend yield of 0% and risk-free interest rate of 1.45%.

 

The exercise price of the warrants was adjusted downward to $2.1122 on March 4, 2020 in connection with a private placement of common stock. Per guidance of ASC 260, the Company recorded a deemed dividend of $129 on the 143,501 unexercised warrants that contained this antidilution price adjustment protection provision and was calculated as the difference between the fair value of the warrants immediately prior to downward exercise price adjustment and immediately after the adjustment using a Black Scholes model based on the following significant inputs: on March 4, 2020, common stock price of $2.88; comparable company volatility of 74.5%; remaining term 2.71 years; dividend yield of 0% and risk-free interest rate of 0.68%.

 

The exercise price of the warrants was adjusted downward to $1.3659 on October 26, 2020 in connection with an inducement offering of common stock. Per guidance of ASC 260, the Company recorded a deemed dividend of $22 on the 143,501 unexercised warrants that contained this antidilution price adjustment protection provision and was calculated as the difference between the fair value of the warrants immediately prior to downward exercise price adjustment and immediately after the adjustment using a Black Scholes model based on the following significant inputs: On October 26, 2020, common stock price of $1.47; comparable company volatility of 96.5%; remaining term 2.08 years; dividend yield of 0% and risk-free interest rate of 0.18%.

 

On June 20, 2018, the Company entered into an agreement with a holder of 56,696 of the November 2017 warrants to exercise its original warrant representing 56,696 shares of common stock for cash at the $30.00 exercise price for gross proceeds of $1.7 million and the Company issued to holder a new warrant to purchase 56,696 shares of common stock at an exercise price of $36.40 per share. The new warrant did not contain the antidilution price adjustment protection that was contained within the exercised warrants. In June 2018, the Company recorded stock compensation expense of $1,700 representing the fair value of the of 56,696 inducement warrants issued. The Company estimated the fair value of the common stock warrants, exercisable at $36.40 per share, to be $1,700 using a Black Scholes model based on the following significant inputs: common stock price of $42.20; comparable company volatility of 72.6%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.8%. Also, in June 2018, an additional 17,088 of the November 8, 2017 warrants that were in the money at the time of exercise, were exercised for gross proceeds of $513.

 

On August 13, 2018, in connection with a Rights Offering of 267,853 shares of its common stock, the Company issued 267,853 warrants to purchase shares of its common stock at an exercise price of $23.00 per share. The Company estimated the fair value of the common stock warrants, exercisable at $23.00 per share, to be $3,600 using a Monte Carlo model based on the following significant inputs: common stock price of $18.80; comparable company volatility of 159.0%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.77%.

 

In connection with the closing of the Rights Offering, the Company issued a warrant to purchase 13,393 shares of common stock to Maxim Partners LLC, an affiliate of the dealer-manager of the Rights Offering. The Company estimated the fair value of the common stock warrants, exercisable at $34.50 per share, to be $169 using a using a Monte Carlo model based on the following significant inputs: common stock price of $18.80; comparable company volatility of 159.0%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.77%.

 

15

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 9 - Common Stock Warrants and Common Stock Warrant Liability – (continued)

 

Common Stock Warrant Issued to Underwriter of Common Stock Offering

 

In July 2019, the Company issued to H.C. Wainwright & Co., as placement agent, a warrant to purchase 8,334 shares of common stock at an exercise price of $33.75 per share as consideration for providing services in connection with a common stock offering in July 2019. The warrant was fully vested and exercisable on the date of issuance. The common stock warrant is exercisable until five years from the date of grant. The Company estimated the fair value of the common stock warrants, exercisable at $33.75 per share, to be $127 using a lattice model based on the following significant inputs: common stock price of $26.80; comparable company volatility of 133.3%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.07%.

 

Common Stock Warrants Issued in January and March 2020 Private Placements

 

In January and March 2020, in separate private placements concurrent with registered direct offerings (collectively, the “2020 Registered Direct Offerings”) of shares of the Company’s common stock, the Company also issued warrants to purchase an aggregate of up to 353,872 shares of common stock to certain institutional and accredited investors that participated in the 2020 Registered Direct Offerings (the “2020 Warrants”). The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”) and Rule 506(b) of Regulation D promulgated thereunder. Terms used but not otherwise defined herein will have the meanings given them in the warrants, attached as Exhibit 4.1 to our Form 8-K filed on January 28, 2020, and our Form 8-K filed on March 6, 2020.

 

The warrants issued in January 2020 to purchase 177,500 shares of common stock have an exercise price of $9.00 per share, are exercisable after July 28, 2020 and will expire July 28, 2025. The Company estimated the fair value of the common stock warrants, exercisable at $9.00 per share, to be $813 using a Black Scholes model based on the following significant inputs: common stock price of $7.90; comparable company volatility of 73.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 1.53%.

 

The warrants issued in March 2020 to purchase 176,372 shares of common stock have an exercise price of $2.88 per share, are immediately exercisable and will expire September 8, 2025. The Company estimated the fair value of the common stock warrants, exercisable at $2.88 per share, to be $242 using a Black Scholes model based on the following significant inputs: common stock price of $2.35; comparable company volatility of 74.8%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.39%.

 

For so long as the 2020 Warrants remain outstanding, the exercise price and number of shares of common stock issuable upon exercise of the warrants are subject to adjustment as follows: (a) upon payment of a stock dividend or other distribution on a class or series of shares common stock, not including shares issued under this warrant; (b) upon subdivision (by stock spilt, stock dividend, recapitalization, or otherwise) or combination (by reverse stock split or otherwise) of shares of common stock; or (c) upon the issuance of any shares of capital stock by reclassification of shares of the common stock.

 

16

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 9 - Common Stock Warrants and Common Stock Warrant Liability – (continued)

 

In the event that the Company declares or makes any dividend or other distribution of its assets to holders of its common stock, each 2020 Warrant holder will be entitled to participate in such distribution to the same extent that such holder would have participated therein if the holder had held the number of shares of common stock acquirable upon exercise of the 2020 Warrant.

 

In the event of a Fundamental Transaction, as described in the 2020 Warrants and generally including the sale, transfer or other disposition of all or substantially all of our properties or assets; our consolidation or merger with or into another person or reorganization; a recapitalization, reorganization or reclassification in which our common stock is converted into other securities, cash or property; or any acquisition of our outstanding common stock that results in any person or group becoming the beneficial owner of 50% of the voting power represented by our outstanding common stock, then the holders of the 2020 Warrants will be entitled to receive upon exercise of such warrants the kind and amount of securities, cash, assets or other property that the holders would have received had they exercised the 2020 Warrants immediately prior to such Fundamental Transaction. Subject to certain limitations, in the event of a Fundamental Transaction the 2020 Warrant holder may at its option require the Company or any Successor Entity to purchase such warrant from the holder by paying to the holder an amount of cash equal to the Black Scholes Value of the remaining unexercised portion of the 2020 Warrant on the date of the consummation of the Fundamental Transaction.

 

Any time that the Company grants, issues, or sells any securities pro rata to all of the record holders of the common stock (the “2020 Purchase Right”), each holder of 2020 Warrants will be entitled to acquire the aggregate amount of securities that the holder could have acquired if the holder had held the number of shares of common stock acquirable upon exercise of the applicable 2020 Warrant. However, to the extent that an exercise of a 2020 Purchase Right would exceed the Beneficial Ownership Limitation (defined below), then to such extent the 2020 Purchase Right will be held in abeyance until such time, if ever, that complete exercise of the 2020 Purchase Right would not exceed the Beneficial Ownership Limitation.

 

After the Initial Exercisability Date (as defined in the 2020 Warrants), the 2020 Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise notice accompanied by payment in full for the number of shares of our common stock purchased upon such exercise. If, at the time a holder exercises the 2020 Warrant (but not sooner than six months following the date of such warrant), a registration statement registering the issuance of the shares of common stock underlying the 2020 Warrants under the Securities Act is not then effective or available, nor is any current prospectus thereto available, and an exemption from registration under the Securities Act is not available for the issuance of such shares, then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the number of shares of common stock determined according to a formula set forth in the 2020 Warrant.

 

Limitations on Exercise. A holder (together with its affiliates) may not exercise any portion of the 2020 Warrants to the extent that the holder would own more than 4.99% of the outstanding common stock after exercise (the “Beneficial Ownership Limitation”), except that upon at least 61 days’ prior notice from the holder to us, the holder may increase the Beneficial Ownership Limitation up to 9.99% of the number of shares of our common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the 2020 Warrants. No fractional shares of common stock will be issued in connection with the exercise of a 2020 Warrant. In lieu of fractional shares, we will either pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price or round up to the next whole share.

 

Except as otherwise provided in the 2020 Warrants or by virtue of such holder’s ownership of shares of our common stock, the holders of the 2020 Warrants do not have the rights or privileges of holders of our common stock, including any voting rights, unless and until they exercise such warrants.

 

Common Stock Warrants Issued in April 2020 Public Offering

 

On April 24, 2020, in connection with a previously announced public offering of 145,586 Class A Units and 1,428,722 Class B Units, the Company issued warrants to purchase 1,574,308 shares of common stock to the participants in the public offering and have an exercise price of $3.05 per share (the “April 2020 Warrants”). These warrants are immediately exercisable and will expire April 24, 2025.

 

17

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 9 - Common Stock Warrants and Common Stock Warrant Liability – (continued)

 

The Common Stock, Pre-Funded Warrants and Warrants sold in this Public Offering were offered and sold pursuant to a registration statement on Form S-1 (File No. 333-236302) initially filed with the SEC on February 7, 2020, as amended (“Registration Statement”), which was declared effective by the SEC on February 14, 2020. The Post-Effective Amendment No. 2 to the Registration Statement was declared effective by the SEC on April 21, 2020.

 

The Company estimated the fair value of the common stock warrants, exercisable at $3.05 per share, to be $2,402 using a Black Scholes model based on the following significant inputs: common stock price of $2.40; comparable company volatility of 87.9%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 0.18%.

 

Common Stock Warrants Issued to Placement Agent in 2020 Registered Direct Offerings and Private Placement

 

In connection with the separate private placements concurrent with registered direct offerings of shares of the Company’s common stock in January and March 2020, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, a warrant to purchase 13,228 shares of common stock and a warrant to purchase 13,313 shares of common stock. The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. These warrants have substantially similar terms as the 2020 Warrants described above, except that the placement agent warrant issued in January 2020 has an exercise price of $10.00 per share, and the placement agent warrant issued in March 2020 has an exercise price of $3.7563 per share.

 

The Company estimated the fair value of the common stock warrants issued in January, with an exercise price of $10.00 per share, to be $58 using a Black Scholes model based on the following significant inputs: common stock price of $7.90; comparable company volatility of 73.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 1.53%.

 

The Company estimated the fair value of the common stock warrants issued in March, with an exercise price of $3.7563 per share, to be $17 using a Black Scholes model based on the following significant inputs: common stock price of $2.35; comparable company volatility of 74.8%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.39%.

 

In connection with the public offering of 145,586 Class A Units and 1,428,722 Class B Units on April 24, 2020, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, warrants to purchase 118,073 shares of common stock. The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. These warrants have substantially similar terms as the April 2020 Warrants described above, except that the placement agent warrant issued has an exercise price of $3.97 per share.

 

The Company estimated the fair value of the common stock warrants issued in April, with an exercise price of $3.97 per share, to be $167 using a Black Scholes model based on the following significant inputs: common stock price of $2.40; comparable company volatility of 87.9%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%.

 

Common Stock Warrants Issued in October 2020 Private Warrant Inducement

 

In October 2020, in connection with an inducement agreement with an existing accredited investor to exercise 1,700,680 outstanding warrants (the “Original Warrants”) to purchase an equal number of shares of the Company’s common stock, the Company issued new unregistered warrants to purchase up to an aggregate of 1,700,680 shares of common stock at an exercise price of $1.725 per share. The warrants issued were immediately exercisable with an exercise period of five and one-half years from the date of issuance. The Original Warrants were issued on March 6, 2020 and on April 24, 2020. Pursuant to the Letter Agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. The Company estimated the fair value of the common stock warrants, exercisable at $1.725 per share, to be $1,806 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%.

 

In connection with the private warrant inducement in October 2020 of 1,700,680 shares of the Company’s common warrants, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, warrants to purchase 85,034 shares of common stock. These warrants have substantially similar terms as the 2020 Warrants described above, except that the placement agent warrant issued in October 2020 has an exercise price of $2.156 per share.

 

The Company estimated the fair value of these common stock warrants, with an exercise price of $2.156 per share, to be $86 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%.

 

18

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 9 - Common Stock Warrants and Common Stock Warrant Liability – (continued)

 

Common Stock Warrants Issued in February 2021 Private Placement Agreement

 

In February 2021, in connection with a private placement agreement with certain institutional and accredited investors, the Company issued common stock warrants to purchase up to an aggregate of 2,194,427 shares of common stock at an exercise price of $2.216 per share. The warrants were exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The warrant holder may not exercise any portion of such holder’s warrants to the extent that the holder, together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding shares of common stock immediately after exercise, except that upon at least 61 days’ prior notice from the holder to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise. The Company estimated the fair value of the common stock warrants, exercisable at $2.216 per share, to be $3,052 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%.

 

 Common Stock Warrants Issued to Placement Agent in February 2021 Private Placement Agreement

 

In connection with the private placement in February 2021, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, warrants to purchase up to 329,164 shares of Common Stock with an exercise price of $2.8481 per share. The warrants are exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.8481 per share, to be $435 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%.

 

Common Stock Warrants Issued to Placement Agent in March 2021 Registered Direct Offering

 

On March 23, 2021, the Company consummated a registered direct offering with certain institutional investors and issued an aggregate of 1,975,000 shares of the Company’s common stock, par value $0.001 per share at a purchase price of $2.00 per share for gross proceeds to the Company of approximately $3.95 million, before deducting fees payable to the placement agent and other estimated offering expenses payable by the Company. The 1,975,000 shares of Common Stock sold in the Offering were offered and sold pursuant to a prospectus, dated August 24, 2018, and a prospectus supplement, dated March 22, 2021, in connection with a takedown from the Company’s shelf registration statement on Form S-3 (File No. 333-225712).

 

In connection with the registered direct offering in March 2021, the Company issued to H.C. Wainwright & Co., LLC, as the placement agent, warrants to purchase up to 148,125 shares of Common Stock. The Placement Agent Warrants will be exercisable commencing six months following the date of issuance, expire five years following the date of sale and have an exercise price per share of $2.50 per share. The Placement Agent Warrants, and the shares of Common Stock issuable upon exercise thereof, will be issued in reliance on the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Regulation D promulgated thereunder. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.50 per share, to be $181 using a Black Scholes model based on the following significant inputs: common stock price of $1.76; comparable company volatility of 100.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 0.31%.

 

Deemed Dividend Adjustment-Warrant Modified Terms Revaluation

 

On March 3, 2020, the Company issued an aggregate of 51,414 common shares in a cashless exercise of 56,625 warrants issued in December 2016 and November 2017. Consideration for the exercise of these warrants was the full settlement of an outstanding litigation reserve of $238.

 

On October 26, 2020, in connection with the private warrant inducement with an existing accredited investor to exercise 1,700,680 Original Warrants, the Company agreed to modify the terms of the Original Warrants that were originally issued on March 6, 2020 and on April 24, 2020. Pursuant to the agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725.

 

Per recent proposed guidance of ASC 260, the Company determined that this was an exchange of the existing 1,700,680 warrants that were affected and the difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was a cost of raising capital and was recorded as a reduction of equity. The difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was calculated as $237, using a Black Scholes model based on the following significant inputs: On October 26, 2020: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 4.5-4.8 years; dividend yield of 0% and risk-free interest rate of 0.18%.

 

19

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 10 - Stockholders’ Deficit

 

Capital Stock

 

The Company was organized under the laws of the state of Nevada on July 27, 2004 and was subsequently reincorporated under the laws of the state of Delaware on November 10, 2015. In connection with the reincorporation, as approved by the stockholders, the Company changed its authorized capital stock to consist of (i) 100 million shares of common stock, $.001 par value, and (ii) 2 million shares of preferred stock, $0.001 par value, designated as Series A convertible preferred stock. In December 2015, the Company amended its Certificate of Incorporation to change its authorized capital stock to provide for 15 million authorized shares of preferred stock of which 7,515,000 was designated as Series B convertible preferred stock, par value $.001 per share.

 

Prior to November 10, 2015, the Company’s authorized capital stock consisted of 100 million shares of common stock, $.001 par value, and 10 million shares of preferred stock, $.001 par value.

 

Common Stock

 

The Company had 12,164,046 and 5,099,512 shares of common stock issued and outstanding as of March 31, 2021 and December 31, 2020, respectively.

 

During the three months ended March 31, 2021, the Company issued 7,064,534 shares of common stock as follows:

 

  an aggregate of 4,388,854 shares in connection with a private placement offering and exercise of pre-funded warrants issued in connection with the offering, generating net proceeds to the Company in February 2021 of approximately $8,898, as further described below; 
     
  an aggregate of 1,975,000 shares in connection with a registered direct offering generating net proceeds to the Company in March 2021 of approximately $3,523, as further described below; and
     
  an aggregate of 700,680 shares in connection with the exercise of common stock warrants, generating net proceeds to the Company in March 2020 of approximately $1,209, as further described below.
     

Public Offerings and Registered Direct Offerings

 

On February 2, 2021, the Company consummated a private placement agreement with certain institutional and accredited investors and issued an aggregate of 3,968,854 shares of its common stock, par value $0.001 per share at a purchase price of $2.2785 per share, pre-funded warrants to purchase up to an aggregate of 420,000 shares of common stock at a purchase price of $2.2775 per pre-funded warrant and associated warrants to purchase up to an aggregate of 2,194,427 shares of common stock, for gross proceeds of approximately $10.0 million, prior to deducting placement agent fees and offering expenses. At March 29, 2021, all 420,000 pre-funded shares had been distributed. In connection with the offering, we issued the placement agent warrants to purchase up to 329,164 shares of Common Stock with an exercise price of $2.8481 per share.

 

On March 23, 2021, the Company consummated a registered direct offering with certain institutional investors and issued an aggregate of 1,975,000 shares of the Company’s common stock, par value $0.001 per share at a purchase price of $2.00 per share for gross proceeds to the Company of approximately $3.95 million, pursuant to a prospectus, dated August 24, 2018, and a prospectus supplement, dated March 22, 2021, in connection with a takedown from the Company’s shelf registration statement on Form S-3 (File No. 333-225712).

 

In connection with the offering, we issued the placement agent warrants to purchase up to 148,125 shares of Common Stock at an exercise price per share of $2.50 per share.

 

On March 19, 2021, the Company issued an aggregate of 700,680 shares of commons stock for the exercise of certain warrants. The net proceeds to the Company for these exercises was $1,209.

 

20

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 11 - Stock-based Compensation

 

On June 12, 2018, the Company’s stockholders approved the 2018 Equity Incentive Plan (the “2018 Plan”) to replace the Company’s 2015 Equity Incentive Plan (the “2015 Plan”). On July 8, 2020, the Company’s stockholders approved an amendment to the 2018 Plan to increase the number of shares of common stock available for issuance under the 2018 Plan by 800,000 shares from 50,000 to 850,000. In addition, up to 122,279 shares of our common stock previously reserved for issuance under the 2015 Plan are available for issuance under the 2018 Plan to the extent such shares were available for issuance under the 2015 Plan as of June 12, 2018 or thereafter cease to be subject to awards outstanding under the 2015 Plan, such as by expiration, cancellation, or forfeiture of such awards.

 

Stock options are generally issued with a per share exercise price equal to no less than fair market value of our common stock at the date of grant. Options granted under the 2018 Plan generally vest immediately, or ratably over a two- to 36-month period coinciding with their respective service periods. Options under the 2018 Plan generally have a term of five years. Certain stock option awards provide for accelerated vesting upon a change in control.

 

As of March 31, 2021, the Company had 419,061 shares of common stock available for issuance under the 2018 Plan.

 

The Company measures the fair value of stock options with service-based vesting criteria to employees, directors and consultants on the date of grant using the Black-Scholes option pricing model. The Black-Scholes valuation model requires the Company to make certain estimates and assumptions, including assumptions related to the expected price volatility of the Company’s stock, the period during which the options will be outstanding, the rate of return on risk-free investments, and the expected dividend yield for the Company’s stock.

 

The weighted-average assumptions used in the Black-Scholes option-pricing model used to calculate the fair value of options granted during the three months ended March 31, 2021 were as follows:

 

Expected volatility     96.2 %  
Expected dividend yield        
Expected term (in years)     5    
Risk-free interest rate      0.26 %  

 

21

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 11 - Stock-based Compensation – (continued)

 

The weighted average grant date fair value of options granted during the three months ended March 31, 2021 was $1.94 per share, as per the table above.

 

Due to the Company’s limited operating history and lack of company-specific historical or implied volatility, the expected volatility assumption was determined based on historical volatilities from traded options of biotech companies of comparable size and stability, whose share prices are publicly available. The expected term of options granted to employees is calculated based on the mid-point between the vesting date and the end of the contractual term according to the simplified method as described in SEC Staff Accounting Bulletin 110 because the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term due to the limited period of time its awards have been outstanding. For non-employee options, the expected term of options granted is the contractual term of the options. The risk-free interest rate is determined by reference to the implied yields of U.S. Treasury securities with a remaining term equal to the expected term assumed at the time of grant. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts. The Company has not paid and does not intend to pay dividends.

 

The following table summarizes the stock option activity, for both equity plans, for the periods indicated as follows: 

 

   Number of
Options
   Weighted
Average
Exercise
Price Per
Share
   Weighted
Average
Remaining
Contractual
Term
(years)
   Aggregate
Intrinsic
Value (1)
 
Outstanding at December 31, 2020   496,471   $8.63    3.9   $ 
Granted   12,756   $1.84    4.8   $ 
Exercised      $       $ 
Forfeited   (2,375)  $       $ 
Expired      $       $ 
Outstanding at March 31, 2021   506,852   $8.15    2.3   $ 
Exercisable at March 31, 2021   228,481   $14.45    2.1   $ 

 

(1) The aggregate intrinsic value in the table was calculated based on the difference between the estimated fair market value of the Company’s stock and the exercise price of the underlying options. The estimated stock values used in the calculation were $1.73 and $1.66 per share for the year ended December 31, 2020 and the three months ended March 31, 2021, respectively.

 

Restricted Stock Units

 

The following table summarizes restricted stock unit activity for the three months ended March 31, 2021:

 

   Number  of
Units
   Weighted Average
Grant-Date Fair
Value Per Unit
 
Outstanding as of December 31, 2020   32,072   $4.05 
Granted      $ 
Vested   (667)  $1.80 
Forfeited      $ 
Outstanding as of March 31, 2021   31,405   $2.58 

 

22

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 11 - Stock-based Compensation – (continued)

 

The stock-based compensation expense was recorded as follows:

 

   Three Months Ended
March 31,
 
   2021   2020 
Research and development  $2   $3 
Selling, general and administrative   153    148 
Total stock-based compensation expense  $155   $151 

 

The allocation between research and development and selling, general and administrative expense was based on the department and services performed by the employee or non-employee.

 

At March 31, 2021, the total compensation cost related to restricted stock units and unvested options not yet recognized was $629, which will be recognized over a weighted average period of 34 months, assuming the employees and non-employees complete their service period required for vesting.

 

Note 12 - Commitments and Contingencies

 

Legal Proceedings 

 

The Company may be subject to legal proceedings and claims arising from contracts or other matters from time to time in the ordinary course of business. Management is not aware of any pending or threatened litigation where the ultimate disposition or resolution could have a material adverse effect on its financial position, results of operations or liquidity.

 

Lease Commitments

 

In February 2012, the Company entered into an operating lease for its then corporate headquarters in Flagstaff, Arizona, which expired in December 2019. In December 2019, we extended the lease for only the manufacturing facilities located in Flagstaff, Arizona, occupying a total of 7,632 square feet of space. The lease for these manufacturing facilities expired in December 2020.

 

On November 16, 2016, we leased an additional 1,954 square feet of research and development space, also in Flagstaff. This lease expired on November 15, 2018 but was extended for an additional 24 months, through November 2020. A subsequent amendment to the lease allows for the Company to cancel the lease at any time through the lease term with 30 days’ notice. The Company provided a 30-day cancellation notice effective February 2020.

 

On December 1, 2019, we entered into a lease for our corporate headquarters in Phoenix, Arizona where we lease and occupy approximately 5,529 square feet of office space. This lease expires in November 2024.

 

On August 1, 2020, we entered into a lease for our manufacturing and research facility in Phoenix, Arizona where we occupy approximately 5,105 square feet of manufacturing and warehouse space. This lease expires on November 30, 2024.

 

We believe that our existing facilities are adequate and meet our current needs for business, manufacturing and research.

 

23

 

SENESTECH, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

 

Note 12 - Commitments and Contingencies – (continued)

 

Rent expense was $54 and $69 for the three months ended March 31, 2021 and 2020, respectively. The future minimum lease payments under non-cancellable operating lease and future minimum finance lease payments as of March 31, 2021 are follows:

 

Years Ending December 31,   Finance
Leases
    Operating
Lease
 
2021     43       142  
2022     28       194  
2023     -       198  
2024     -       186  
Total minimum lease payments   $ 71     $ 720  

 

    Finance
Leases
 
Less: amounts representing interest (ranging from 11.43% to 14.68%)   $ 5  
Present value of minimum lease payments     66  
Less: current installments under finance lease obligations     52  
Total long-term portion   $ 14  

 

Note 13 - Subsequent Events

 

[Share Issuances for Services 

 

On April 8, 2021, the Company issued 667 shares of common stock for service for restricted stock units that vested on that date.

 

On April 29, 2021, the Company net issued 20,284 shares of common stock for service for the net settlement of restricted stock units that vested on that date. The shares of common stock withheld were used to satisfy required withholding tax liability in connection with the vesting of shares.]

 

COVID-19

 

The travel and other restrictions that began in March 2020 in response to the COVID-19 global pandemic have resulted in a significant slowdown in our field studies and sales efforts. We were able to resume some projects by mid-year 2020, however, we still have delays on certain projects that might remain on hold until certain government restrictions are lifted. These continued delays have impacted our results of operations and could impact our results in future quarters. In addition, extended stay at home orders and other social distancing initiatives continue to severely limit our ability to communicate with current and potential commercial customers. The COVID-19 pandemic is also placing a significant budgetary burden on federal, state and local governments, which may impede or delay their ability to purchase our products.

 

The Company has evaluated subsequent events from the balance sheet date through May 14, 2021, the date at which the financial statements were issued, and determined that there were no other items that require adjustment to or disclosure in the financial statements. 

 

24

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

As used in this Quarterly Report on Form 10-Q, “SenesTech,” the “Company,” “we,” “us,” or “our” refer to SenesTech, Inc., a Delaware corporation.  

 

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with our condensed financial statements and related notes.

 

Forward-Looking Statements

 

Some statements and information contained in this Management’s Discussion and Analysis of Financial Condition and Results of Operations, notes to our condensed financial statements and elsewhere in this report are not historical facts but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and within the meaning of the safe-harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can often be identified by words such as: “expect,” “believe,” “estimate,” “plan,” “strategy,” “future,” “potential,” “continue,” “may,” “should,” “will,” and similar references to future periods. Examples include, among others, statements about:

 

The impacts and implications of the COVID-19 pandemic;
   
Our commercialization and promotion strategy and plans, including key elements to our business strategy, how we commercialize, our sales approach, the tools we use, our hiring and retention strategy; our areas and markets of focus, our pricing strategy, our strategic relationships and which geographic markets we target;
   
The success and effectiveness of our products;
   
Our seeking, obtaining or maintaining regulatory approvals for our product candidates;
   
Our expectations regarding the potential market size for our products and how the market may develop;
   
  Our estimates or expectations related to our revenue, cash flow, expenses, operating results, capital requirements and need for additional financing;
     
  Our ability, and the time required, to improve our cost structure and gross margins, and limit our cash burn;
     
  Our plans for our business, including for research and development;
     
  Our ability to enter into strategic arrangements and to achieve the expected results from such arrangements;
     
  The adequacy of our facilities to meet our current needs;
     
  The initiation, timing, progress and results of field studies and other studies and trials and our research and development programs;
     
  Our financial performance, including our ability to fund operations;
     
  Developments and projections relating to our projects, competitors and our industry, including legislative developments and impacts from those developments.

 

These forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and situations that are difficult to predict and that may cause our own, or our industry’s, actual results to be materially different from the future results that are expressed or implied by these statements. Accordingly, actual results may differ materially from those anticipated or expressed in such statements as a result of a variety of factors, including those discussed in Item 1A-“Risk Factors” of Part I of our Annual Report on Form 10-K, for the year ended December 31, 2020, filed with the SEC on March 29, 2021, and Item 1A of Part II of this Form 10-Q, in each case entitled “Risk Factors,” and those contained from time to time in our other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

 

25

 

Overview

 

Since our inception, we have sustained significant operating losses in the course of our research and development activities and commercialization efforts and expect such losses to continue for the near future. We have generated limited revenue to date from product sales, research grants and licensing fees received under a former license. We have primarily funded our operations to date through the sale of equity securities, including convertible preferred stock, common stock and warrants to purchase common stock; and debt financing, consisting primarily of convertible notes. 

 

Through March 31, 2021, we have received net proceeds of $89.3 million from our sales of common stock, preferred stock and warrant exercises and issuance of convertible and other promissory notes, an aggregate of $1.7 million from licensing fees and an aggregate of $1.0 million in net product sales. As of March 31, 2021, we had an accumulated deficit of $106.1 million and cash and cash equivalents of $15.2 million.

 

On April 15, 2020, the Company also received cash proceeds of $645,700 from the Paycheck Protection Program (or “PPP”) of the Coronavirus Aid, Relief, and Economic Security Act. We used the proceeds from the PPP Loan to retain employees, maintain payroll and make lease, interest and utility payments.

 

We have incurred significant operating losses every year since our inception. Our net losses were $1.8 million and $2.7 million for the three months ended March 31, 2021 and 2020, respectively. We expect to continue to incur significant expenses and generate operating losses for at least the next 12 months.

 

We will need additional funding in order to continue to fund our operations and achieve profitability and become cash flow positive and will continue to seek additional financing. If such equity or debt financing is not available at adequate levels or on acceptable terms, we may need to delay, limit or terminate commercialization and development efforts or discontinue operations.

 

While it is difficult to measure the effect and impact of the COVID-19 pandemic on revenue during the three months ended March 31, 2021, the travel and other restrictions that started in March 2020 resulted in a significant slowdown in our proof-of-concept field studies and sales efforts. While we were able to resume field studies in some important projects by mid-year 2020 and initially believed that we would re-start all our most significant field studies as we obtained limited waivers of certain travel bans, we still have delays on certain projects that might remain on hold until further lifting of government restrictions. These continued delays could impact our results in future quarters. Initially, we believed that pest control would continue through the pandemic as a necessity and we were and have been able to maintain our manufacturing with cautionary, best practices put in place. However, we have concerns about distributor, pest control operator and individual consumer spending as restrictive measures related to the pandemic continue. Extended stay at home orders across the world have impeded our ability to communicate with current and prospective customers, potentially reducing sales until the orders are lifted. In addition, federal, state and municipal budgets continue to be severely strained as a result of the pandemic. This may delay or impede their ability to make near term purchases of our products. While we have stocked certain long lead time inventory raw material ingredients, any prolonged impact on the suppliers we rely on for the purchase of these items by the COVID-19 pandemic could impact future manufacturing operations.

 

Components of our Results of Operations

 

Sales

 

Sales are comprised primarily of sales, net of discounts and promotions, of ContraPest and related components, to our distributors and customers, as well as consulting and implementation services provided in conjunction with ContraPest deployments. 

 

Cost of Sales

 

Cost of sales consist primarily of cost of products sold, including scrap and reserves for obsolescence. We continue to focus on improving our cost structure, with the goals of shifting resources to commercialization, significantly reducing our year-over-year burn rate and achieving a 50% or greater gross margin. Steps have included relocating to more cost-efficient space, organizational restructuring, and improving our manufacturing and supply processes and reducing staffing. We expect to realize the benefits from these steps in the coming quarters.

 

26

 

Operating Expenses

 

Research and Development Expenses

 

Research and development expenses consist primarily of costs incurred in connection with the research and development of ContraPest and our other product candidates, which costs include:

 

  Employee related expenses, including salaries, related benefits, travel and stock-based compensation expense for employees engaged in research and development functions;
     
  Expenses incurred in connection with the development of our product candidates; and
     
  Facilities, depreciation and other expenses, which include direct and allocated expenses for rent and maintenance of facilities, insurance and supplies.

 

We expense research and development costs as incurred.

 

We continue to investigate other applications of our core technology to other product candidates, which includes laboratory tests and academic collaborations. We also continue to develop our supply chain, particularly identifying and improving our sourcing of triptolide, a key active ingredient for our product candidates. At this time, we cannot reasonably estimate the costs for further development of ContraPest or the cost associated with the development of any of our other product candidates.

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses consist primarily of salaries and related costs, including stock-based compensation, for personnel in executive, finance, sales, marketing and administrative functions. Selling, general and administrative expenses also include direct and allocated facility-related costs as well as professional fees for legal, consulting, accounting and audit services.

 

We plan to continue to utilize various forms of stock-based compensation awards in order to attract and retain qualified employees. As a result, we anticipate that stock-based compensation expense will continue to represent a significant portion of our selling, general and administrative expenses for the foreseeable future.

 

Interest Income

 

Interest income consists primarily of interest income earned on cash and cash equivalents.

 

Interest Expense

 

Interest expense consists primarily of interest accrued on our finance lease and note commitments.

 

Other Income (Expense), Net

 

Other income (expense), net, consists primarily of any recognized gains or losses related to the sale of fixed assets. In 2021, other income also included the reversal of a payroll benefits accrual from 2019 that was reversed as the liability period had expired.

 

Income Taxes

 

Deferred tax assets and liabilities are determined based on differences between the financial statement and tax basis of assets and liabilities, as well as a consideration of net operating loss and credit carry forwards, using enacted tax rates in effect for the period in which the differences are expected to impact taxable income. A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount that is more likely than not to be realized. The Company’s effective tax rate for the three months ended March 31, 2021, as well as for the year ended December 31, 2020, has been impacted by the full valuation allowance on the Company’s deferred tax assets.

 

27

 

Since our inception, we have not recorded any U.S. federal or state income tax benefits for the net operating losses we have incurred in each year in our history or for our generated research and development tax credits, due to the uncertainty regarding our ability to realize a benefit from these tax attributes. At March 31, 2021, the Company has federal and state net operating loss carryforwards of approximately $69.5 million and $56.1 million, respectively, not considering any potential IRC Section 382 annual limitation discussed below. The federal loss carryforwards begin to expire in 2032, unless previously utilized. Included in the $69.5 million of federal loss carryforwards are approximately $25.1 million of net operating losses that do not expire due to the tax law changes promulgated in conjunction with the Tax Cuts and Jobs Act of 2017.

 

Additionally, the utilization of the net operating loss carryforwards are subject to an annual limitation under Section 382 and 383 of the Internal Revenue Code od 1986, and similar state tax provisions due to ownership change limitations that have occurred previously or that could occur in the future. These ownership changes limit the amount of net operating loss carryforwards and other deferred tax assets that can be utilized to offset future taxable income and tax, respectively. In general, an ownership change, as defined by Section 382 and 383 results from transactions increasing ownership of certain stockholders or public groups in the stock of the corporation by more than 50 percent points over a three-year period. The Company has not conducted an analysis of an ownership change under section 382. To the extent that a study is completed and an ownership change is deemed to occur, the Company’s net operating losses could be limited.

 

Comparison of the Three Months Ended March 31, 2021 and 2020

 

The following table summarizes our results of operations for the three months ended March 31, 2021 and 2020:

 

   For the Three Months 
   Ended March 31, 
   2021   2020 
         
Revenue:        
Sales  $88   $37 
Cost of sales   50    22 
Gross profit   38    15 
           
Operating expenses:          
Research and development   455    296 
Selling, general and administrative   1,422    2,045 
Total operating expenses   1,877    2,341 
           
Net operating loss   (1,839)   (2,326)
           
Other income (expense):          
Interest income   2    2 
Interest expense   (5)   (8)
Other income   21    15 
Total other income   18    9 
           
Net loss and comprehensive loss   (1,821)   (2,317)
Deemed dividend-warrant price protection-revaluation adjustment   -    414 
Net loss attributable to common shareholders  $(1,821)  $(2,731)
           
Weighted average common shares outstanding - basic and fully diluted   8,137,038    1,611,304 
           
Net loss per common share - basic and fully diluted  $(0.22)  $(1.69)

 

28

 

Sales

 

Sales, shown net of sales discounts and promotions, were $88,000 for the three months ended March 31, 2021, compared to $37,000 for the same period in 2020. Sales increased by $51,000 in the first three months of 2021 due, in part, to our implementation of an internet sales capability, augmenting our existing pull through sales strategy, where demand from the consumer market encourages, or pulls, resellers and pest management professionals to offer our products, as well as billings of $4,000 for customer product implementation services. These initiatives have shown initial promise. However, we believe the benefit has been offset by reduced sales, reflecting continued reduced spending by customers due to the COVID-19 pandemic.

 

Cost of Sales

 

Cost of sales was $50,000 or 56.8% of net sales for the three months ended March 31, 2021, compared to $22,000 or 59.5% of net sales for the three months ended March 31, 2020. The increase in cost of goods sold of $28,000 in 2021 is primarily due to higher sales volume. The decrease in cost of sales as a percentage of net sales was primarily due to the impact of customer product implementation billings. We continue to focus on manufacturing process improvement and efficiencies. We anticipate cost of goods sold as a percentage of sales will improve in the future due to manufacturing efficiencies as a result of scale-up activities.

 

Gross Profit

 

Gross profit for the three months ended March 31, 2021 was $38,000 or 43.2% of net sales, compared to a gross profit of $15,000 or 40.5% of net sales, for the same period in 2020. The increase in gross profit was a direct result of the impact of customer product implementation billings.

 

Research and Development Expenses

 

   Three Months Ended
March 31,
   Increase 
   2021   2020   (Decrease) 
   (in thousands) 
Direct research and development expenses:            
Personnel related (including stock-based compensation)  $232   $137   $95 
Facility-related   20    42    (22)
Other   203    117    86 
Total research and development expenses  $455   $296   $159 

 

Research and development expenses were $455,000 for the three months ended March 31, 2021, compared to $296,000 for the same period in 2020. The $159,000 increase in research and development expenses was primarily due to an increase of $95,000 in personnel-related costs, including stock-based compensation expense, due to an increase in manufacturing and regulatory headcount to meet current and future demand.

 

Facility-related expenses decreased $22,000 due primarily to the expiration of a facility lease of 7,632 square feet of manufacturing space in Flagstaff, Arizona at December 31, 2020.

 

The increase in other research and development expenses of $86,000 in the three months ended March 31, 2021 compared to the same period in 2020 was primarily due to increased expenses related to field and product improvement studies as well as increased annual EPA and state registrations. We also continue to develop our supply chain, particularly identifying and improving our sourcing of key ingredients for our product candidates.

 

29

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses were approximately $1.4 million for the three months ended March 31, 2021, as compared to approximately $2.0 million for the three months ended March 31, 2020. The decrease of $600,000 in selling, general and administrative expenses was primarily due to a decrease of $142,000 in net salary costs, a decrease of $28,000 in travel expenses, a $350,000 decrease in professional service fees, a $71,000 decrease in transfer agent fees and a $29,000 decrease in marketing expenses. The decrease in net salary costs of $142,000 was due primarily to a decrease in administration headcount in March 2020 to control expenses. The decrease in professional services expenses was primarily due to reduced legal expenses related to a litigation settlement incurred in the three months ended March 31, 2020 that were not incurred in the same period of 2021. The decrease in travel expenses was a direct result of COVID-19 travel restrictions put in place at the end of March 2020. Likewise, the pandemic continued to restrict access to trade shows and other marketing activities in the three months ended March 31, 2021, resulting in lower marketing expenses than the same period in 2020. The $71,000 decrease in transfer agent fees in the three months ended March 31, 2021 over the same period of 2020 was due to expenses related to a 20 for 1 reverse stock split effected by the Company in February 2020.

 

Interest Income/Expense, Net

 

We recorded interest expense, net of $3,000 for the three months ended March 31, 2020, as compared to interest expense, net of $6 for the same period in 2020. The $3,000 decrease in interest expense, net for the period was a result of decreased interest expense on certain notes payable and finance leases that expired after March 31, 2020.

 

Other Income (Expense)

 

Other income, net, was $21,000 for the three months ended March 31, 2021 as compared to $15,000 for the period ended March 31, 2020.  The $21,000 of other income, net for the three months ended March 31, 2021 represented a payroll benefits accrual from 2019 that was reversed as the liability period had expired. The $15,000 other income, net for the period ended March 31, 2020 represented recognized gains on the sale of fixed assets during the period.

 

Liquidity and Capital Resources

 

Since our inception, we have sustained significant operating losses in the course of our research and development activities and commercialization efforts and expect such losses to continue for the near future. We have generated limited revenue to date from product sales, research grants and licensing fees received under a former license. We have primarily funded our operations to date through the sale of equity securities, including convertible preferred stock, common stock and warrants to purchase common stock; and debt financing, consisting primarily of convertible notes. 

 

Through March 31, 2021, we have received net proceeds of $89.3 million from our sales of common stock, preferred stock and warrant exercises and issuance of convertible and other promissory notes, an aggregate of $1.7 million from licensing fees and an aggregate of $1.0 million in net product sales. As of March 31, 2021, we had an accumulated deficit of $106.1 million and cash and cash equivalents of $15.2 million.

 

As discussed in Note 8 - Borrowings, of our Notes to Condensed Financial Statements, on April 15, 2020, the Company also received cash proceeds of $645,700 from the PPP of the Coronavirus Aid, Relief, and Economic Security Act. We used the proceeds from the PPP Loan to retain employees, maintain payroll and make lease, interest and utility payments.

 

Our ultimate success depends upon the outcome of a combination of factors, including: (i) successful commercialization of ContraPest and maintaining and obtaining regulatory approval of our products and product candidates; (ii) market acceptance, commercial viability and profitability of ContraPest and other products; (iii) the ability to market our products and establish an effective sales force and marketing infrastructure to generate significant revenue; (iv) the success of our research and development; (v) the ability to retain and attract key personnel to develop, operate and grow our business; and (vi) our ability to meet our working capital needs.

 

30

 

Based upon our current operating plan, we expect that cash and cash equivalents at March 31, 2021, in combination with anticipated revenue and any additional sales of our equity securities, will be sufficient to fund our current operations for at least the next 12 months. We have evaluated and will continue to evaluate our operating expenses and will concentrate our resources toward the successful commercialization of ContraPest in the United States. However, if anticipated revenue targets and margin targets are not achieved or expenses are more than we have budgeted, we may need to raise additional financing before that time. If we need more financing and we are unable to raise necessary capital through the sale of our securities, we may be required to take other measures that could impair our ability to be successful and operate as a going concern. In any event, we may require additional capital in order to fund our operating losses and research and development activities before we become profitable and may opportunistically raise capital. We may never achieve profitability or generate positive cash flows, and unless and until we do, we will continue to need to raise capital through equity or debt financing. If such equity or debt financing is not available at adequate levels or on acceptable terms, we may need to delay, limit or terminate commercialization and development efforts or discontinue operations.

 

Additional Funding Requirements

 

We expect our expenses to continue or increase in connection with our ongoing activities, particularly as we focus on marketing and sales of ContraPest. Further, the COVID-19 pandemic will likely delay completion of field studies and achievement of sales, which will further increase our need for financing. In addition, we will continue to incur costs associated with operating as a public company.

 

In particular, we expect to incur substantial and increased expenses as we:

 

  Work to maximize market acceptance for, and generate sales of, our products;
     
  Manage the infrastructure for the sales, marketing and distribution of ContraPest and any other product candidates for which we may receive regulatory approval;
     
  Continue the development of ContraPest and our other product candidates, including engaging in any necessary field studies;
     
  Seek additional regulatory approvals for ContraPest and our other product candidates;
     
  Scale up manufacturing processes and quantities to meet future demand of ContraPest and any other product candidates for which we receive regulatory approval;
     
  Continue product development of ContraPest and advance our research and development activities and advance the research and development programs for other product candidates;
     
  Maintain, expand and protect our intellectual property portfolio;
     
  Add operational, financial and management information systems and personnel, including personnel to support our product development and commercialization efforts and operations as a public company; and
     
  Expand regulatory approvals for ContraPest, with an effort to make the product more user friendly and available for use in an increased number of applications.

 

We believe we will need additional financing to fund these continuing and additional expenses.

 

31

 

Cash Flows

 

The following table summarizes our sources and uses of cash for each of the periods presented:

 

   Three Months Ended
March  31,
 
   2021   2020 
Cash used in operating activities  $(2,015)  $(1,871)
Cash (used in) provided by investing activities   (63)   40 
Cash provided by financing activities   13,600    1,387 
Net increase (decrease) in cash and cash equivalents  $11,522   $(444)

 

Operating Activities.

 

During the three months ended March 31, 2021, operating activities used $2.0 million of cash, primarily resulting from our net loss of $1.8 million and by changes in our operating assets and liabilities of $424,000, offset by non-cash charges of $228,000, consisting primarily of stock-based compensation, depreciation and amortization. Our net loss was primarily attributable to research and development activities and our selling, general and administrative expenses, as we generated limited product revenue during the period. Net cash used by changes in our operating assets and liabilities for the three months ended March 31, 2021 of $424,000 consisted primarily of a net decrease in accrued expenses and accounts payable of $283,000, an increase in prepaid expenses of $182,000 and an increase in accounts receivable of 2,000, offset by a decrease in inventory of $40,000 and a decrease in other assets of $3,000.

 

During the three months ended March 31, 2020, operating activities used $1.9 million of cash, primarily resulting from our net loss of $2.3 million offset by changes in our operating assets and liabilities of $233,000 and by non-cash charges of $213,000, consisting primarily of stock-based compensation, depreciation and gains recognized on sale of equipment. Our net loss was primarily attributable to research and development activities and our selling, general and administrative expenses, as we generated limited product revenue during the period. Net cash used by changes in our operating assets and liabilities for the three months ended March 31, 2020 consisted primarily of a net increase in prepaid expenses of $40,000 offset by a net decrease in accrued expenses and accounts payable of $119,000, a decrease in accounts receivable-trade and accounts receivable-other of $127,000, a decrease in other assets of $9,000 and a decrease in inventory of $18,000.

 

Investing Activities.

 

For the three months ended March 31, 2021, net cash used in investing activities was $63,000 due to the purchases of property, plant and equipment and construction in progress.

 

For the three months ended March 31, 2020, we generated $40,000 in net cash related to investing activities as a result of sales of fixed assets.

 

Financing Activities.

 

During the three months ended March 31, 2021, net cash provided by financing activities was $13.6 million as a result of $12.4 million in net proceeds from the issuance of common stock and net proceeds of $1.2 million from the exercise of warrants, offset by $17,000 of repayments related to notes payable and $13,000 in repayments of finance lease obligations.

 

During the three months ended March 31, 2020, net cash provided by financing activities was $1.4 million as a result of proceeds received from the issuance of common stock of $1.4 million offset by $34,000 related to payments of finance lease obligations and 14,000 of payments of notes payable.

 

32

 

Off-Balance Sheet Arrangements

 

None.

 

Critical Accounting Policies and Significant Judgments and Estimates

 

Our financial statements are prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP. The preparation of our financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and the disclosure of contingent assets and liabilities in our financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.

 

While our significant accounting policies are described in more detail in Note 2 to our financial statements included elsewhere in this Quarterly Report on Form 10-Q, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our financial statements.

 

Revenue Recognition

 

Effective January 1, 2018, the Company adopted Accounting Standards Codification (“ASC”) 606 — Revenue from Contracts with Customers (“ASC 606”). Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition (“ASC 605”). Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of the fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The performance obligations identified by the Company under ASC 606 are straightforward and similar to the unit of account and performance obligation determination under ASC Topic 605, Revenue Recognition.

 

The Company recognizes revenue when product is shipped at a fixed selling price on payment terms of 30 to 120 days from invoicing. The Company recognizes other revenue earned from pilot studies, consulting and implementation services upon the performance of specific services under the respective service contract.

 

The Company derives revenue primarily from commercial sales of products, net of discounts and promotions, as well as consulting and implementation services provided in conjunction with our product deployments.

 

Stock-Based Compensation

 

We recognize compensation costs related to stock options granted to employees based on the estimated fair value of the awards on the date of grant, net of estimated forfeitures, in accordance with ASC Topic 718 — Stock Compensation. We estimate the grant date fair value of the awards, and the resulting stock-based compensation expense, using the Black-Scholes option-pricing model. The grant date fair value of stock-based awards is expensed on a straight-line basis over the vesting period of the respective award.

 

We recorded stock-based compensation expense of approximately $155,000 and $151,000 for the three months ended March 31, 2021 and March 31, 2020, respectively. We expect to continue to grant stock options and other equity-based awards in the future and continue to recognize stock-based compensation expense in future periods.

 

33

 

The Black-Scholes option-pricing model requires the use of highly subjective and complex assumptions, which determine the fair value of stock-based awards. If we had made different assumptions, our stock-based compensation expense, net loss and loss per share of common stock could have been significantly different. Our assumptions are as follows:

 

  Expected term. The expected term represents the period that the stock-based awards are expected to be outstanding. Our historical share option exercise experience does not provide a reasonable basis upon which to estimate an expected term because of a lack of sufficient data. Therefore, we estimate the expected term by using the simplified method, which calculates the expected term as the average of the time-to-vesting and the contractual life of the options.
     
  Expected volatility. Expected volatility is derived from the average historical volatilities of publicly traded companies within our industry that we consider to be comparable to our business over a period approximately equal to the expected term. We intend to continue to consistently apply this process using the same or similar public companies unless circumstances change such that the identified companies are no longer similar to us, in which case, more suitable companies whose share prices are publicly available would be utilized in the calculation.
     
  Risk-free interest rate. The risk-free interest rate is based on the U.S. Treasury yield in effect at the time of grant for zero coupon U.S. Treasury notes with maturities approximately equal to the expected term.
     
  Expected dividend. The expected dividend is assumed to be zero as we have never paid dividends and have no current plans to pay any dividends on our common stock.
     
  Expected forfeitures. We use historical data to estimate pre-vesting option forfeitures and record stock-based compensation expense only for those awards that are expected to vest. To the extent actual forfeitures differ from the estimates, the difference will be recorded as a cumulative adjustment in the period that the estimates are revised.

 

Significant Factors, Assumptions and Methodologies Used in Determining Fair Value of Our Common Stock

 

As noted above, we are required to estimate the fair value of the common stock underlying our stock-based awards when performing the fair value calculations using the Black-Scholes option-pricing model. In the absence of an active market for our common stock, we utilized methodologies in accordance with the framework of the American Institute of Certified Public Accountants’ Technical Practice Aid, Valuation of Privately-Held Company Equity Securities Issued as Compensation, to estimate the fair value of our common stock. In addition, we have conducted periodic assessments of the valuation of our common stock.

 

The assumptions underlying these valuations represent management’s best estimates, which involve inherent uncertainties and the application of management’s judgment. If we had made different assumptions than those used, the amount of our stock-based compensation expense, net income and net income per share amounts could have been significantly different. The fair value per share of our common stock for purposes of determining stock-based compensation expense is the closing price of our common stock as reported on the applicable grant date. The compensation cost that has been included in the statements of operations and comprehensive loss for all stock-based compensation arrangements is as follows:

 

   Three Months Ended
March 31,
 
   2021   2020 
Research and development  $2   $3 
Selling, general and administrative   153    148 
Total stock-based compensation expense  $155   $151 

 

The intrinsic value of stock options outstanding as of March 31, 2021 was $0.

 

34

 

Emerging Growth Company Status

 

The Jumpstart Our Business Startups Act of 2012, or the JOBS Act, permits an “emerging growth company” such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies. We have irrevocably elected to “opt out” of this provision and, as a result, we intend to comply with new or revised accounting standards when they are required to be adopted by public companies that are not emerging growth companies. 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Not applicable.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

We conducted an evaluation (pursuant to Rule 13a-15(b) of the Exchange Act), under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e)) as of the end of the period covered by this report.

 

These disclosure controls and procedures are designed to ensure that information required to be disclosed in our reports that are filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Our disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that this information is accumulated and communicated to management, including the principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

 

Based on the evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures were effective as of the end of the period covered by this report.

 

Changes in Internal Control over Financial Reporting

 

There was no change in our internal control over financial reporting that occurred during the quarter ended March 31, 2021, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

35

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

For information regarding legal proceedings in which we are involved, see Note 12 - Commitments and Contingencies under the subsection titled “Legal Proceedings” in our Notes to Condensed Financial Statements in Part I, Item 1 of this Quarterly Report on Form 10-Q.

 

Item 1A. Risk Factors

 

There have been no material changes in the risk factors set forth in Part I, Item 1A, “Risk Factors” in our 2020 Annual Report.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None.

 

36

 

Item 6. Exhibits

 

INDEX TO EXHIBITS

 

Exhibit
Number
      Filed or
Furnished
Herewith
     
Incorporated by Reference
  Description     Form   Filing Date   Exhibit   File No.
3.1   Amended and Restated Certificate of Incorporation, as amended by the Certificate of Amendment to the Amended and Restated Certificate of Incorporation       10-K   3/29/2021   3.1   001-37941
                         
3.2   Amended and Restated Bylaws       S-1   9/21/2016   3.5   333-213736
                         
4.1   Form of Pre-Funded Warrant       8-K   2/2/2021   4.1   001-37941
                         
4.2   Form of Warrant       8-K   2/2/2021   4.2   001-37941
                         
4.3   Form of Placement Agent Warrant       8-K   2/2/2021   4.3   001-37941
                         
4.4   Form of Placement Agent Warrant       8-K   3/23/2021   4.1   001-37941
                         
10.1   Form of Securities Purchase Agreement, dated as of January 27, 2021       8-K   2/2/2021   10.1   001-37941
                         
10.2   Form of Registration Rights Agreement, dated as of January 27, 2021        8-K   2/2/2021   10.2   001-37941
                         
10.3   Form of Securities Purchase Agreement, dated as of March 19, 2021, between the Company and the purchasers thereto       8-K   3/23/2021   10.1   001-37941
                         
31.1   Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934   X                
                         
31.2   Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934   X                
                         
32.1   Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002   X                
                         
32.2   Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002   X                
                         
101.INS   XBRL Instance Document   X                
                         
101.SCH   XBRL Taxonomy Extension Schema   X                
                         
101.CAL   XBRL Taxonomy Extension Calculation Linkbase   X                
                         
101.DEF   XBRL Taxonomy Extension Definition Linkbase   X                
                         
101.LAB   XBRL Taxonomy Extension Label Linkbase   X                
                         
101.PRE   XBRL Taxonomy Extension Presentation Linkbase   X                
                         
   
+ Indicates a management contract or compensatory plan.

 

37

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  SENESTECH, INC.
(Registrant)
     
Dated: May 14, 2021 By: /s/ Kenneth Siegel
    Kenneth Siegel
    Chief Executive Officer
     
Dated: May 14, 2021 By: /s/ Thomas C. Chesterman
    Thomas C. Chesterman
    Chief Financial Officer and Treasurer

 

38
EX-31.1 2 f10q0321ex31-1_senestech.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 

RULE 13(a)-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

I, Kenneth Siegel, certify that: 

 

1. I have reviewed this Quarterly Report on Form 10-Q of SenesTech, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: May 14, 2021 /s/ Kenneth Siegel
  Kenneth Siegel
  Chief Executive Officer  

 

EX-31.2 3 f10q0321ex31-2_senestech.htm CERTIFICATION

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 

RULE 13(a)-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

I, Thomas C. Chesterman, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of SenesTech, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: May 14, 2021 /s/ Thomas C. Chesterman
  Thomas C. Chesterman
  Chief Financial Officer and Treasurer

 

EX-32.1 4 f10q0321ex32-1_senestech.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350

 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Kenneth Siegel, Chief Executive Officer of SenesTech, Inc., certify that:

 

1. To my knowledge, this report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. To my knowledge, the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of SenesTech, Inc.

 

Dated: May 14, 2021 /s/Kenneth Siegel
  Kenneth Siegel
  Chief Executive Officer
EX-32.2 5 f10q0321ex32-2_senestech.htm CERTIFICATION

Exhibit 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350

 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Thomas C. Chesterman, Chief Financial Officer and Treasurer of SenesTech, Inc., certify that:

 

1. To my knowledge, this report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. To my knowledge, the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of SenesTech, Inc.

 

Dated: May 14, 2021 /s/ Thomas C. Chesterman
  Thomas C. Chesterman
  Chief Financial Officer and Treasurer

 

 

EX-101.INS 6 snes-20210331.xml XBRL INSTANCE FILE 0001680378 2021-01-01 2021-03-31 0001680378 2021-05-14 0001680378 2021-03-31 0001680378 2020-12-31 0001680378 2020-01-01 2020-03-31 0001680378 us-gaap:CommonStockMember 2019-12-31 0001680378 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001680378 us-gaap:RetainedEarningsMember 2019-12-31 0001680378 2019-12-31 0001680378 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001680378 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001680378 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001680378 us-gaap:CommonStockMember 2020-03-31 0001680378 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001680378 us-gaap:RetainedEarningsMember 2020-03-31 0001680378 2020-03-31 0001680378 us-gaap:CommonStockMember 2020-12-31 0001680378 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001680378 us-gaap:RetainedEarningsMember 2020-12-31 0001680378 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001680378 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001680378 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001680378 us-gaap:CommonStockMember 2021-03-31 0001680378 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001680378 us-gaap:RetainedEarningsMember 2021-03-31 0001680378 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-03-31 0001680378 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-03-31 0001680378 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-03-31 0001680378 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0001680378 us-gaap:WarrantMember 2021-01-01 2021-03-31 0001680378 us-gaap:WarrantMember 2020-01-01 2020-03-31 0001680378 us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0001680378 us-gaap:RestrictedStockMember 2020-01-01 2020-03-31 0001680378 snes:CommonStockOptionsMember 2021-01-01 2021-03-31 0001680378 snes:CommonStockOptionsMember 2020-01-01 2020-03-31 0001680378 snes:ResearchAndDevelopmentEquipmentMember 2021-01-01 2021-03-31 0001680378 snes:ResearchAndDevelopmentEquipmentMember 2021-03-31 0001680378 snes:ResearchAndDevelopmentEquipmentMember 2020-12-31 0001680378 snes:OfficeAndComputerEquipmentMember 2021-01-01 2021-03-31 0001680378 snes:OfficeAndComputerEquipmentMember 2021-03-31 0001680378 snes:OfficeAndComputerEquipmentMember 2020-12-31 0001680378 snes:AutosTrucksMember 2021-01-01 2021-03-31 0001680378 snes:AutosTrucksMember 2021-03-31 0001680378 snes:AutosTrucksMember 2020-12-31 0001680378 us-gaap:FurnitureAndFixturesMember 2021-01-01 2021-03-31 0001680378 us-gaap:FurnitureAndFixturesMember 2021-03-31 0001680378 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001680378 us-gaap:LeaseholdImprovementsMember 2021-01-01 2021-03-31 0001680378 us-gaap:LeaseholdImprovementsMember 2021-03-31 0001680378 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001680378 us-gaap:ConstructionInProgressMember 2021-03-31 0001680378 us-gaap:ConstructionInProgressMember 2020-12-31 0001680378 srt:MinimumMember snes:FinanceLeaseObligationsMember 2021-03-31 0001680378 srt:MaximumMember snes:FinanceLeaseObligationsMember 2021-03-31 0001680378 snes:OtherPromissoryNotesMember 2021-01-01 2021-03-31 0001680378 srt:MinimumMember snes:OtherPromissoryNotesMember 2021-03-31 0001680378 srt:MaximumMember snes:OtherPromissoryNotesMember 2021-03-31 0001680378 snes:DealerManagerWarrants4Member 2017-11-01 2017-11-21 0001680378 snes:PublicOfferingMember 2017-11-21 0001680378 snes:DealerManagerWarrants4Member 2017-11-21 0001680378 snes:DealerManagerWarrants4Member 2018-08-13 0001680378 snes:CommonStockWarrantIssuedToUnderwriterOfCommonStockOfferingMember 2020-01-28 0001680378 snes:DealerManagerWarrants4Member 2020-01-28 0001680378 snes:DealerManagerWarrants4Member 2020-01-02 2020-01-28 0001680378 2020-01-02 2020-01-28 0001680378 snes:CommonStockWarrantIssuedToUnderwriterOfCommonStockOfferingMember 2020-03-01 2020-03-04 0001680378 snes:CommonStockWarrantIssuedToUnderwriterOfCommonStockOfferingMember 2020-03-04 0001680378 2020-03-01 2020-03-04 0001680378 snes:CommonStockWarrantIssuedToUnderwriterOfCommonStockOfferingMember 2020-10-01 2020-10-26 0001680378 snes:CommonStockWarrantIssuedToUnderwriterOfCommonStockOfferingMember 2020-10-26 0001680378 2020-10-01 2020-10-26 0001680378 snes:November2017WarrantsMember 2018-06-01 2018-06-20 0001680378 2018-06-20 0001680378 snes:DealerManagerWarrants4Member 2018-06-20 0001680378 snes:DealerManagerWarrants4Member 2018-06-01 2018-06-30 0001680378 snes:DealerManagerWarrants4Member 2018-06-30 0001680378 snes:NewWarrantsMember 2018-06-30 0001680378 snes:NewWarrantsMember 2018-06-01 2018-06-30 0001680378 snes:RightOfferingMember 2018-08-01 2018-08-13 0001680378 snes:RightOfferingMember 2018-08-13 0001680378 snes:CommonStockWarrantIssuedToUnderwriterOfCommonStockOfferingMember snes:HCWainwrightAndCoMember 2019-07-31 0001680378 2019-07-01 2019-07-31 0001680378 snes:CommonStockWarrantIssuedToUnderwriterOfCommonStockOfferingMember snes:HCWainwrightAndCoMember 2019-07-01 2019-07-31 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentIn2020RegisteredDirectOfferingsAndPrivatePlacementMember snes:HCWainwrightAndCoMember 2019-07-01 2019-07-31 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentIn2020RegisteredDirectOfferingsAndPrivatePlacementMember 2019-07-01 2019-07-31 0001680378 snes:CommonStockWarrantsIssuedInJanuaryAndMarchPrivatePlacementsMember 2020-01-01 2020-01-31 0001680378 snes:CommonStockWarrantsIssuedInJanuaryAndMarchPrivatePlacementsMember 2020-01-31 0001680378 snes:CommonStockWarrantsIssuedInJanuaryAndMarchPrivatePlacementsMember 2020-03-31 0001680378 snes:CommonStockWarrantsIssuedInJanuaryAndMarchPrivatePlacementsMember 2020-03-01 2020-03-31 0001680378 snes:CommonStockWarrantsIssuedInJanuaryAndMarchPrivatePlacementsMember 2021-01-01 2021-03-31 0001680378 snes:CommonStockWarrantsIssuedinApril2020PublicOfferingMember us-gaap:CommonClassAMember 2020-04-01 2020-04-24 0001680378 snes:CommonStockWarrantsIssuedinApril2020PublicOfferingMember us-gaap:CommonClassBMember 2020-04-01 2020-04-24 0001680378 snes:CommonStockWarrantsIssuedinApril2020PublicOfferingMember 2020-04-24 0001680378 snes:CommonStockWarrantsIssuedinApril2020PublicOfferingMember 2020-04-01 2020-04-24 0001680378 snes:CommonStockWarrantsIssuedinApril2020PublicOfferingMember 2021-01-01 2021-03-31 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentInOctober2020InducementOfferingMember 2021-01-01 2021-03-31 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentIn2020RegisteredDirectOfferingsAndPrivatePlacementMember 2020-01-01 2020-01-31 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentInOctober2020InducementOfferingMember 2020-01-01 2020-03-31 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentIn2020RegisteredDirectOfferingsAndPrivatePlacementMember us-gaap:CommonClassAMember 2020-04-01 2020-04-24 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentIn2020RegisteredDirectOfferingsAndPrivatePlacementMember us-gaap:CommonClassBMember 2020-04-01 2020-04-24 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentIn2020RegisteredDirectOfferingsAndPrivatePlacementMember snes:HCWainwrightAndCoMember 2020-04-24 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentIn2020RegisteredDirectOfferingsAndPrivatePlacementMember 2020-04-24 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentIn2020RegisteredDirectOfferingsAndPrivatePlacementMember 2021-01-01 2021-03-31 0001680378 snes:CommonStockWarrantsIssuedInOctober2020PrivateWarrantInducementMember 2020-10-01 2020-10-31 0001680378 snes:CommonStockWarrantsIssuedInOctober2020PrivateWarrantInducementMember 2020-10-31 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentInOctober2020InducementOfferingMember 2020-10-01 2020-10-31 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentInOctober2020InducementOfferingMember snes:HCWainwrightAndCoMember 2020-10-01 2020-10-31 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentInOctober2020InducementOfferingMember snes:HCWainwrightAndCoMember 2020-10-31 0001680378 snes:CommonStockWarrantIssuedToUnderwriterOfCommonStockOfferingMember 2020-10-01 2020-10-31 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentInOctober2020InducementOfferingMember 2020-10-31 0001680378 snes:CommonStockWarrantsIssuedInFebruaryTwoThousandTwentyOnePrivatePlacementAgreementMember 2021-02-01 2021-02-28 0001680378 snes:CommonStockWarrantsIssuedInFebruaryTwoThousandTwentyOnePrivatePlacementAgreementMember 2021-02-28 0001680378 snes:CommonStockWarrantsIssuedInFebruaryTwoThousandTwentyOnePrivatePlacementAgreementMember 2021-01-01 2021-03-31 0001680378 snes:CommonStockWarrantsIssuedInFebruaryTwoThousandTwentyOnePrivatePlacementAgreementMember 2021-03-31 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentInFebruaryTwoThousandTwentyOnePrivatePlacementAgreementMember snes:HCWainwrightCoLLCMember 2021-02-01 2021-02-28 0001680378 snes:CommonStockWarrantsIssuedInFebruaryTwoThousandTwentyOnePrivatePlacementAgreementMember snes:HCWainwrightCoLLCMember 2021-02-28 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentInFebruaryTwoThousandTwentyOnePrivatePlacementAgreementMember 2021-03-31 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentInFebruaryTwoThousandTwentyOnePrivatePlacementAgreementMember 2021-01-01 2021-03-31 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentInMarchTwoThousandTwentyOneRegisteredDirectOfferingMember 2021-03-01 2021-03-23 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentInMarchTwoThousandTwentyOneRegisteredDirectOfferingMember 2021-03-23 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentInMarchTwoThousandTwentyOneRegisteredDirectOfferingMember 2021-01-01 2021-03-31 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentInMarchTwoThousandTwentyOneRegisteredDirectOfferingMember 2021-03-31 0001680378 snes:DeemedDividendAdjustmentWarrantModifiedTermsRevaluationMember 2020-03-01 2020-03-03 0001680378 snes:DeemedDividendAdjustmentWarrantModifiedTermsRevaluationMember 2020-10-01 2020-10-26 0001680378 snes:CommonStockWarrantsIssuedToPlacementAgentInOctober2020InducementOfferingMember 2020-10-01 2020-10-26 0001680378 srt:MinimumMember snes:DeemedDividendAdjustmentWarrantModifiedTermsRevaluationMember 2020-10-01 2020-10-26 0001680378 srt:MaximumMember snes:DeemedDividendAdjustmentWarrantModifiedTermsRevaluationMember 2020-10-01 2020-10-26 0001680378 snes:VariousWarrantMember 2019-01-01 2019-12-31 0001680378 snes:VariousWarrantMember 2018-12-31 0001680378 snes:VariousWarrantMember 2020-01-01 2020-12-31 0001680378 snes:VariousWarrantMember 2021-01-01 2021-03-31 0001680378 snes:CommonStockOfferingWarrantsMember 2019-01-01 2019-12-31 0001680378 snes:CommonStockOfferingWarrantsMember 2018-12-31 0001680378 snes:CommonStockOfferingWarrantsMember 2020-01-01 2020-12-31 0001680378 snes:CommonStockOfferingWarrantsMember 2020-12-31 0001680378 snes:CommonStockOfferingWarrantsMember 2021-01-01 2021-03-31 0001680378 snes:CommonStockOfferingWarrantsMember 2021-03-31 0001680378 snes:DealerManagerWarrantsMember 2019-01-01 2019-12-31 0001680378 snes:DealerManagerWarrantsMember 2018-12-31 0001680378 snes:DealerManagerWarrantsMember 2020-01-01 2020-12-31 0001680378 snes:WarrantReissueMember 2019-01-01 2019-12-31 0001680378 snes:WarrantReissueMember 2018-12-31 0001680378 snes:WarrantReissueMember 2020-01-01 2020-12-31 0001680378 snes:WarrantReissueMember 2020-12-31 0001680378 snes:WarrantReissueMember 2021-01-01 2021-03-31 0001680378 snes:WarrantReissueMember 2021-03-31 0001680378 snes:RightsOfferingWarrantsMember 2019-01-01 2019-12-31 0001680378 snes:RightsOfferingWarrantsMember 2018-12-31 0001680378 snes:RightsOfferingWarrantsMember 2020-01-01 2020-12-31 0001680378 snes:RightsOfferingWarrantsMember 2020-12-31 0001680378 snes:RightsOfferingWarrantsMember 2021-01-01 2021-03-31 0001680378 snes:RightsOfferingWarrantsMember 2021-03-31 0001680378 snes:DealerManagerWarrantsOneMember 2019-01-01 2019-12-31 0001680378 snes:DealerManagerWarrantsOneMember 2018-12-31 0001680378 snes:DealerManagerWarrantsOneMember 2020-01-01 2020-12-31 0001680378 snes:DealerManagerWarrantsOneMember 2020-12-31 0001680378 snes:DealerManagerWarrantsOneMember 2021-01-01 2021-03-31 0001680378 snes:DealerManagerWarrantsOneMember 2021-03-31 0001680378 snes:DealerManagerWarrantsTwoMember 2019-01-01 2019-12-31 0001680378 snes:DealerManagerWarrantsTwoMember 2018-12-31 0001680378 snes:DealerManagerWarrantsTwoMember 2020-01-01 2020-12-31 0001680378 snes:DealerManagerWarrantsTwoMember 2020-12-31 0001680378 snes:DealerManagerWarrantsTwoMember 2021-01-01 2021-03-31 0001680378 snes:DealerManagerWarrantsTwoMember 2021-03-31 0001680378 snes:RegisteredDirectOfferingMember 2019-01-01 2019-12-31 0001680378 snes:RegisteredDirectOfferingMember 2018-12-31 0001680378 snes:RegisteredDirectOfferingMember 2020-01-01 2020-12-31 0001680378 snes:RegisteredDirectOfferingMember 2020-12-31 0001680378 snes:RegisteredDirectOfferingMember 2021-01-01 2021-03-31 0001680378 snes:RegisteredDirectOfferingMember 2021-03-31 0001680378 snes:DealerManagerWarrantsThreeMember 2019-01-01 2019-12-31 0001680378 snes:DealerManagerWarrantsThreeMember 2018-12-31 0001680378 snes:DealerManagerWarrantsThreeMember 2020-01-01 2020-12-31 0001680378 snes:DealerManagerWarrantsThreeMember 2020-12-31 0001680378 snes:DealerManagerWarrantsThreeMember 2021-01-01 2021-03-31 0001680378 snes:DealerManagerWarrantsThreeMember 2021-03-31 0001680378 snes:RegisteredDirectOfferingOneMember 2019-01-01 2019-12-31 0001680378 snes:RegisteredDirectOfferingOneMember 2018-12-31 0001680378 snes:RegisteredDirectOfferingOneMember 2020-01-01 2020-12-31 0001680378 snes:RegisteredDirectOfferingOneMember 2020-12-31 0001680378 snes:RegisteredDirectOfferingOneMember 2021-01-01 2021-03-31 0001680378 snes:RegisteredDirectOfferingOneMember 2021-03-31 0001680378 snes:DealerManagerWarrantsFourMember 2019-01-01 2019-12-31 0001680378 snes:DealerManagerWarrantsFourMember 2018-12-31 0001680378 snes:DealerManagerWarrantsFourMember 2020-01-01 2020-12-31 0001680378 snes:DealerManagerWarrantsFourMember 2020-12-31 0001680378 snes:DealerManagerWarrantsFourMember 2021-01-01 2021-03-31 0001680378 snes:DealerManagerWarrantsFourMember 2021-03-31 0001680378 snes:DealerManagerWarrantsFiveMember 2019-01-01 2019-12-31 0001680378 snes:DealerManagerWarrantsFiveMember 2018-12-31 0001680378 snes:DealerManagerWarrantsFiveMember 2020-01-01 2020-12-31 0001680378 snes:DealerManagerWarrantsFiveMember 2020-12-31 0001680378 snes:DealerManagerWarrantsFiveMember 2021-01-01 2021-03-31 0001680378 snes:DealerManagerWarrantsFiveMember 2021-03-31 0001680378 snes:RegisteredDirectOfferingTwoMember 2019-01-01 2019-12-31 0001680378 snes:RegisteredDirectOfferingTwoMember 2018-12-31 0001680378 snes:RegisteredDirectOfferingTwoMember 2020-01-01 2020-12-31 0001680378 snes:RegisteredDirectOfferingTwoMember 2020-12-31 0001680378 snes:RegisteredDirectOfferingTwoMember 2021-01-01 2021-03-31 0001680378 snes:RegisteredDirectOfferingTwoMember 2021-03-31 0001680378 snes:PrivateWarrantInducementMember 2019-01-01 2019-12-31 0001680378 snes:PrivateWarrantInducementMember 2018-12-31 0001680378 snes:PrivateWarrantInducementMember 2020-01-01 2020-12-31 0001680378 snes:PrivateWarrantInducementMember 2020-12-31 0001680378 snes:PrivateWarrantInducementMember 2021-01-01 2021-03-31 0001680378 snes:PrivateWarrantInducementMember 2021-03-31 0001680378 snes:DealerManagerWarrantsSixMember 2019-01-01 2019-12-31 0001680378 snes:DealerManagerWarrantsSixMember 2018-12-31 0001680378 snes:DealerManagerWarrantsSixMember 2020-01-01 2020-12-31 0001680378 snes:DealerManagerWarrantsSixMember 2020-12-31 0001680378 snes:DealerManagerWarrantsSixMember 2021-01-01 2021-03-31 0001680378 snes:DealerManagerWarrantsSixMember 2021-03-31 0001680378 snes:PrivatePlacementAgreementOneMember 2019-01-01 2019-12-31 0001680378 snes:PrivatePlacementAgreementOneMember 2018-12-31 0001680378 snes:PrivatePlacementAgreementOneMember 2020-01-01 2020-12-31 0001680378 snes:PrivatePlacementAgreementOneMember 2020-12-31 0001680378 snes:PrivatePlacementAgreementOneMember 2021-01-01 2021-03-31 0001680378 snes:PrivatePlacementAgreementOneMember 2021-03-31 0001680378 snes:DealerManagerWarrantsSevenMember 2019-01-01 2019-12-31 0001680378 snes:DealerManagerWarrantsSevenMember 2018-12-31 0001680378 snes:DealerManagerWarrantsSevenMember 2020-01-01 2020-12-31 0001680378 snes:DealerManagerWarrantsSevenMember 2020-12-31 0001680378 snes:DealerManagerWarrantsSevenMember 2021-01-01 2021-03-31 0001680378 snes:DealerManagerWarrantsSevenMember 2021-03-31 0001680378 snes:DealerManagerWarrantsEightMember 2019-01-01 2019-12-31 0001680378 snes:DealerManagerWarrantsEightMember 2018-12-31 0001680378 snes:DealerManagerWarrantsEightMember 2020-01-01 2020-12-31 0001680378 snes:DealerManagerWarrantsEightMember 2020-12-31 0001680378 snes:DealerManagerWarrantsEightMember 2021-01-01 2021-03-31 0001680378 snes:DealerManagerWarrantsEightMember 2021-03-31 0001680378 2018-12-31 0001680378 us-gaap:CommonStockMember 2015-11-10 0001680378 us-gaap:PreferredClassAMember 2015-11-10 0001680378 2015-12-31 0001680378 us-gaap:PreferredClassBMember 2015-12-31 0001680378 2015-11-01 2015-11-10 0001680378 us-gaap:CommonStockMember 2021-02-01 2021-02-28 0001680378 us-gaap:CommonStockMember 2020-03-01 2020-03-31 0001680378 us-gaap:PrivatePlacementMember 2021-02-02 0001680378 us-gaap:PrivatePlacementMember 2021-01-25 2021-02-02 0001680378 us-gaap:PrivatePlacementMember 2021-03-01 2021-03-29 0001680378 2021-03-01 2021-03-23 0001680378 snes:PlacementAgentWarrantsMember 2021-03-31 0001680378 2021-03-01 2021-03-19 0001680378 snes:EquityIncentivePlan2018Member 2018-06-12 0001680378 srt:MinimumMember 2018-06-12 0001680378 srt:MaximumMember 2018-06-12 0001680378 snes:EquityIncentivePlan2018Member 2018-06-01 2018-06-12 0001680378 snes:EquityIncentivePlan2018Member 2021-03-31 0001680378 us-gaap:RestrictedStockUnitsRSUMember 2021-03-31 0001680378 snes:EmployeeMember 2021-01-01 2021-03-31 0001680378 us-gaap:RestrictedStockMember 2020-12-31 0001680378 us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0001680378 us-gaap:RestrictedStockMember 2021-03-31 0001680378 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-03-31 0001680378 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-03-31 0001680378 snes:ResearchAndDevelopmentEquipmentMember 2016-11-16 0001680378 snes:ResearchAndDevelopmentEquipmentMember 2016-11-02 2016-11-16 0001680378 2019-11-15 2019-12-02 0001680378 2020-07-15 2020-08-01 0001680378 us-gaap:SubsequentEventMember 2021-04-08 0001680378 snes:InstitutionalInvestorsMember us-gaap:SubsequentEventMember 2021-04-01 2021-04-29 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure utr:sqft In the three months ended March 31, 2021, the Company received net proceeds of less than $1 in the sale of research and development equipment resulting in gains on the sale of these assets of less than $1. In the three months ended March 31, 2020, the Company received net proceeds of $40 in the sale of research and development equipment and office and computer equipment, resulting in a gain on the sale of these assets of $15. Shorter of lease term or estimated useful life The initial exercise price of these warrants was $30.00 per share. Pursuant to antidilution price adjustment protection contained within these warrants, the initial exercise price of these warrants was adjusted downward to $29.40 on July 24, 2018, the record date of the Right’s Offering and downward to $19.00 per share on August 13, 2018. These warrants were further adjusted downward from $19.00 to $7.13 and to $2.1122 on January 28, 2020 and March 4, 2020, respectively, in connection with separate Registered Direct Offerings. These warrants were further adjusted downward from $2.1122 to $1.3659 on October 26, 2020 in connection with a Registered Direct Offering. These warrants are subject to further adjustment pursuant to antidilution price adjustment protection. The aggregate intrinsic value in the table was calculated based on the difference between the estimated fair market value of the Company’s stock and the exercise price of the underlying options. The estimated stock values used in the calculation were $1.73 and $1.66 per share for the year ended December 31, 2020 and the three months ended March 31, 2021, respectively. DE false --12-31 Q1 2021 2021-03-31 10-Q 0001680378 Yes true true 001-37941 Non-accelerated Filer Yes SenesTech, Inc. false true 12184997 15165000 3643000 27000 25000 360000 178000 905000 945000 26000 28000 16483000 4819000 627000 665000 528000 538000 17638000 6022000 79000 98000 175000 404000 238000 292000 492000 794000 662000 673000 636000 671000 1790000 2138000 12000 5000 0.001 0.001 100000000 100000000 12164046 5099512 12164046 5099512 121897000 108119000 -106061000 -104240000 15848000 3884000 17638000 6022000 88000 37000 50000 22000 38000 15000 455000 296000 1422000 2045000 1877000 2341000 -1839000 -2326000 2000 2000 5000 8000 21000 15000 18000 9000 -1821000 -2317000 -414000 -1821000 -2731000 8137038 1611304 -0.22 -1.69 1414671 1000 98433000 -95867000 2567000 151000 151000 353872 1000 1707000 1708000 51414 238000 238000 -273000 -273000 24 414000 414000 -2731000 -2731000 1819981 2000 100670000 -98598000 2074000 5099512 5000 108119000 -104240000 155000 155000 6163854 6000 12586000 12592000 900680 1000 1208000 1209000 -171000 -171000 -1821000 -1821000 12164046 12000 121897000 -106061000 73000 77000 155000 151000 15000 2000 -4000 -123000 -5000 -9000 182000 40000 -40000 -18000 -229000 474000 -54000 -355000 -2015000 -1871000 40000 63000 -63000 40000 12421000 1435000 17000 14000 13000 34000 -1209000 13600000 1387000 11522000 -444000 1936000 1492000 5000 8000 238000 414000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1 - Organization and Description of Business</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SenesTech, Inc. (referred to in this report as &#x201c;SenesTech,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we&#x201d; or &#x201c;us&#x201d;) has developed and is commercializing a global, proprietary technology for managing animal pest populations, initially rat populations, through fertility control.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although there are myriad tools available to control rat populations, most rely on some form of lethal method to achieve effectiveness. Each of these solutions is inherently limited by rat species&#x2019; resilience and survival mechanisms as well as their extraordinary rate of reproduction. ContraPest&#xae;, our initial product, is unique in the pest control industry in attacking the reproductive systems of both male and female rats, which our field data shows results in a sustained reduction of the rat population.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rats have plagued humanity throughout history. They pose significant threats to the environment and to the health and food security of many communities. In addition, rodents cause extensive product loss and damage through consumption and contamination. Rats also cause significant damage to critical infrastructure by burrowing beneath foundations and gnawing on electrical wiring, insulation, fire proofing systems, electronics and computer equipment.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The most prevalent solution to rat infestations is the use of increasingly powerful rodenticides. Although these solutions provide short term results, there are growing concerns about secondary exposure and bioaccumulation of rodenticides in the environment, as well as concerns about rodenticides that have no antidotes. The pest management industry and Pest Management Professionals (&#x201c;PMPs&#x201d;) are being asked for new solutions that are both effective and less toxic. Our goal is to provide customers with not only a solution to combat their most difficult rat problems, but also offer an effective, non-lethal option to serve customers that are looking to decrease or remove the amount of rodenticide used in their pest control programs.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ContraPest is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (&#x201c;VCD&#x201d;) and triptolide. ContraPest limits reproduction of male and female rats beginning with the first breeding cycle following consumption. ContraPest is being marketed for use in controlling Norway and roof rat populations.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SenesTech began the registration process with the United States Environmental Protection Agency (the &#x201c;EPA&#x201d;) for ContraPest on August 23, 2015. On August 2, 2016, the EPA granted an unconditional registration for ContraPest as a Restricted Use Product (&#x201c;RUP&#x201d;), due to the need for applicator expertise for deployment. On October 18, 2018, the EPA approved the removal of the RUP designation. We believe ContraPest is the first and only non-lethal, fertility control product approved by the EPA for the management of rodent populations.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the EPA registration of ContraPest in the United States, ContraPest must obtain registration from the various state regulatory agencies prior to selling in each state. We have received registration for ContraPest in all 50 states and the District of Columbia, 48 of which have approved the removal of the RUP designation.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect to continue to pursue regulatory approvals and amendments to the existing U.S. registration for ContraPest to broaden the marketability and use of ContraPest, and if ContraPest begins to generate sufficient revenue, regulatory approvals for additional jurisdictions beyond the United States. In certain cases, our EPA and state registrations require completion of testing and certifications even though we have received approval for the product or its labelling. We continue to seek to comply with these requirements.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also continues to research and develop enhancements to ContraPest that align with our target verticals and other potential fertility control options for additional species.&#xa0;</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We were formed in July 2004 and incorporated in the state of Nevada. The Company subsequently reincorporated in the state of Delaware in November 2015. Our corporate headquarters and manufacturing site are in Phoenix, Arizona. On December 8, 2016, we went public and are currently traded on Nasdaq under the symbol SNES.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 4, 2020, we amended our amended and restated certificate of incorporation to effect a 1-for-20 reverse split of our issued and outstanding shares of our common stock. The accompanying condensed financial statements and notes thereto give retrospective effect to the reverse stock split for all periods presented. All issued and outstanding common stock, options and warrants exercisable for common stock, restricted stock units, preferred stock conversions to common stock and per share amounts contained in our condensed financial statements have been retrospectively adjusted.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Going Concern</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our financial statements as of March 31, 2021, December 31, 2020 and March 31, 2020 have been prepared under the assumption that we will continue as a going concern. Our independent registered public accounting firm included in its opinion for the years ended December 31, 2020 and 2019 an explanatory paragraph referring to our net loss from operations and net capital deficiency and expressing substantial doubt in our ability to continue as a going concern without additional capital becoming available. If we encounter continued issues or delays in the commercialization of ContraPest, our prior losses and expected future losses could have an adverse effect on our financial condition and negatively impact our ability to fund continued operations, obtain additional financing in the future and continue as a going concern. There are no assurances that such financing, if necessary, will be available to us at all or will be available in sufficient amounts or on reasonable terms. Our financial statements do not include any adjustments that may result from the outcome of this uncertainty. If we are unable to generate additional funds in the future through additional financings, sales of our products, licensing fees, royalty payments or from other sources or transactions, we will exhaust our resources and will be unable to continue operations.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Liquidity and Capital Resources</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since our inception, we have sustained significant operating losses in the course of our research and development and commercialization activities and expect such losses to continue for the near future. We have generated limited revenue to date from product sales, research grants and licensing fees received under our former license agreement. We have primarily funded our operations to date through the sale of equity securities, including convertible preferred stock, common stock and warrants to purchase common stock. See Note 10 for a description of our public equity sales.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have also raised capital through debt financing, consisting primarily of convertible notes and government loan programs, and, to a lesser extent, payments received in connection with product sales, research grants and licensing fees.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through March 31, 2021, we received net proceeds of $89.3 million from our sales of common stock, preferred stock and warrant exercises and issuance of convertible and other promissory notes, an aggregate of $1.7 million from licensing fees and an aggregate of $1.0 million in net product sales. As of March 31, 2021, we had an accumulated deficit of $106.1 million and cash and cash equivalents of $15.2 million.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ultimate success depends upon the outcome of a combination of factors, including: (i) successful commercialization of ContraPest and maintaining and obtaining regulatory approval of our products and product candidates; (ii) market acceptance, commercial viability and profitability of ContraPest and other products; (iii) the ability to market our products and establish an effective sales force and marketing infrastructure to generate significant revenue; (iv) the success of our research and development; (v) the ability to retain and attract key personnel to develop, operate and grow our business; and (vi) our ability to meet our working capital needs.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based upon our current operating plan, we expect that cash and cash equivalents at March 31, 2021, in combination with anticipated revenue and any additional sales of our equity securities, will be sufficient to fund our current operations for at least the next 12 months. We have evaluated and will continue to evaluate our operating expenses and will concentrate our resources toward the successful commercialization of ContraPest in the United States. However, if anticipated revenue targets and margin targets are not achieved or expenses are more than we have budgeted, we may need to raise additional financing before that time. If we need more financing and we are unable to raise necessary capital through the sale of our securities, we may be required to take other measures that could impair our ability to be successful and operate as a going concern. In any event, we may require additional capital in order to fund our operating losses and research and development activities before we become profitable and may opportunistically raise capital. We may never achieve profitability or generate positive cash flows, and unless and until we do, we will continue to need to raise capital through equity or debt financing. If such equity or debt financing is not available at adequate levels or on acceptable terms, we may need to delay, limit or terminate commercialization and development efforts or discontinue operations.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Basis of Presentation</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) for interim financial reporting. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;) have been condensed or omitted pursuant to such rules and regulations. In the Company&#x2019;s opinion, the unaudited condensed financial statements include all material adjustments, all of which are of a normal and recurring nature, necessary to present fairly the Company&#x2019;s financial position as of March 31, 2021, the Company&#x2019;s operating results for the three months ended March 31, 2021 and 2020, and the Company&#x2019;s cash flows for the three months ended March 31, 2021 and 2020. The accompanying financial information as of December 31, 2020 is derived from audited financial statements. Interim results are not necessarily indicative of results for a full year. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 29, 2021. All amounts shown in these financial statements and accompanying notes are in thousands, except percentages and per share and share amounts.&#xa0;</p><br/> 89300000 1700000 1000000 106100000 15200000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 2 - Summary of Significant Accounting Policies</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and classification of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The significant estimates in the Company&#x2019;s financial statements include the valuation of preferred stock, if issued, common stock and related warrants, and other stock-based awards. Actual results could differ from such estimates.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Reclassifications</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no material impact on net earnings, financial position or cash flows.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cash and Cash Equivalents</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers money market fund investments to be cash equivalents. The Company had cash equivalents in the form of money market fund investment of $7,000 and $1,500 at March 31, 2021 and December 31, 2020, respectively, included in cash as reported.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Accounts Receivable-Trade</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivable-trade consist primarily of receivables from customers. The Company provides an allowance for doubtful trade receivables equal to the estimated uncollectible amounts. That estimate is based on historical collection experience, current economic and market conditions and a review of the current status of each customer&#x2019;s trade accounts receivable. The allowance for doubtful trade receivables was $0 at March 31, 2021 and December 31, 2020.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Inventories</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories are stated at the lower of cost or market value, using the first-in, first-out convention. Inventories consist of raw materials, work in progress and finished goods. Raw materials are stocked to reduce the risk of impact on manufacturing for potential supply interruptions due to the COVID-19 pandemic or long lead times on certain ingredients.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Components of inventory are:</p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">March&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Raw materials</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">935</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">950</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Work in progress</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">4</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">24</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Finished goods</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">89</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">94</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 10pt">Total inventory</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">1,028</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">1,068</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Less:</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Reserve for obsolete</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(123</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(123</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Total net inventory</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">905</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">945</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Prepaid Expenses</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prepaid expenses consist primarily of payments made for director and officer insurance, director compensation, rent, legal and inventory purchase deposits and seminar fees to be expensed in the current year.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Property and Equipment</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are stated at cost less accumulated depreciation. Equipment held under finance leases are stated at the present value of minimum lease payments less accumulated amortization.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation on property and equipment is computed using the straight-line method over the estimated useful lives of the respective assets. The cost of leasehold improvements is amortized over the life of the improvement or the term of the lease, whichever is shorter. Equipment held under finance leases is amortized over the shorter of the lease term or estimated useful life of the asset. The Company incurs repair and maintenance costs on its major equipment, which are expensed as incurred.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Impairment of Long-Lived Assets</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require long-lived assets or asset groups to be tested for possible impairment, the Company compares the undiscounted cash flows expected to be generated from the use of the asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment charge is recognized to the extent that the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques, such as discounted cash flow models and the use of third-party independent appraisals. The Company has not recorded an impairment of long-lived assets since its inception.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Revenue Recognition</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective January 1, 2018, the Company adopted Accounting Standards Codification (&#x201c;ASC&#x201d;) 606 &#x2014; <i>Revenue from Contracts with Customers </i>(&#x201c;ASC 606&#x201d;)<i>. </i>Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes revenue when product is shipped at a fixed selling price on payment terms of 30 to 120 days from invoicing. The Company recognizes other revenue earned from pilot studies, consulting and implementation services upon the performance of specific services under the respective service contract.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company derives revenue primarily from commercial sales of products, net of discounts and promotions, as well as consulting and implementation services provided in conjunction with our product deployments.&#xa0;</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Research and Development</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development costs are expensed as incurred. Research and development expenses primarily consist of salaries and benefits for research and development employees, stock-based compensation, consulting fees, lab supplies, costs incurred related to conducting scientific trials and field studies, regulatory compliance costs, and manufacturing costs associated with process improvement. Research and development expenses include an allocation of facilities related costs, including depreciation of research and development equipment.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Stock-based Compensation</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock based awards, consisting of stock options and restricted stock units expected to be settled in shares of the Company&#x2019;s common stock, are recorded as equity awards. The grant date fair value of these awards is measured using the Black-Scholes option pricing model for stock options and grant date market value for restricted stock units. The Company expenses the grant date fair value of its stock options on a straight-line basis over their respective vesting periods.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The stock-based compensation expense recorded for the three months ended March 31, 2021 and 2020, is as follows:</p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended<br/> March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Research and development</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">153</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">148</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Total stock-based compensation expense</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">155</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">151</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See Note 11 for additional discussion on stock-based compensation.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Income Taxes</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements and tax bases of assets and liabilities and net operating loss carryforwards using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period that includes the enactment date.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized. These deferred tax assets are subject to periodic assessments as to recoverability and if it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recorded which would increase the provision for income taxes. In making such determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies a more-likely-than-not recognition threshold for all tax uncertainties. Only those benefits that have a greater than fifty percent likelihood of being sustained upon examination by the taxing authorities are recognized. Based on its evaluation, the Company has concluded there are no significant uncertain tax positions requiring recognition in its financial statements.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes interest and/or penalties related to uncertain tax positions in income tax expense. There are no uncertain tax positions as of March 31, 2021 or December 31, 2020 and as such, no interest or penalties were recorded in income tax expense.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Comprehensive Loss</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net loss and comprehensive loss were the same for all periods presented; therefore, a separate statement of comprehensive loss is not included in the accompanying financial statements.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Loss Per Share Attributable to Common Stockholders</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic loss per share attributable to common stockholders is calculated by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share attributable to common stockholders is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury stock and if-converted methods. For purposes of the computation of diluted loss per share attributable to common stockholders, common stock purchase warrants, and common stock options are considered to be potentially dilutive securities but have been excluded from the calculation of diluted loss per share attributable to common stockholders because their effect would be anti-dilutive given the net loss reported for the three months ended March 31, 2021 and 2020. Therefore, basic and diluted loss per share attributable to common stockholders are the same for each period presented.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted loss per share attributable to common stockholders (in common stock equivalent shares):</p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Common stock purchase warrants</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 9%; text-align: right">4,553,733</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 9%; text-align: right">812,963</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Restricted stock units</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">31,405</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">5,877</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common stock options</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">506,852</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">136,239</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; padding-left: 10pt">Total</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#xa0;</td><td style="border-bottom: Black 4pt double; text-align: right">5,091,990</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#xa0;</td><td style="border-bottom: Black 4pt double; text-align: right">955,079</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Adoption of New Accounting Standard:</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2018, the FASB issued <i>ASU 2018-15 Accounting for Implementation Costs Related to Cloud Computing or Hosting Arrangements,</i> authoritative guidance intended to address a customer&#x2019;s accounting for implementation costs incurred in a cloud computing arrangement that is a service contract. This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires presentation of the capitalized implementation costs in the statement of financial position and in the statement of cash flows in the same line item that a prepayment for the fees of the associated hosting arrangement would be presented, and the expense related to the capitalized implementation costs to be presented in the same line item in the statement of operations as the fees associated with the hosting element (service) of the arrangement. This guidance was effective for annual periods beginning after December&#xa0;15, 2019, including interim periods within those annual periods, with early adoption permitted. Effective January 1, 2020, the Company adopted the guidance and determined there was no applicability to the Company at this time and as such, there was no impact on our financial position, results of operations, or cash flows.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other than the item noted above, there have been no new accounting pronouncements not yet effective or adopted in the current year that we believe have a significant impact, or potential significant impact, to our unaudited condensed interim financial statements.</p><br/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and classification of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The significant estimates in the Company&#x2019;s financial statements include the valuation of preferred stock, if issued, common stock and related warrants, and other stock-based awards. Actual results could differ from such estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Reclassifications</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no material impact on net earnings, financial position or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cash and Cash Equivalents</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers money market fund investments to be cash equivalents. The Company had cash equivalents in the form of money market fund investment of $7,000 and $1,500 at March 31, 2021 and December 31, 2020, respectively, included in cash as reported.</p> 7000000 1500000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Accounts Receivable-Trade</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivable-trade consist primarily of receivables from customers. The Company provides an allowance for doubtful trade receivables equal to the estimated uncollectible amounts. That estimate is based on historical collection experience, current economic and market conditions and a review of the current status of each customer&#x2019;s trade accounts receivable. The allowance for doubtful trade receivables was $0 at March 31, 2021 and December 31, 2020.</p> 0 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Inventories</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories are stated at the lower of cost or market value, using the first-in, first-out convention. Inventories consist of raw materials, work in progress and finished goods. Raw materials are stocked to reduce the risk of impact on manufacturing for potential supply interruptions due to the COVID-19 pandemic or long lead times on certain ingredients.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Components of inventory are:</p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">March&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Raw materials</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">935</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">950</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Work in progress</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">4</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">24</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Finished goods</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">89</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">94</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 10pt">Total inventory</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">1,028</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">1,068</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Less:</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Reserve for obsolete</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(123</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(123</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Total net inventory</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">905</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">945</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Prepaid Expenses</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prepaid expenses consist primarily of payments made for director and officer insurance, director compensation, rent, legal and inventory purchase deposits and seminar fees to be expensed in the current year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Property and Equipment</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are stated at cost less accumulated depreciation. Equipment held under finance leases are stated at the present value of minimum lease payments less accumulated amortization.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation on property and equipment is computed using the straight-line method over the estimated useful lives of the respective assets. The cost of leasehold improvements is amortized over the life of the improvement or the term of the lease, whichever is shorter. Equipment held under finance leases is amortized over the shorter of the lease term or estimated useful life of the asset. The Company incurs repair and maintenance costs on its major equipment, which are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Impairment of Long-Lived Assets</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require long-lived assets or asset groups to be tested for possible impairment, the Company compares the undiscounted cash flows expected to be generated from the use of the asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment charge is recognized to the extent that the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques, such as discounted cash flow models and the use of third-party independent appraisals. The Company has not recorded an impairment of long-lived assets since its inception.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Revenue Recognition</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective January 1, 2018, the Company adopted Accounting Standards Codification (&#x201c;ASC&#x201d;) 606 &#x2014; <i>Revenue from Contracts with Customers </i>(&#x201c;ASC 606&#x201d;)<i>. </i>Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes revenue when product is shipped at a fixed selling price on payment terms of 30 to 120 days from invoicing. The Company recognizes other revenue earned from pilot studies, consulting and implementation services upon the performance of specific services under the respective service contract.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company derives revenue primarily from commercial sales of products, net of discounts and promotions, as well as consulting and implementation services provided in conjunction with our product deployments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Research and Development</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development costs are expensed as incurred. Research and development expenses primarily consist of salaries and benefits for research and development employees, stock-based compensation, consulting fees, lab supplies, costs incurred related to conducting scientific trials and field studies, regulatory compliance costs, and manufacturing costs associated with process improvement. Research and development expenses include an allocation of facilities related costs, including depreciation of research and development equipment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Stock-based Compensation</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock based awards, consisting of stock options and restricted stock units expected to be settled in shares of the Company&#x2019;s common stock, are recorded as equity awards. The grant date fair value of these awards is measured using the Black-Scholes option pricing model for stock options and grant date market value for restricted stock units. The Company expenses the grant date fair value of its stock options on a straight-line basis over their respective vesting periods.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The stock-based compensation expense recorded for the three months ended March 31, 2021 and 2020, is as follows:</p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended<br/> March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Research and development</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">153</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">148</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Total stock-based compensation expense</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">155</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">151</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See Note 11 for additional discussion on stock-based compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Income Taxes</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements and tax bases of assets and liabilities and net operating loss carryforwards using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period that includes the enactment date.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized. These deferred tax assets are subject to periodic assessments as to recoverability and if it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recorded which would increase the provision for income taxes. In making such determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies a more-likely-than-not recognition threshold for all tax uncertainties. Only those benefits that have a greater than fifty percent likelihood of being sustained upon examination by the taxing authorities are recognized. Based on its evaluation, the Company has concluded there are no significant uncertain tax positions requiring recognition in its financial statements.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes interest and/or penalties related to uncertain tax positions in income tax expense. There are no uncertain tax positions as of March 31, 2021 or December 31, 2020 and as such, no interest or penalties were recorded in income tax expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Comprehensive Loss</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net loss and comprehensive loss were the same for all periods presented; therefore, a separate statement of comprehensive loss is not included in the accompanying financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Loss Per Share Attributable to Common Stockholders</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic loss per share attributable to common stockholders is calculated by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share attributable to common stockholders is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury stock and if-converted methods. For purposes of the computation of diluted loss per share attributable to common stockholders, common stock purchase warrants, and common stock options are considered to be potentially dilutive securities but have been excluded from the calculation of diluted loss per share attributable to common stockholders because their effect would be anti-dilutive given the net loss reported for the three months ended March 31, 2021 and 2020. Therefore, basic and diluted loss per share attributable to common stockholders are the same for each period presented.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted loss per share attributable to common stockholders (in common stock equivalent shares):</p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Common stock purchase warrants</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 9%; text-align: right">4,553,733</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 9%; text-align: right">812,963</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Restricted stock units</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">31,405</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">5,877</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common stock options</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">506,852</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">136,239</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; padding-left: 10pt">Total</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#xa0;</td><td style="border-bottom: Black 4pt double; text-align: right">5,091,990</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#xa0;</td><td style="border-bottom: Black 4pt double; text-align: right">955,079</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Adoption of New Accounting Standard:</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2018, the FASB issued <i>ASU 2018-15 Accounting for Implementation Costs Related to Cloud Computing or Hosting Arrangements,</i> authoritative guidance intended to address a customer&#x2019;s accounting for implementation costs incurred in a cloud computing arrangement that is a service contract. This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires presentation of the capitalized implementation costs in the statement of financial position and in the statement of cash flows in the same line item that a prepayment for the fees of the associated hosting arrangement would be presented, and the expense related to the capitalized implementation costs to be presented in the same line item in the statement of operations as the fees associated with the hosting element (service) of the arrangement. This guidance was effective for annual periods beginning after December&#xa0;15, 2019, including interim periods within those annual periods, with early adoption permitted. Effective January 1, 2020, the Company adopted the guidance and determined there was no applicability to the Company at this time and as such, there was no impact on our financial position, results of operations, or cash flows.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other than the item noted above, there have been no new accounting pronouncements not yet effective or adopted in the current year that we believe have a significant impact, or potential significant impact, to our unaudited condensed interim financial statements.</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">March&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Raw materials</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">935</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">950</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Work in progress</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">4</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">24</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Finished goods</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">89</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">94</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 10pt">Total inventory</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">1,028</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">1,068</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Less:</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Reserve for obsolete</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(123</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(123</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Total net inventory</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">905</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">945</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table> 935000 950000 4000 24000 89000 94000 1028000 1068000 123000 123000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended<br/> March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Research and development</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">153</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">148</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Total stock-based compensation expense</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">155</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">151</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table> 2000 3000 153000 148000 155000 151000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Common stock purchase warrants</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 9%; text-align: right">4,553,733</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 9%; text-align: right">812,963</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Restricted stock units</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">31,405</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">5,877</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common stock options</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">506,852</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">136,239</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; padding-left: 10pt">Total</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#xa0;</td><td style="border-bottom: Black 4pt double; text-align: right">5,091,990</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">&#xa0;</td><td style="border-bottom: Black 4pt double; text-align: right">955,079</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table> 4553733 812963 31405 5877 506852 136239 5091990 955079 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 3 - Fair Value Measurements</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company issued common stock warrants to purchase shares of common stock in June of 2015 (see Note 9 - Common Stock Warrants and Common Stock Warrant Liability) that expired in June of 2020. These warrants contained a cash settlement provision that resulted in a common stock warrant liability that was revalued at the end of each reporting period.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We valued these warrant derivatives at fair value. The accounting guidance for fair value, among other things, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The framework for measuring fair value consists of a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows:<i>&#xa0;</i></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify"><i>Level 1</i>&#x2014;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify"><i>Level 2</i>&#x2014;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify"><i>Level 3</i>&#x2014;Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An asset&#x2019;s or liability&#x2019;s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assets and liabilities measured at fair value are based on one or more of the following three valuation techniques:</p><br/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.5in">&#xa0;</td> <td style="width: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">A.</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Market approach: Prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.</font></td></tr> <tr style="vertical-align: top"> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: justify">&#xa0;</td></tr> <tr style="vertical-align: top"> <td>&#xa0;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">B.</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Cost approach: Amount that would be required to replace the service capacity of an asset (replacement cost).</font></td></tr> <tr style="vertical-align: top"> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: justify">&#xa0;</td></tr> <tr style="vertical-align: top"> <td>&#xa0;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">C.</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Income approach: Techniques to convert future amounts to a single present amount based upon market expectations, including present value techniques, option-pricing and excess earnings models.</font></td></tr> </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#x2019;s common stock warrant liabilities are classified as Level 3 because there is limited activity or less transparency around the inputs to valuation.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Financial Instruments Not Carried at Fair Value</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying amounts of the Company&#x2019;s financial instruments, including accounts payable and accrued liabilities, approximate fair value due to their short maturities. The estimated fair value of the convertible notes and other notes, not recorded at fair value, are recorded at cost or amortized cost which was deemed to estimate fair value.</p><br/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 4 - Credit Risk</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is potentially subject to concentrations of credit risk in its accounts receivable. Credit risk with respect to receivables is limited due to the number of companies comprising the Company&#x2019;s customer base, however the Company did identify a potentially uncollectable account and at December 31, 2019 and maintained a reserve for this receivable balance of $123. At December 31, 2020, the account was deemed uncollectable and offset against the reserve. The Company did not have any potentially uncollectable account at March 31, 2021 or December 31, 2020 and therefore, did not record a reserve for uncollectable accounts at March 31, 2021 or December 31, 2020. The Company does not require collateral or other securities to support its accounts receivable.</p><br/> 123000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 5 - Prepaid Expenses</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prepaid expenses consist of the following:</p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold">&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Director, officer and other insurance</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">181</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">18</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">NASDAQ fees</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">33</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Legal retainer</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">25</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">25</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Marketing programs and conferences</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">73</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">106</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Professional services retainer</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">12</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">8</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td>Rent</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">18</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">18</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Engineering, software licenses and other</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Total prepaid expenses</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">360</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">178</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table><br/> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold">&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Director, officer and other insurance</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">181</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">18</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">NASDAQ fees</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">33</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Legal retainer</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">25</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">25</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Marketing programs and conferences</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">73</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">106</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Professional services retainer</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">12</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">8</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td>Rent</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">18</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">18</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Engineering, software licenses and other</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Total prepaid expenses</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">360</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">178</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table> 181000 18000 33000 25000 25000 73000 106000 12000 8000 18000 18000 18000 3000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 6 - Property and Equipment</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Property and equipment, net consist of the following:</p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td>&#xa0;</td> <td style="text-align: center"><b>Useful</b></td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold">&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Life</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Research and development equipment</td><td style="width: 1%">&#xa0;</td> <td style="width: 11%; text-align: center">5 years</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,420</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,397</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Office and computer equipment <sup>(1)</sup></td><td>&#xa0;</td> <td style="text-align: center">3 years</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">749</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">733</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Autos</td><td>&#xa0;</td> <td style="text-align: center">5 years</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">54</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">54</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Furniture and fixtures</td><td>&#xa0;</td> <td style="text-align: center">7 years</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">41</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">41</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Leasehold improvements</td><td>&#xa0;</td> <td style="text-align: center">*</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">102</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">283</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Construction in progress</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">36</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">115</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">2,402</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">2,623</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,874</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,085</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: center; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">528</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">538</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table><br/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">*</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Shorter of lease term or estimated useful life</font></td></tr> <tr style="vertical-align: top"> <td>&#xa0;</td> <td style="text-align: justify">&#xa0;</td></tr> <tr style="vertical-align: top"> <td><font style="font: 10pt Times New Roman, Times, Serif">(1)</font></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the three months ended March 31, 2021, the Company received net proceeds of less than $1 in the sale of research and development equipment resulting in gains on the sale of these assets of less than $1. In the three months ended March 31, 2020, the Company received net proceeds of $40 in the sale of research and development equipment and office and computer equipment, resulting in a gain on the sale of these assets of $15.</p> </td></tr> </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation and amortization expense was approximately $73 and $77 for the three months ended March 31, 2021 and 2020, respectively.</p><br/> 1000 1000 40000 15000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td>&#xa0;</td> <td style="text-align: center"><b>Useful</b></td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold">&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Life</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Research and development equipment</td><td style="width: 1%">&#xa0;</td> <td style="width: 11%; text-align: center">5 years</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,420</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,397</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Office and computer equipment <sup>(1)</sup></td><td>&#xa0;</td> <td style="text-align: center">3 years</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">749</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">733</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Autos</td><td>&#xa0;</td> <td style="text-align: center">5 years</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">54</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">54</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Furniture and fixtures</td><td>&#xa0;</td> <td style="text-align: center">7 years</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">41</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">41</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Leasehold improvements</td><td>&#xa0;</td> <td style="text-align: center">*</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">102</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">283</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Construction in progress</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">36</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">115</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">2,402</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">2,623</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,874</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,085</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: center; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">528</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">538</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">*</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Shorter of lease term or estimated useful life</font></td></tr> <tr style="vertical-align: top"> <td>&#xa0;</td> <td style="text-align: justify">&#xa0;</td></tr> <tr style="vertical-align: top"> <td><font style="font: 10pt Times New Roman, Times, Serif">(1)</font></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the three months ended March 31, 2021, the Company received net proceeds of less than $1 in the sale of research and development equipment resulting in gains on the sale of these assets of less than $1. In the three months ended March 31, 2020, the Company received net proceeds of $40 in the sale of research and development equipment and office and computer equipment, resulting in a gain on the sale of these assets of $15.</p> </td></tr> </table> P5Y 1420000 1397000 P3Y 749000 733000 P5Y 54000 54000 P7Y 41000 41000 102000 283000 36000 115000 2402000 2623000 1874000 2085000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 7 - Accrued Expenses</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accrued expenses consist of the following:</p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">March&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Compensation and related benefits</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">209</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">218</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Board Compensation</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">5</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">3</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Personal property and franchise tax</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">8</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">57</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total accrued expenses</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">238</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">292</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> </table><br/> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">March&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Compensation and related benefits</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">209</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">218</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Board Compensation</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">5</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">3</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Personal property and franchise tax</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">8</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">57</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total accrued expenses</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">238</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">292</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> </table> 209000 218000 5000 3000 -8000 -57000 16000 14000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 8 - Borrowings</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A summary of the Company&#x2019;s borrowings, including finance lease obligations, is as follows:</p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">March&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>Short-term debt:</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Current portion of long-term debt</td><td style="width: 1%; padding-bottom: 1.5pt">&#xa0;</td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">79</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="width: 1%; padding-bottom: 1.5pt">&#xa0;</td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">98</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 20pt">Total short-term debt</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">79</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">98</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Long-term debt:</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 10pt">Finance lease obligations</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">66</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">79</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other promissory notes</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">675</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">692</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 20pt">Total</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">741</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">771</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Less: current portion of long-term debt</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(79</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(98</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt; padding-left: 20pt">Total long-term debt</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">662</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">673</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Finance Lease Obligations&#xa0;</i></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Finance lease obligations at March 31, 2021 are for computer and lab equipment leased through GreatAmerica Financial Services and ENGS Commercial Finance Co. These finance leases expire at various dates through April 2022 and carry interest rates ranging from 11.4% to 18.3%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Other Promissory Notes</i></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also included in the table above are notes payable to Direct Capital, M2 Financing and Fidelity Capital, all for the financing of fixed assets. These notes expire at various dates through June 2022 and carry interest rates ranging from 13.1% to 13.3%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also included in the table above is a loan agreement payable to BMO Harris Bank National Association as the lender in an aggregate principal amount of $645,700 pursuant to the Paycheck Protection Program (the &#x201c;PPP&#x201d;) under the Coronavirus Aid, Relief, and Economic Security Act (the &#x201c;CARES Act&#x201d;). The loan is evidenced by a promissory note dated April 15, 2020 and matures April 15, 2022. The loan bears interest at a rate of 1.00% per annum and contains customary events of default including, among other things, payment defaults. The loan closed and was funded April 20, 2020. Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of loans granted under the PPP. The loan is subject to forgiveness to the extent proceeds are used for qualifying expenses, including certain payroll, utility, rent and mortgage interest expenses. No assurance is provided that the Company will obtain forgiveness of the loan in whole or in part.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to amendments to the CARES Act, as long as the Company submits its application for loan forgiveness within ten months after the expiration of the applicable covered period, the Company will not be required to make any payments until the forgiveness amount is remitted to the lender by the SBA. The Company applied for forgiveness in February 2021. We cannot guarantee that the PPP loan will be forgiven. In the event the PPP loan is not forgiven in whole or in part, the lender is responsible for notifying the Company of the date on which the Company&#x2019;s first repayment is due.</p><br/> 0.114 0.183 These notes expire at various dates through June 2022 and carry interest rates ranging from 13.1% to 13.3%. 0.131 0.133 645700000 The loan is evidenced by a promissory note dated April 15, 2020 and matures April 15, 2022. 0.0100 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">March&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td><td style="font-weight: bold">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#xa0;31,</td><td style="font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>Short-term debt:</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Current portion of long-term debt</td><td style="width: 1%; padding-bottom: 1.5pt">&#xa0;</td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">79</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="width: 1%; padding-bottom: 1.5pt">&#xa0;</td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">98</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 20pt">Total short-term debt</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">79</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">98</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Long-term debt:</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 10pt">Finance lease obligations</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">66</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">79</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other promissory notes</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">675</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">692</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 20pt">Total</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">741</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">771</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Less: current portion of long-term debt</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(79</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(98</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt; padding-left: 20pt">Total long-term debt</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">662</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">673</td><td style="padding-bottom: 4pt; text-align: left">&#xa0;</td></tr> </table> 79000 98000 66000 79000 675000 692000 741000 771000 79000 98000 662000 673000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 9 - Common Stock Warrants and Common Stock Warrant Liability</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The table summarizes the common stock warrant activity as of March 31, 2021 as follows:</p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 7pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td> <td style="text-align: center">&#xa0;</td><td style="font-weight: bold; text-align: center">&#xa0;</td> <td style="font-weight: bold; text-align: center">Term</td><td style="font-weight: bold; text-align: center">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold; text-align: center">&#xa0;</td><td style="font-weight: bold; text-align: center">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">Balance</td><td style="font-weight: bold; text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td> <td colspan="2" style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td> <td colspan="2" style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td> <td colspan="2" style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td><td style="font-weight: bold; text-align: center">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">Balance</td><td style="font-weight: bold; text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td> <td colspan="2" style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td> <td colspan="2" style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td> <td colspan="2" style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td><td style="font-weight: bold; text-align: center">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">Balance</td><td style="font-weight: bold; text-align: center">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issue&#xa0;Date</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant&#xa0;Type</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Date</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#xa0;31,&#xa0;2019</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercised</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expired</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#xa0;31,&#xa0;2020</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercised</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expired</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March&#xa0;31,&#xa0;2021</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: center">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: center">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; width: 8%">2016 and prior</td><td style="width: 1%">&#xa0;</td> <td style="width: 10%; text-align: center">Various</td><td style="width: 1%">&#xa0;</td> <td style="width: 10%; text-align: center">Various-2020/2021</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">Various</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">17,059</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">(9,375</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">(7,684</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">November 21,2017</td><td>&#xa0;</td> <td style="text-align: center">Common Stock Offering Warrants</td><td>&#xa0;</td> <td style="text-align: center">November 21, 2022</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">1.3659</td><td style="text-align: left"><sup>(1)</sup></td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">143,501</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">143,501</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">143,501</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">November 21,2017</td><td>&#xa0;</td> <td style="text-align: center">Dealer Manager Warrants</td><td>&#xa0;</td> <td style="text-align: center">November 21, 2022</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">30.00</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">47,250</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">(47,250</td><td style="text-align: left">)</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">June 20,2018</td><td>&#xa0;</td> <td style="text-align: center">Warrant Reissue</td><td>&#xa0;</td> <td style="text-align: center">December 20, 2023</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">36.40</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">56,696</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">56,696</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">56,696</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">August 13,2018</td><td>&#xa0;</td> <td style="text-align: center">Rights Offering Warrants</td><td>&#xa0;</td> <td style="text-align: center">July 25, 2023</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">23.00</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">202,943</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">202,943</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">202,943</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">August 13,2018</td><td>&#xa0;</td> <td style="text-align: center">Dealer Manager Warrants</td><td>&#xa0;</td> <td style="text-align: center">August 13, 2023</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">34.50</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,393</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,393</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,393</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">July 16,2019</td><td>&#xa0;</td> <td style="text-align: center">Dealer Manager Warrants</td><td>&#xa0;</td> <td style="text-align: center">July 11, 2024</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">33.75</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">8,334</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">8,334</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">8,334</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">January 28,2020</td><td>&#xa0;</td> <td style="text-align: center">Registered Direct Offering</td><td>&#xa0;</td> <td style="text-align: center">July 28,2025</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">9.00</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">177,500</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">177,500</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">177,500</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">January 28,2020</td><td>&#xa0;</td> <td style="text-align: center">Dealer Manager Warrants</td><td>&#xa0;</td> <td style="text-align: center">July 28,2025</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">10.00</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,315</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,315</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,315</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">March 6,2020</td><td>&#xa0;</td> <td style="text-align: center">Registered Direct Offering</td><td>&#xa0;</td> <td style="text-align: center">September 8,2025</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">2.88</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">176,372</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">(176,372</td><td style="text-align: left">)</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">March 6,2020</td><td>&#xa0;</td> <td style="text-align: center">Dealer Manager Warrants</td><td>&#xa0;</td> <td style="text-align: center">March 4,2025</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">3.76</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,228</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,228</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,228</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">April 21,2020</td><td>&#xa0;</td> <td style="text-align: center">Dealer Manager Warrants</td><td>&#xa0;</td> <td style="text-align: center">April 21,2025</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">3.97</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">118,073</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">118,073</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">118,073</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">April 24,2020</td><td>&#xa0;</td> <td style="text-align: center">Registered Direct Offering</td><td>&#xa0;</td> <td style="text-align: center">April 24,2025</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">3.05</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">1,574,308</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">(1,524,308</td><td style="text-align: left">)</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">October 26, 2020</td><td>&#xa0;</td> <td style="text-align: center">Private Warrant Inducement</td><td>&#xa0;</td> <td style="text-align: center">April 27,2026</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">1.73</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">1,700,680</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">1,700,680</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">(700,680</td><td style="text-align: left">)</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">1,000,000</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">October 26, 2020</td><td>&#xa0;</td> <td style="text-align: center">Dealer Manager Warrants</td><td>&#xa0;</td> <td style="text-align: center">April 27,2026</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">2.16</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">85,034</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">85,034</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">85,034</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">February 2, 2021</td><td>&#xa0;</td> <td style="text-align: center">Private Placement Agreement</td><td>&#xa0;</td> <td style="text-align: center">August 2,2026</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">2.216</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">2,194,427</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">2,194,427</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">February 2, 2021</td><td>&#xa0;</td> <td style="text-align: center">Dealer Manager Warrants</td><td>&#xa0;</td> <td style="text-align: center">August 2,2026</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">2.848</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">329,164</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">329,164</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: center">March 23, 2021</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: center">Dealer Manager Warrants</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: center">March 23, 2026</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">2.50</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: right">148,125</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: right">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: right">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">148,125</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="text-align: right; padding-bottom: 4pt">&#xa0;</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; border-bottom: Black 4pt double">&#xa0;</td><td style="text-align: right; border-bottom: Black 4pt double">489,176</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="text-align: right; padding-bottom: 4pt">&#xa0;</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="text-align: right; padding-bottom: 4pt">&#xa0;</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="text-align: right; padding-bottom: 4pt">&#xa0;</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; border-bottom: Black 4pt double">&#xa0;</td><td style="text-align: right; border-bottom: Black 4pt double">2,582,697</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="text-align: right; padding-bottom: 4pt">&#xa0;</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="text-align: right; padding-bottom: 4pt">&#xa0;</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="text-align: right; padding-bottom: 4pt">&#xa0;</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; border-bottom: Black 4pt double">&#xa0;</td><td style="text-align: right; border-bottom: Black 4pt double">4,553,733</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td></tr> </table><br/><table cellpadding="0" cellspacing="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"><font style="font: 10pt Times New Roman, Times, Serif">(1)</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The initial exercise price of these warrants was $30.00 per share. Pursuant to antidilution price adjustment protection contained within these warrants, the initial exercise price of these warrants was adjusted downward to $29.40 on July 24, 2018, the record date of the Right&#x2019;s Offering and downward to $19.00 per share on August 13, 2018. These warrants were further adjusted downward from $19.00 to $7.13 and to $2.1122 on January 28, 2020 and March 4, 2020, respectively, in connection with separate Registered Direct Offerings.&#xa0;These warrants were further adjusted downward from $2.1122 to $1.3659 on October 26, 2020 in connection with a Registered Direct Offering.&#xa0;&#xa0;These warrants are subject to further adjustment pursuant to antidilution price adjustment protection.</font></td></tr> </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Outstanding Warrants</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2021, we had 4,553,733 shares of common stock issuable upon exercise of outstanding common stock warrants, at a weighted-average exercise price of $3.98603 per share.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 21, 2017, the Company issued a total of 232,875 detachable common stock warrants issued with the second public offering of 293,000 shares of its common stock at $20.00 per share. The common stock warrant is exercisable until five years from the date of grant. The common shares of the Company&#x2019;s stock and detachable warrants exist independently as separate securities. As such, the Company estimated the fair value of the common stock warrants, exercisable at $30.00 per share, to be $661 using a lattice model based on the following significant inputs: common stock price of $20.00; comparable company volatility of 73.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 1.87%. The initial exercise price of these warrants was $30.00 per share, which adjusted downward to $29.40 on July 24, 2018, the record date of the Right&#x2019;s Offering and downward to $19.00 per share on August 13, 2018, the date of the Rights Offering, pursuant to antidilution price adjustment protection contained within these warrants. The exercise price of the warrants was adjusted downward to $7.13 on January 28, 2020 in connection with a private placement of common stock. Per guidance of ASC 260, the Company recorded a deemed dividend of $285 on the 143,501 unexercised warrants that contained this antidilution price adjustment protection provision and was calculated as the difference between the fair value of the warrants immediately prior to downward exercise price adjustment and immediately after the adjustment using a Black Scholes model based on the following significant inputs: on January 28, 2020, common stock price of $7.90; comparable company volatility of 73.8%; remaining term 2.82 years; dividend yield of 0% and risk-free interest rate of 1.45%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise price of the warrants was adjusted downward to $2.1122 on March 4, 2020 in connection with a private placement of common stock. Per guidance of ASC 260, the Company recorded a deemed dividend of $129 on the 143,501 unexercised warrants that contained this antidilution price adjustment protection provision and was calculated as the difference between the fair value of the warrants immediately prior to downward exercise price adjustment and immediately after the adjustment using a Black Scholes model based on the following significant inputs: on March 4, 2020, common stock price of $2.88; comparable company volatility of 74.5%; remaining term 2.71 years; dividend yield of 0% and risk-free interest rate of 0.68%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise price of the warrants was adjusted downward to $1.3659 on October 26, 2020 in connection with an inducement offering of common stock. Per guidance of ASC 260, the Company recorded a deemed dividend of $22 on the 143,501 unexercised warrants that contained this antidilution price adjustment protection provision and was calculated as the difference between the fair value of the warrants immediately prior to downward exercise price adjustment and immediately after the adjustment using a Black Scholes model based on the following significant inputs: On October 26, 2020, common stock price of $1.47; comparable company volatility of 96.5%; remaining term 2.08 years; dividend yield of 0% and risk-free interest rate of 0.18%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 20, 2018, the Company entered into an agreement with a holder of 56,696 of the November 2017 warrants to exercise its original warrant representing 56,696 shares of common stock for cash at the $30.00 exercise price for gross proceeds of $1.7 million and the Company issued to holder a new warrant to purchase 56,696 shares of common stock at an exercise price of $36.40 per share. The new warrant did not contain the antidilution price adjustment protection that was contained within the exercised warrants. In June 2018, the Company recorded stock compensation expense of $1,700 representing the fair value of the of 56,696 inducement warrants issued. The Company estimated the fair value of the common stock warrants, exercisable at $36.40 per share, to be $1,700 using a Black Scholes model based on the following significant inputs: common stock price of $42.20; comparable company volatility of 72.6%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.8%. Also, in June 2018, an additional 17,088 of the November 8, 2017 warrants that were in the money at the time of exercise, were exercised for gross proceeds of $513.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 13, 2018, in connection with a Rights Offering of 267,853 shares of its common stock, the Company issued 267,853 warrants to purchase shares of its common stock at an exercise price of $23.00 per share. The Company estimated the fair value of the common stock warrants, exercisable at $23.00 per share, to be $3,600 using a Monte Carlo model based on the following significant inputs: common stock price of $18.80; comparable company volatility of 159.0%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.77%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the closing of the Rights Offering, the Company issued a warrant to purchase 13,393 shares of common stock to Maxim Partners LLC, an affiliate of the dealer-manager of the Rights Offering. The Company estimated the fair value of the common stock warrants, exercisable at $34.50 per share, to be $169 using a using a Monte Carlo model based on the following significant inputs: common stock price of $18.80; comparable company volatility of 159.0%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.77%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Common Stock Warrant Issued to Underwriter of Common Stock Offering</i></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2019, the Company issued to H.C. Wainwright &amp; Co., as placement agent, a warrant to purchase 8,334 shares of common stock at an exercise price of $33.75 per share as consideration for providing services in connection with a common stock offering in July 2019. The warrant was fully vested and exercisable on the date of issuance. The common stock warrant is exercisable until five years from the date of grant. The Company estimated the fair value of the common stock warrants, exercisable at $33.75 per share, to be $127 using a lattice model based on the following significant inputs: common stock price of $26.80; comparable company volatility of 133.3%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.07%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Common Stock Warrants Issued in January and March 2020 Private Placements</i></b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January and March 2020, in separate private placements concurrent with registered direct offerings (collectively, the &#x201c;2020 Registered Direct Offerings&#x201d;) of shares of the Company&#x2019;s common stock, the Company also issued warrants to purchase an aggregate of up to 353,872 shares of common stock to certain institutional and accredited investors that participated in the 2020 Registered Direct Offerings (the &#x201c;2020 Warrants&#x201d;). The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;) and Rule 506(b) of Regulation D promulgated thereunder. Terms used but not otherwise defined herein will have the meanings given them in the warrants, attached as Exhibit&#xa0;4.1 to our Form&#xa0;8-K filed on January 28, 2020, and our Form&#xa0;8-K filed on March 6, 2020.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants issued in January 2020 to purchase 177,500 shares of common stock have an exercise price of $9.00 per share, are exercisable after July&#xa0;28, 2020 and will expire July 28, 2025. The Company estimated the fair value of the common stock warrants, exercisable at $9.00 per share, to be $813 using a Black Scholes model based on the following significant inputs: common stock price of $7.90; comparable company volatility of 73.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 1.53%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants issued in March 2020 to purchase 176,372 shares of common stock have an exercise price of $2.88 per share, are immediately exercisable and will expire September 8, 2025. The Company estimated the fair value of the common stock warrants, exercisable at $2.88 per share, to be $242 using a Black Scholes model based on the following significant inputs: common stock price of $2.35; comparable company volatility of 74.8%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.39%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For so long as the 2020 Warrants remain outstanding, the exercise price and number of shares of common stock issuable upon exercise of the warrants are subject to adjustment as follows: (a)&#xa0;upon payment of a stock dividend or other distribution on a class or series of shares common stock, not including shares issued under this warrant; (b)&#xa0;upon subdivision (by stock spilt, stock dividend, recapitalization, or otherwise) or combination (by reverse stock split or otherwise) of shares of common stock; or (c) upon the issuance of any shares of capital stock by reclassification of shares of the common stock.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that the Company declares or makes any dividend or other distribution of its assets to holders of its common stock, each 2020 Warrant holder will be entitled to participate in such distribution to the same extent that such holder would have participated therein if the holder had held the number of shares of common stock acquirable upon exercise of the 2020 Warrant.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a Fundamental Transaction, as described in the 2020 Warrants and generally including the sale, transfer or other disposition of all or substantially all of our properties or assets; our consolidation or merger with or into another person or reorganization; a recapitalization, reorganization or reclassification in which our common stock is converted into other securities, cash or property; or any acquisition of our outstanding common stock that results in any person or group becoming the beneficial owner of 50% of the voting power represented by our outstanding common stock, then the holders of the 2020 Warrants will be entitled to receive upon exercise of such warrants the kind and amount of securities, cash, assets or other property that the holders would have received had they exercised the 2020 Warrants immediately prior to such Fundamental Transaction. Subject to certain limitations, in the event of a Fundamental Transaction the 2020 Warrant holder may at its option require the Company or any Successor Entity to purchase such warrant from the holder by paying to the holder an amount of cash equal to the Black Scholes Value of the remaining unexercised portion of the 2020 Warrant on the date of the consummation of the Fundamental Transaction.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any time that the Company grants, issues, or sells any securities pro rata to all of the record holders of the common stock (the &#x201c;2020 Purchase Right&#x201d;), each holder of 2020 Warrants will be entitled to acquire the aggregate amount of securities that the holder could have acquired if the holder had held the number of shares of common stock acquirable upon exercise of the applicable 2020 Warrant. However, to the extent that an exercise of a 2020 Purchase Right would exceed the Beneficial Ownership Limitation (defined below), then to such extent the 2020 Purchase Right will be held in abeyance until such time, if ever, that complete exercise of the 2020 Purchase Right would not exceed the Beneficial Ownership Limitation.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After the Initial Exercisability Date (as defined in the 2020 Warrants), the 2020 Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise notice accompanied by payment in full for the number of shares of our common stock purchased upon such exercise. If, at the time a holder exercises the 2020 Warrant (but not sooner than six months following the date of such warrant), a registration statement registering the issuance of the shares of common stock underlying the 2020 Warrants under the Securities Act is not then effective or available, nor is any current prospectus thereto available, and an exemption from registration under the Securities Act is not available for the issuance of such shares, then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the number of shares of common stock determined according to a formula set forth in the 2020 Warrant.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Limitations on Exercise</i>. A holder (together with its affiliates) may not exercise any portion of the 2020 Warrants to the extent that the holder would own more than 4.99% of the outstanding common stock after exercise (the &#x201c;Beneficial Ownership Limitation&#x201d;), except that upon at least 61 days&#x2019; prior notice from the holder to us, the holder may increase the Beneficial Ownership Limitation up to 9.99% of the number of shares of our common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the 2020 Warrants. No fractional shares of common stock will be issued in connection with the exercise of a 2020 Warrant. In lieu of fractional shares, we will either pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price or round up to the next whole share.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as otherwise provided in the 2020 Warrants or by virtue of such holder&#x2019;s ownership of shares of our common stock, the holders of the 2020 Warrants do not have the rights or privileges of holders of our common stock, including any voting rights, unless and until they exercise such warrants.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Common Stock Warrants Issued in April 2020 Public Offering</i></b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 24, 2020, in connection with a previously announced public offering of 145,586 Class A Units and 1,428,722 Class B Units, the Company issued warrants to purchase 1,574,308 shares of common stock to the participants in the public offering and have an exercise price of $3.05 per share (the &#x201c;April 2020 Warrants&#x201d;). These warrants are immediately exercisable and will expire April 24, 2025.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Common Stock, Pre-Funded Warrants and Warrants sold in this Public Offering were offered and sold pursuant to a registration statement on Form S-1 (File No. 333-236302) initially filed with the SEC on February 7, 2020, as amended (&#x201c;Registration Statement&#x201d;), which was declared effective by the SEC on February 14, 2020. The Post-Effective Amendment No. 2 to the Registration Statement was declared effective by the SEC on April 21, 2020.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company estimated the fair value of the common stock warrants, exercisable at $3.05 per share, to be $2,402 using a Black Scholes model based on the following significant inputs: common stock price of $2.40; comparable company volatility of 87.9%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 0.18%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Common Stock Warrants Issued to Placement Agent in 2020 Registered Direct Offerings and Private Placement</i></b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the separate private placements concurrent with registered direct offerings of shares of the Company&#x2019;s common stock in January and March 2020, the Company issued to H.C. Wainwright &amp; Co., LLC, as placement agent, a warrant to purchase 13,228 shares of common stock and a warrant to purchase 13,313 shares of common stock. The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. These warrants have substantially similar terms as the 2020 Warrants described above, except that the placement agent warrant issued in January 2020 has an exercise price of $10.00 per share, and the placement agent warrant issued in March 2020 has an exercise price of $3.7563 per share.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company estimated the fair value of the common stock warrants issued in January, with an exercise price of $10.00 per share, to be $58 using a Black Scholes model based on the following significant inputs: common stock price of $7.90; comparable company volatility of 73.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 1.53%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company estimated the fair value of the common stock warrants issued in March, with an exercise price of $3.7563 per share, to be $17 using a Black Scholes model based on the following significant inputs: common stock price of $2.35; comparable company volatility of 74.8%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.39%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the public offering of 145,586 Class A Units and 1,428,722 Class B Units on April 24, 2020, the Company issued to H.C. Wainwright &amp; Co., LLC, as placement agent, warrants to purchase 118,073 shares of common stock. The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. These warrants have substantially similar terms as the April 2020 Warrants described above, except that the placement agent warrant issued has an exercise price of $3.97 per share.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company estimated the fair value of the common stock warrants issued in April, with an exercise price of $3.97 per share, to be $167 using a Black Scholes model based on the following significant inputs: common stock price of $2.40; comparable company volatility of 87.9%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Common Stock Warrants Issued in October 2020 Private Warrant Inducement </i></b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2020, in connection with an inducement agreement with an existing accredited investor to exercise 1,700,680 outstanding warrants (the &#x201c;Original Warrants&#x201d;) to purchase an equal number of shares of the Company&#x2019;s common stock, the Company issued new unregistered warrants to purchase up to an aggregate of 1,700,680 shares of common stock at an exercise price of $1.725 per share. The warrants issued were immediately exercisable with an exercise period of five and one-half years from the date of issuance. The Original Warrants were issued on March 6, 2020 and on April 24, 2020. Pursuant to the Letter Agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. The Company estimated the fair value of the common stock warrants, exercisable at $1.725 per share, to be $1,806 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the private warrant inducement in October 2020 of 1,700,680 shares of the Company&#x2019;s common warrants, the Company issued to H.C. Wainwright &amp; Co., LLC, as placement agent, warrants to purchase 85,034 shares of common stock. These warrants have substantially similar terms as the 2020 Warrants described above, except that the placement agent warrant issued in October 2020 has an exercise price of $2.156 per share.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company estimated the fair value of these common stock warrants, with an exercise price of $2.156 per share, to be $86 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Common Stock Warrants Issued in February 2021 Private Placement Agreement </i></b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2021, in connection with a private placement agreement with certain institutional and accredited investors, the Company issued common stock warrants to purchase up to an aggregate of 2,194,427 shares of common stock at an exercise price of $2.216 per share. The warrants were exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The warrant holder may not exercise any portion of such holder&#x2019;s warrants to the extent that the holder, together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of the Company&#x2019;s outstanding shares of common stock immediately after exercise, except that upon at least 61 days&#x2019; prior notice from the holder to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise. The Company estimated the fair value of the common stock warrants, exercisable at $2.216 per share, to be $3,052 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#xa0;<b><i>Common Stock Warrants Issued to Placement Agent in February 2021 Private Placement Agreement</i></b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the private placement in February 2021, the Company issued to H.C. Wainwright &amp; Co., LLC, as placement agent, warrants to purchase up to 329,164 shares of Common Stock with an exercise price of $2.8481 per share. The warrants are exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.8481 per share, to be $435 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Common Stock Warrants Issued to Placement Agent in March 2021 Registered Direct Offering</i></b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 23, 2021, the Company consummated a registered direct offering with certain institutional investors and issued an aggregate of 1,975,000 shares of the Company&#x2019;s common stock, par value $0.001 per share at a purchase price of $2.00 per share for gross proceeds to the Company of approximately $3.95 million, before deducting fees payable to the placement agent and other estimated offering expenses payable by the Company. The 1,975,000 shares of Common Stock sold in the Offering were offered and sold pursuant to a prospectus, dated August 24, 2018, and a prospectus supplement, dated March 22, 2021, in connection with a takedown from the Company&#x2019;s shelf registration statement on Form S-3 (File No. 333-225712).</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the registered direct offering in March 2021, the Company issued to H.C. Wainwright &amp; Co., LLC, as the placement agent, warrants to purchase up to 148,125 shares of Common Stock. The Placement Agent Warrants will be exercisable commencing six months following the date of issuance, expire five years following the date of sale and have an exercise price per share of $2.50 per share. The Placement Agent Warrants, and the shares of Common Stock issuable upon exercise thereof, will be issued in reliance on the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Regulation D promulgated thereunder. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.50 per share, to be $181 using a Black Scholes model based on the following significant inputs: common stock price of $1.76; comparable company volatility of 100.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 0.31%.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Deemed Dividend Adjustment-Warrant Modified Terms Revaluation</i></b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 3, 2020, the Company issued an aggregate of 51,414 common shares in a cashless exercise of 56,625 warrants issued in December 2016 and November 2017. Consideration for the exercise of these warrants was the full settlement of an outstanding litigation reserve of $238.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 26, 2020, in connection with the private warrant inducement with an existing accredited investor to exercise 1,700,680 Original Warrants, the Company agreed to modify the terms of the Original Warrants that were originally issued on March 6, 2020 and on April 24, 2020. Pursuant to the agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Per recent proposed guidance of ASC 260, the Company determined that this was an exchange of the existing 1,700,680 warrants that were affected and the difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was a cost of raising capital and was recorded as a reduction of equity. The difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was calculated as $237, using a Black Scholes model based on the following significant inputs: On October 26, 2020: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 4.5-4.8 years; dividend yield of 0% and risk-free interest rate of 0.18%.</p><br/> The initial exercise price of these warrants was $30.00 per share. Pursuant to antidilution price adjustment protection contained within these warrants, the initial exercise price of these warrants was adjusted downward to $29.40 on July 24, 2018, the record date of the Right&#x2019;s Offering and downward to $19.00 per share on August 13, 2018. These warrants were further adjusted downward from $19.00 to $7.13 and to $2.1122 on January 28, 2020 and March 4, 2020, respectively, in connection with separate Registered Direct Offerings. These warrants were further adjusted downward from $2.1122 to $1.3659 on October 26, 2020 in connection with a Registered Direct Offering. 4553733 3.98603 232875 293000 20.00 P5Y 30.00 661000 20.00 0.738 P5Y 0.00 0.0187 The initial exercise price of these warrants was $30.00 per share, which adjusted downward to $29.40 on July 24, 2018, the record date of the Right&#x2019;s Offering and downward to $19.00 per share on August 13, 2018, the date of the Rights Offering, pursuant to antidilution price adjustment protection contained within these warrants. 19.00 7.13 285000 143501 7.90 0.738 P2Y299D 0.00 0.0145 2.1122 129000 143501 2.88 0.745 P2Y259D 0.00 0.0068 1.3659 22 143501 1.47 0.965 P2Y29D 0.00 0.0018 56696 56696 30.00 1700000 56696 36.40 1700000 56696 36.40 1700000 42.20 0.726 P5Y 0.00 0.028 17088 513000 267853 267853 23.00 23.00 3600000 18.80 1.590 P5Y 0.00 0.0277 In connection with the closing of the Rights Offering, the Company issued a warrant to purchase 13,393 shares of common stock to Maxim Partners LLC, an affiliate of the dealer-manager of the Rights Offering. The Company estimated the fair value of the common stock warrants, exercisable at $34.50 per share, to be $169 using a using a Monte Carlo model based on the following significant inputs: common stock price of $18.80; comparable company volatility of 159.0%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.77%. 8334 33.75 5 33.75 127000 26.80 1.333 P5Y 0.00 0.0207 353872 177500 9.00 0.738 P5Y 0.00 0.0153 176372 2.88 0.748 P5Y6M 0.00 0.0039 A holder (together with its affiliates) may not exercise any portion of the 2020 Warrants to the extent that the holder would own more than 4.99% of the outstanding common stock after exercise (the &#x201c;Beneficial Ownership Limitation&#x201d;), except that upon at least 61 days&#x2019; prior notice from the holder to us, the holder may increase the Beneficial Ownership Limitation up to 9.99% of the number of shares of our common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the 2020 Warrants. 145586 1428722 1574308 3.05 2025-04-24 0.879 P5Y 0.00 0.0018 In connection with the separate private placements concurrent with registered direct offerings of shares of the Company&#x2019;s common stock in January and March 2020, the Company issued to H.C. Wainwright &amp; Co., LLC, as placement agent, a warrant to purchase 13,228 shares of common stock and a warrant to purchase 13,313 shares of common stock. The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. These warrants have substantially similar terms as the 2020 Warrants described above, except that the placement agent warrant issued in January 2020 has an exercise price of $10.00 per share, and the placement agent warrant issued in March 2020 has an exercise price of $3.7563 per share. The Company estimated the fair value of the common stock warrants issued in January, with an exercise price of $10.00 per share, to be $58 using a Black Scholes model based on the following significant inputs: common stock price of $7.90; comparable company volatility of 73.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 1.53%. The Company estimated the fair value of the common stock warrants issued in March, with an exercise price of $3.7563 per share, to be $17 using a Black Scholes model based on the following significant inputs: common stock price of $2.35; comparable company volatility of 74.8%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.39%. In connection with the public offering of 145,586 Class A Units and 1,428,722 Class B Units on April 24, 2020, the Company issued to H.C. Wainwright &amp; Co., LLC, as placement agent, warrants to purchase 118,073 shares of common stock. The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. The Company estimated the fair value of the common stock warrants issued in January, with an exercise price of $10.00 per share, to be $58 using a Black Scholes model based on the following significant inputs: common stock price of $7.90; comparable company volatility of 73.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 1.53%. The Company estimated the fair value of the common stock warrants issued in March, with an exercise price of $3.7563 per share, to be $17 using a Black Scholes model based on the following significant inputs: common stock price of $2.35; comparable company volatility of 74.8%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.39%. In connection with the public offering of 145,586 Class A Units and 1,428,722 Class B Units on April 24, 2020, the Company issued to H.C. Wainwright &amp; Co., LLC, as placement agent, warrants to purchase 118,073 shares of common stock. The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. These warrants have substantially similar terms as the April 2020 Warrants described above, except that the placement agent warrant issued has an exercise price of $3.97 per share. The Company estimated the fair value of the common stock warrants issued in April, with an exercise price of $3.97 per share, to be $167 using a Black Scholes model based on the following significant inputs: common stock price of $2.40; comparable company volatility of 87.9%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued in October 2020 Private Warrant Inducement In October 2020, in connection with an inducement agreement with an existing accredited investor to exercise 1,700,680 outstanding warrants (the &#x201c;Original Warrants&#x201d;) to purchase an equal number of shares of the Company&#x2019;s common stock, the Company issued new unregistered warrants to purchase up to an aggregate of 1,700,680 shares of common stock at an exercise price of $1.725 per share. The warrants issued were immediately exercisable with an exercise period of five and one-half years from the date of issuance. The Original Warrants were issued on March 6, 2020 and on April 24, 2020. Pursuant to the Letter Agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. The Company estimated the fair value of the common stock warrants, exercisable at $1.725 per share, to be $1,806 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. In connection with the private warrant inducement in October 2020 of 1,700,680 shares of the Company&#x2019;s common warrants, the Company issued to H.C. Wainwright &amp; Co., LLC, as placement agent, warrants to purchase 85,034 shares of common stock. These warrants have substantially similar terms as the 2020 Warrants described above, except that the placement agent warrant issued in October 2020 has an exercise price of $2.156 per share. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.156 per share, to be $86 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued in February 2021 Private Placement Agreement In February 2021, in connection with a private placement agreement with certain institutional and accredited investors, the Company issued common stock warrants to purchase up to an aggregate of 2,194,427 shares of common stock at an exercise price of $2.216 per share. The warrants were exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The warrant holder may not exercise any portion of such holder&#x2019;s warrants to the extent that the holder, together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of the Company&#x2019;s outstanding shares of common stock immediately after exercise, except that upon at least 61 days&#x2019; prior notice from the holder to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise. The Company estimated the fair value of the common stock warrants, exercisable at $2.216 per share, to be $3,052 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued to Placement Agent in February 2021 Private Placement Agreement In connection with the private placement in February 2021, the Company issued to H.C. Wainwright &amp; Co., LLC, as placement agent, warrants to purchase up to 329,164 shares of Common Stock with an exercise price of $2.8481 per share. The warrants are exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.8481 per share, to be $435 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued to Placement Agent in March 2021 Registered Direct Offering On March 23, 2021, the Company consummated a registered direct offering with certain institutional investors and issued an aggregate of 1,975,000 shares of the Company&#x2019;s common stock, par value $0.001 per share at a purchase price of $2.00 per share for gross proceeds to the Company of approximately $3.95 million, before deducting fees payable to the placement agent and other estimated offering expenses payable by the Company. The 1,975,000 shares of Common Stock sold in the Offering were offered and sold pursuant to a prospectus, dated August 24, 2018, and a prospectus supplement, dated March 22, 2021, in connection with a takedown from the Company&#x2019;s shelf registration statement on Form S-3 (File No. 333-225712). In connection with the registered direct offering in March 2021, the Company issued to H.C. Wainwright &amp; Co., LLC, as the placement agent, warrants to purchase up to 148,125 shares of Common Stock. The Placement Agent Warrants will be exercisable commencing six months following the date of issuance, expire five years following the date of sale and have an exercise price per share of $2.50 per share. The Placement Agent Warrants, and the shares of Common Stock issuable upon exercise thereof, will be issued in reliance on the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Regulation D promulgated thereunder. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.50 per share, to be $181 using a Black Scholes model based on the following significant inputs: common stock price of $1.76; comparable company volatility of 100.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 0.31%. Deemed Dividend Adjustment-Warrant Modified Terms Revaluation On March 3, 2020, the Company issued an aggregate of 51,414 common shares in a cashless exercise of 56,625 warrants issued in December 2016 and November 2017. Consideration for the exercise of these warrants was the full settlement of an outstanding litigation reserve of $238. On October 26, 2020, in connection with the private warrant inducement with an existing accredited investor to exercise 1,700,680 Original Warrants, the Company agreed to modify the terms of the Original Warrants that were originally issued on March 6, 2020 and on April 24, 2020. Pursuant to the agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. Per recent proposed guidance of ASC 260, the Company determined that this was an exchange of the existing 1,700,680 warrants that were affected and the difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was a cost of raising capital and was recorded as a reduction of equity. The difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was calculated as $237, using a Black Scholes model based on the following significant inputs: On October 26, 2020: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 4.5-4.8 years; dividend yield of 0% and risk-free interest rate of 0.18%. The Company estimated the fair value of the common stock warrants issued in March, with an exercise price of $3.7563 per share, to be $17 using a Black Scholes model based on the following significant inputs: common stock price of $2.35; comparable company volatility of 74.8%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.39%. In connection with the public offering of 145,586 Class A Units and 1,428,722 Class B Units on April 24, 2020, the Company issued to H.C. Wainwright &amp; Co., LLC, as placement agent, warrants to purchase 118,073 shares of common stock. The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. These warrants have substantially similar terms as the April 2020 Warrants described above, except that the placement agent warrant issued has an exercise price of $3.97 per share. The Company estimated the fair value of the common stock warrants issued in April, with an exercise price of $3.97 per share, to be $167 using a Black Scholes model based on the following significant inputs: common stock price of $2.40; comparable company volatility of 87.9%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued in October 2020 Private Warrant Inducement In October 2020, in connection with an inducement agreement with an existing accredited investor to exercise 1,700,680 outstanding warrants (the &#x201c;Original Warrants&#x201d;) to purchase an equal number of shares of the Company&#x2019;s common stock, the Company issued new unregistered warrants to purchase up to an aggregate of 1,700,680 shares of common stock at an exercise price of $1.725 per share. The warrants issued were immediately exercisable with an exercise period of five and one-half years from the date of issuance. The Original Warrants were issued on March 6, 2020 and on April 24, 2020. Pursuant to the Letter Agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. The Company estimated the fair value of the common stock warrants, exercisable at $1.725 per share, to be $1,806 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. In connection with the private warrant inducement in October 2020 of 1,700,680 shares of the Company&#x2019;s common warrants, the Company issued to H.C. Wainwright &amp; Co., LLC, as placement agent, warrants to purchase 85,034 shares of common stock. These warrants have substantially similar terms as the 2020 Warrants described above, except that the placement agent warrant issued in October 2020 has an exercise price of $2.156 per share. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.156 per share, to be $86 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued in February 2021 Private Placement Agreement In February 2021, in connection with a private placement agreement with certain institutional and accredited investors, the Company issued common stock warrants to purchase up to an aggregate of 2,194,427 shares of common stock at an exercise price of $2.216 per share. The warrants were exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The warrant holder may not exercise any portion of such holder&#x2019;s warrants to the extent that the holder, together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of the Company&#x2019;s outstanding shares of common stock immediately after exercise, except that upon at least 61 days&#x2019; prior notice from the holder to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise. The Company estimated the fair value of the common stock warrants, exercisable at $2.216 per share, to be $3,052 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued to Placement Agent in February 2021 Private Placement Agreement In connection with the private placement in February 2021, the Company issued to H.C. Wainwright &amp; Co., LLC, as placement agent, warrants to purchase up to 329,164 shares of Common Stock with an exercise price of $2.8481 per share. The warrants are exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.8481 per share, to be $435 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued to Placement Agent in March 2021 Registered Direct Offering On March 23, 2021, the Company consummated a registered direct offering with certain institutional investors and issued an aggregate of 1,975,000 shares of the Company&#x2019;s common stock, par value $0.001 per share at a purchase price of $2.00 per share for gross proceeds to the Company of approximately $3.95 million, before deducting fees payable to the placement agent and other estimated offering expenses payable by the Company. The 1,975,000 shares of Common Stock sold in the Offering were offered and sold pursuant to a prospectus, dated August 24, 2018, and a prospectus supplement, dated March 22, 2021, in connection with a takedown from the Company&#x2019;s shelf registration statement on Form S-3 (File No. 333-225712). In connection with the registered direct offering in March 2021, the Company issued to H.C. Wainwright &amp; Co., LLC, as the placement agent, warrants to purchase up to 148,125 shares of Common Stock. The Placement Agent Warrants will be exercisable commencing six months following the date of issuance, expire five years following the date of sale and have an exercise price per share of $2.50 per share. The Placement Agent Warrants, and the shares of Common Stock issuable upon exercise thereof, will be issued in reliance on the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Regulation D promulgated thereunder. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.50 per share, to be $181 using a Black Scholes model based on the following significant inputs: common stock price of $1.76; comparable company volatility of 100.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 0.31%. Deemed Dividend Adjustment-Warrant Modified Terms Revaluation On March 3, 2020, the Company issued an aggregate of 51,414 common shares in a cashless exercise of 56,625 warrants issued in December 2016 and November 2017. Consideration for the exercise of these warrants was the full settlement of an outstanding litigation reserve of $238. On October 26, 2020, in connection with the private warrant inducement with an existing accredited investor to exercise 1,700,680 Original Warrants, the Company agreed to modify the terms of the Original Warrants that were originally issued on March 6, 2020 and on April 24, 2020. Pursuant to the agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. Per recent proposed guidance of ASC 260, the Company determined that this was an exchange of the existing 1,700,680 warrants that were affected and the difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was a cost of raising capital and was recorded as a reduction of equity. The difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was calculated as $237, using a Black Scholes model based on the following significant inputs: On October 26, 2020: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 4.5-4.8 years; dividend yield of 0% and risk-free interest rate of 0.18%. 145586 1428722 118073 3.97 The Company estimated the fair value of the common stock warrants issued in April, with an exercise price of $3.97 per share, to be $167 using a Black Scholes model based on the following significant inputs: common stock price of $2.40; comparable company volatility of 87.9%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued in October 2020 Private Warrant Inducement In October 2020, in connection with an inducement agreement with an existing accredited investor to exercise 1,700,680 outstanding warrants (the &#x201c;Original Warrants&#x201d;) to purchase an equal number of shares of the Company&#x2019;s common stock, the Company issued new unregistered warrants to purchase up to an aggregate of 1,700,680 shares of common stock at an exercise price of $1.725 per share. The warrants issued were immediately exercisable with an exercise period of five and one-half years from the date of issuance. The Original Warrants were issued on March 6, 2020 and on April 24, 2020. Pursuant to the Letter Agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. The Company estimated the fair value of the common stock warrants, exercisable at $1.725 per share, to be $1,806 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. In connection with the private warrant inducement in October 2020 of 1,700,680 shares of the Company&#x2019;s common warrants, the Company issued to H.C. Wainwright &amp; Co., LLC, as placement agent, warrants to purchase 85,034 shares of common stock. These warrants have substantially similar terms as the 2020 Warrants described above, except that the placement agent warrant issued in October 2020 has an exercise price of $2.156 per share. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.156 per share, to be $86 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued in February 2021 Private Placement Agreement In February 2021, in connection with a private placement agreement with certain institutional and accredited investors, the Company issued common stock warrants to purchase up to an aggregate of 2,194,427 shares of common stock at an exercise price of $2.216 per share. The warrants were exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The warrant holder may not exercise any portion of such holder&#x2019;s warrants to the extent that the holder, together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of the Company&#x2019;s outstanding shares of common stock immediately after exercise, except that upon at least 61 days&#x2019; prior notice from the holder to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise. The Company estimated the fair value of the common stock warrants, exercisable at $2.216 per share, to be $3,052 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued to Placement Agent in February 2021 Private Placement Agreement In connection with the private placement in February 2021, the Company issued to H.C. Wainwright &amp; Co., LLC, as placement agent, warrants to purchase up to 329,164 shares of Common Stock with an exercise price of $2.8481 per share. The warrants are exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.8481 per share, to be $435 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued to Placement Agent in March 2021 Registered Direct Offering On March 23, 2021, the Company consummated a registered direct offering with certain institutional investors and issued an aggregate of 1,975,000 shares of the Company&#x2019;s common stock, par value $0.001 per share at a purchase price of $2.00 per share for gross proceeds to the Company of approximately $3.95 million, before deducting fees payable to the placement agent and other estimated offering expenses payable by the Company. The 1,975,000 shares of Common Stock sold in the Offering were offered and sold pursuant to a prospectus, dated August 24, 2018, and a prospectus supplement, dated March 22, 2021, in connection with a takedown from the Company&#x2019;s shelf registration statement on Form S-3 (File No. 333-225712). In connection with the registered direct offering in March 2021, the Company issued to H.C. Wainwright &amp; Co., LLC, as the placement agent, warrants to purchase up to 148,125 shares of Common Stock. The Placement Agent Warrants will be exercisable commencing six months following the date of issuance, expire five years following the date of sale and have an exercise price per share of $2.50 per share. The Placement Agent Warrants, and the shares of Common Stock issuable upon exercise thereof, will be issued in reliance on the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Regulation D promulgated thereunder. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.50 per share, to be $181 using a Black Scholes model based on the following significant inputs: common stock price of $1.76; comparable company volatility of 100.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 0.31%. Deemed Dividend Adjustment-Warrant Modified Terms Revaluation On March 3, 2020, the Company issued an aggregate of 51,414 common shares in a cashless exercise of 56,625 warrants issued in December 2016 and November 2017. Consideration for the exercise of these warrants was the full settlement of an outstanding litigation reserve of $238. On October 26, 2020, in connection with the private warrant inducement with an existing accredited investor to exercise 1,700,680 Original Warrants, the Company agreed to modify the terms of the Original Warrants that were originally issued on March 6, 2020 and on April 24, 2020. Pursuant to the agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. Per recent proposed guidance of ASC 260, the Company determined that this was an exchange of the existing 1,700,680 warrants that were affected and the difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was a cost of raising capital and was recorded as a reduction of equity. The difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was calculated as $237, using a Black Scholes model based on the following significant inputs: On October 26, 2020: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 4.5-4.8 years; dividend yield of 0% and risk-free interest rate of 0.18%. 1700680 1700680 1.725 P5Y The Original Warrants were issued on March 6, 2020 and on April 24, 2020. Pursuant to the Letter Agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. The Company estimated the fair value of the common stock warrants, exercisable at $1.725 per share, to be $1,806 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. 1700680 85034 2.156 2.156 86000 1.47 0.965 P5Y6M 0.00 0.0018 2194427 2.216 The warrant holder may not exercise any portion of such holder&#x2019;s warrants to the extent that the holder, together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of the Company&#x2019;s outstanding shares of common stock immediately after exercise, except that upon at least 61 days&#x2019; prior notice from the holder to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise. 2.216 3052000 1.93 0.956 P5Y6M 0.00 0.0018 329164 2.8481 2.8481 435000 1.93 0.956 P5Y6M 0.00 0.0018 1975000 0.001 2.00 3950000 1975000 148125 P5Y 2.50 2.50 181000 1.76 1.008 P5Y 0.00 0.0031 the Company issued an aggregate of 51,414 common shares in a cashless exercise of 56,625 warrants issued in December 2016 and November 2017. Consideration for the exercise of these warrants was the full settlement of an outstanding litigation reserve of $238. 1700680 the Company agreed to modify the terms of the Original Warrants that were originally issued on March 6, 2020 and on April 24, 2020. Pursuant to the agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. 1700680 237000 1.47 0.965 P4Y6M P8Y 0.00 0.0018 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 7pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td> <td style="text-align: center">&#xa0;</td><td style="font-weight: bold; text-align: center">&#xa0;</td> <td style="font-weight: bold; text-align: center">Term</td><td style="font-weight: bold; text-align: center">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold; text-align: center">&#xa0;</td><td style="font-weight: bold; text-align: center">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">Balance</td><td style="font-weight: bold; text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td> <td colspan="2" style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td> <td colspan="2" style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td> <td colspan="2" style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td><td style="font-weight: bold; text-align: center">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">Balance</td><td style="font-weight: bold; text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td> <td colspan="2" style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td> <td colspan="2" style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td> <td colspan="2" style="text-align: center">&#xa0;</td><td style="text-align: center">&#xa0;</td><td style="font-weight: bold; text-align: center">&#xa0;</td> <td colspan="2" style="font-weight: bold; text-align: center">Balance</td><td style="font-weight: bold; text-align: center">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issue&#xa0;Date</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrant&#xa0;Type</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Date</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#xa0;31,&#xa0;2019</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercised</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expired</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#xa0;31,&#xa0;2020</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercised</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expired</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March&#xa0;31,&#xa0;2021</td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: center">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: center">&#xa0;</td><td>&#xa0;</td><td>&#xa0;</td> <td colspan="2" style="text-align: right">&#xa0;</td><td>&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; width: 8%">2016 and prior</td><td style="width: 1%">&#xa0;</td> <td style="width: 10%; text-align: center">Various</td><td style="width: 1%">&#xa0;</td> <td style="width: 10%; text-align: center">Various-2020/2021</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">Various</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">17,059</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">(9,375</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">(7,684</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 1%">&#xa0;</td> <td style="width: 1%; text-align: left">&#xa0;</td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">November 21,2017</td><td>&#xa0;</td> <td style="text-align: center">Common Stock Offering Warrants</td><td>&#xa0;</td> <td style="text-align: center">November 21, 2022</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">1.3659</td><td style="text-align: left"><sup>(1)</sup></td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">143,501</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">143,501</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">143,501</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">November 21,2017</td><td>&#xa0;</td> <td style="text-align: center">Dealer Manager Warrants</td><td>&#xa0;</td> <td style="text-align: center">November 21, 2022</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">30.00</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">47,250</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">(47,250</td><td style="text-align: left">)</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">June 20,2018</td><td>&#xa0;</td> <td style="text-align: center">Warrant Reissue</td><td>&#xa0;</td> <td style="text-align: center">December 20, 2023</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">36.40</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">56,696</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">56,696</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">56,696</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">August 13,2018</td><td>&#xa0;</td> <td style="text-align: center">Rights Offering Warrants</td><td>&#xa0;</td> <td style="text-align: center">July 25, 2023</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">23.00</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">202,943</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">202,943</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">202,943</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">August 13,2018</td><td>&#xa0;</td> <td style="text-align: center">Dealer Manager Warrants</td><td>&#xa0;</td> <td style="text-align: center">August 13, 2023</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">34.50</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,393</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,393</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,393</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">July 16,2019</td><td>&#xa0;</td> <td style="text-align: center">Dealer Manager Warrants</td><td>&#xa0;</td> <td style="text-align: center">July 11, 2024</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">33.75</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">8,334</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">8,334</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">8,334</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">January 28,2020</td><td>&#xa0;</td> <td style="text-align: center">Registered Direct Offering</td><td>&#xa0;</td> <td style="text-align: center">July 28,2025</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">9.00</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">177,500</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">177,500</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">177,500</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">January 28,2020</td><td>&#xa0;</td> <td style="text-align: center">Dealer Manager Warrants</td><td>&#xa0;</td> <td style="text-align: center">July 28,2025</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">10.00</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,315</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,315</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,315</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">March 6,2020</td><td>&#xa0;</td> <td style="text-align: center">Registered Direct Offering</td><td>&#xa0;</td> <td style="text-align: center">September 8,2025</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">2.88</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">176,372</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">(176,372</td><td style="text-align: left">)</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">March 6,2020</td><td>&#xa0;</td> <td style="text-align: center">Dealer Manager Warrants</td><td>&#xa0;</td> <td style="text-align: center">March 4,2025</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">3.76</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,228</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,228</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">13,228</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">April 21,2020</td><td>&#xa0;</td> <td style="text-align: center">Dealer Manager Warrants</td><td>&#xa0;</td> <td style="text-align: center">April 21,2025</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">3.97</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">118,073</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">118,073</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">118,073</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">April 24,2020</td><td>&#xa0;</td> <td style="text-align: center">Registered Direct Offering</td><td>&#xa0;</td> <td style="text-align: center">April 24,2025</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">3.05</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">1,574,308</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">(1,524,308</td><td style="text-align: left">)</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">October 26, 2020</td><td>&#xa0;</td> <td style="text-align: center">Private Warrant Inducement</td><td>&#xa0;</td> <td style="text-align: center">April 27,2026</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">1.73</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">1,700,680</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">1,700,680</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">(700,680</td><td style="text-align: left">)</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">1,000,000</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">October 26, 2020</td><td>&#xa0;</td> <td style="text-align: center">Dealer Manager Warrants</td><td>&#xa0;</td> <td style="text-align: center">April 27,2026</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">2.16</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">85,034</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">85,034</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">85,034</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">February 2, 2021</td><td>&#xa0;</td> <td style="text-align: center">Private Placement Agreement</td><td>&#xa0;</td> <td style="text-align: center">August 2,2026</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">2.216</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">2,194,427</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">2,194,427</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">February 2, 2021</td><td>&#xa0;</td> <td style="text-align: center">Dealer Manager Warrants</td><td>&#xa0;</td> <td style="text-align: center">August 2,2026</td><td>&#xa0;</td> <td style="text-align: left">$</td><td style="text-align: right">2.848</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">-</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">329,164</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">329,164</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: center">March 23, 2021</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: center">Dealer Manager Warrants</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: center">March 23, 2026</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">2.50</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: right">148,125</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: right">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: right">&#xa0;</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">148,125</td><td style="padding-bottom: 1.5pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: center">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td>&#xa0;</td> <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="text-align: right; padding-bottom: 4pt">&#xa0;</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; border-bottom: Black 4pt double">&#xa0;</td><td style="text-align: right; border-bottom: Black 4pt double">489,176</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="text-align: right; padding-bottom: 4pt">&#xa0;</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="text-align: right; padding-bottom: 4pt">&#xa0;</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="text-align: right; padding-bottom: 4pt">&#xa0;</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; border-bottom: Black 4pt double">&#xa0;</td><td style="text-align: right; border-bottom: Black 4pt double">2,582,697</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="text-align: right; padding-bottom: 4pt">&#xa0;</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="text-align: right; padding-bottom: 4pt">&#xa0;</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="text-align: right; padding-bottom: 4pt">&#xa0;</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td><td style="padding-bottom: 4pt">&#xa0;</td> <td style="text-align: left; border-bottom: Black 4pt double">&#xa0;</td><td style="text-align: right; border-bottom: Black 4pt double">4,553,733</td><td style="text-align: left; padding-bottom: 4pt">&#xa0;</td></tr> </table> 2016 and prior Various-2020/2021 Various 17059 -9375 -7684 November 21,2017 November 21, 2022 $1.3659 143501 143501 143501 November 21,2017 November 21, 2022 $30.00 47250 -47250 June 20,2018 December 20, 2023 $36.40 56696 56696 56696 August 13,2018 July 25, 2023 $23.00 202943 202943 202943 August 13,2018 August 13, 2023 $34.50 13393 13393 13393 July 16,2019 July 11, 2024 $33.75 8334 8334 8334 January 28,2020 July 28,2025 $9.00 177500 177500 177500 January 28,2020 July 28,2025 $10.00 13315 13315 13315 March 6,2020 September 8,2025 $2.88 176372 -176372 March 6,2020 March 4,2025 $3.76 13228 13228 13228 April 21,2020 April 21,2025 $3.97 118073 118073 118073 April 24,2020 April 24,2025 $3.05 1574308 -1524308 50000 50000 October 26, 2020 April 27,2026 $1.73 1700680 1700680 -700680 1000000 October 26, 2020 April 27,2026 $2.16 85034 85034 85034 February 2, 2021 August 2,2026 $2.216 2194427 2194427 February 2, 2021 August 2,2026 $2.848 329164 329164 March 23, 2021 March 23, 2026 $2.50 148125 148125 489176 2582697 4553733 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 10 - Stockholders&#x2019; Deficit</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Capital Stock</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company was organized under the laws of the state of Nevada on July 27, 2004 and was subsequently reincorporated under the laws of the state of Delaware on November 10, 2015. In connection with the reincorporation, as approved by the stockholders, the Company changed its authorized capital stock to consist of (i) 100 million shares of common stock, $.001 par value, and (ii) 2 million shares of preferred stock, $0.001 par value, designated as Series A convertible preferred stock. In December 2015, the Company amended its Certificate of Incorporation to change its authorized capital stock to provide for 15 million authorized shares of preferred stock of which 7,515,000 was designated as Series B convertible preferred stock, par value $.001 per share.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to November 10, 2015, the Company&#x2019;s authorized capital stock consisted of 100 million shares of common stock, $.001 par value, and 10 million shares of preferred stock, $.001 par value.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Common Stock</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had 12,164,046 and 5,099,512 shares of common stock issued and outstanding as of March 31, 2021 and December 31, 2020, respectively.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended March 31, 2021, the Company issued 7,064,534 shares of common stock as follows:</p><br/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; padding-right: 5.4pt; padding-left: 5.4pt">&#xa0;</td> <td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#x25cf;</font></td> <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an aggregate of 4,388,854 shares in connection with a private placement offering and exercise of pre-funded warrants issued in connection with the offering, generating net proceeds to the Company in February 2021 of approximately $8,898, as further described below;&#xa0;</font></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#xa0;</td> <td>&#xa0;</td> <td>&#xa0;</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#xa0;</td> <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#x25cf;</font></td> <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an aggregate of 1,975,000 shares in connection with a registered direct offering generating net proceeds to the Company in March 2021 of approximately $3,523, as further described below;&#xa0;and</font></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#xa0;</td> <td>&#xa0;</td> <td>&#xa0;</td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#xa0;</td> <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#x25cf;</font></td> <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an aggregate of 700,680 shares in connection with the exercise of common stock warrants, generating net proceeds to the Company in March 2020 of approximately $1,209, as further described below.</font></td></tr> <tr style="vertical-align: top"> <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#xa0;</td> <td>&#xa0;</td> <td>&#xa0;</td></tr> </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Public Offerings and Registered Direct Offerings </b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 2, 2021, the Company consummated a private placement agreement with certain institutional and accredited investors and issued an aggregate of 3,968,854 shares of its common stock, par value $0.001 per share at a purchase price of $2.2785 per share, pre-funded warrants to purchase up to an aggregate of 420,000 shares of common stock at a purchase price of $2.2775 per pre-funded warrant and associated warrants to purchase up to an aggregate of 2,194,427 shares of common stock, for gross proceeds of approximately $10.0 million, prior to deducting placement agent fees and offering expenses. At March 29, 2021, all 420,000 pre-funded shares had been distributed. In connection with the offering, we issued the placement agent warrants to purchase up to 329,164 shares of Common Stock with an exercise price of $2.8481 per share.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 23, 2021, the Company consummated a registered direct offering with certain institutional investors and issued an aggregate of 1,975,000 shares of the Company&#x2019;s common stock, par value $0.001 per share at a purchase price of $2.00 per share for gross proceeds to the Company of approximately $3.95 million, pursuant to a prospectus, dated August 24, 2018, and a prospectus supplement, dated March 22, 2021, in connection with a takedown from the Company&#x2019;s shelf registration statement on Form S-3 (File No. 333-225712).</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the offering, we issued the placement agent warrants to purchase up to 148,125 shares of Common Stock at an exercise price per share of $2.50 per share.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 19, 2021, the Company issued an aggregate of 700,680 shares of commons stock for the exercise of certain warrants. The net proceeds to the Company for these exercises was $1,209.</p><br/> 100000000 1 2000000 0.001 15000000 7515000 the Company&#x2019;s authorized capital stock consisted of 100 million shares of common stock, $.001 par value, and 10 million shares of preferred stock, $.001 par value. 7064534 4388854 8898000 1975000 3523000 700680 1209000 3968854 0.001 2.2785 420000 2.2775 2194427 10000000 all 420,000 pre-funded shares had been distributed. In connection with the offering, we issued the placement agent warrants to purchase up to 329,164 shares of Common Stock with an exercise price of $2.8481 per share. the Company consummated a registered direct offering with certain institutional investors and issued an aggregate of 1,975,000 shares of the Company&#x2019;s common stock, par value $0.001 per share at a purchase price of $2.00 per share for gross proceeds to the Company of approximately $3.95 million, pursuant to a prospectus, dated August 24, 2018, and a prospectus supplement, dated March 22, 2021, in connection with a takedown from the Company&#x2019;s shelf registration statement on Form S-3 (File No. 333-225712). 148125 2.50 700680 1209000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 11 - Stock-based Compensation </b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 12, 2018, the Company&#x2019;s stockholders approved the 2018 Equity Incentive Plan (the &#x201c;2018 Plan&#x201d;) to replace the Company&#x2019;s 2015 Equity Incentive Plan (the &#x201c;2015 Plan&#x201d;). On July 8, 2020, the Company&#x2019;s stockholders approved an amendment to the 2018 Plan to increase the number of shares of common stock available for issuance under the 2018 Plan by 800,000 shares from 50,000 to 850,000. In addition, up to 122,279 shares of our common stock previously reserved for issuance under the 2015 Plan are available for issuance under the 2018 Plan to the extent such shares were available for issuance under the 2015 Plan as of June 12, 2018 or thereafter cease to be subject to awards outstanding under the 2015 Plan, such as by expiration, cancellation, or forfeiture of such awards.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock options are generally issued with a per share exercise price equal to no less than fair market value of our common stock at the date of grant. Options granted under the 2018 Plan generally vest immediately, or ratably over a two- to 36-month period coinciding with their respective service periods. Options under the 2018 Plan generally have a term of five years. Certain stock option awards provide for accelerated vesting upon a change in control.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2021, the Company had 419,061 shares of common stock available for issuance under the 2018 Plan.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company measures the fair value of stock options with service-based vesting criteria to employees, directors and consultants on the date of grant using the Black-Scholes option pricing model. The Black-Scholes valuation model requires the Company to make certain estimates and assumptions, including assumptions related to the expected price volatility of the Company&#x2019;s stock, the period during which the options will be outstanding, the rate of return on risk-free investments, and the expected dividend yield for the Company&#x2019;s stock.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The weighted-average assumptions used in the Black-Scholes option-pricing model used to calculate the fair value of options granted during the three months ended March 31, 2021 were as follows:</p><br/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 86%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</font></td> <td style="width: 1%">&#xa0;</td> <td style="width: 1%">&#xa0;</td> <td style="width: 9%; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96.2</font></td> <td style="width: 2%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</font></td> <td style="width: 1%">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected dividend yield</font></td> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#x2014;</font></td> <td>&#xa0;</td> <td>&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (in years)</font></td> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</font></td> <td>&#xa0;</td> <td>&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</font></td> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#xa0;0.26</font></td> <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</font></td> <td>&#xa0;</td></tr> </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The weighted average grant date fair value of options granted during the three months ended March 31, 2021 was $1.94 per share, as per the table above.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the Company&#x2019;s limited operating history and lack of company-specific historical or implied volatility, the expected volatility assumption was determined based on historical volatilities from traded options of biotech companies of comparable size and stability, whose share prices are publicly available. The expected term of options granted to employees is calculated based on the mid-point between the vesting date and the end of the contractual term according to the simplified method as described in SEC Staff Accounting Bulletin 110 because the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term due to the limited period of time its awards have been outstanding. For non-employee options, the expected term of options granted is the contractual term of the options. The risk-free interest rate is determined by reference to the implied yields of U.S. Treasury securities with a remaining term equal to the expected term assumed at the time of grant. The expected dividend assumption is based on the Company&#x2019;s history and expectation of dividend payouts. The Company has not paid and does not intend to pay dividends.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes the stock option activity, for both equity plans, for the periods indicated as follows:&#xa0;</p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number&#xa0;of<br/> Options</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price&#xa0;Per<br/> Share</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> Term<br/> (years)</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Aggregate<br/> Intrinsic<br/> Value (1)</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt">Outstanding at December 31, 2020</td><td style="width: 1%; font-size: 10pt">&#xa0;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 9%; font-size: 10pt; text-align: right">496,471</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 1%; font-size: 10pt">&#xa0;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">8.63</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 1%; font-size: 10pt">&#xa0;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 9%; font-size: 10pt; text-align: right">3.9</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 1%; font-size: 10pt">&#xa0;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">&#x2014;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt">Granted</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">12,756</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1.84</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">4.8</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Exercised</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt">Forfeited</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">(2,375</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.5pt">Expired</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">&#x2014;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right">&#x2014;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right">&#x2014;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right">&#x2014;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; padding-bottom: 4pt">Outstanding at March 31, 2021</td><td style="font-size: 10pt; padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">&#xa0;</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">506,852</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">$</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: right">8.15</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: right">2.3</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">$</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: right">&#x2014;</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Exercisable at March 31, 2021</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">228,481</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">14.45</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">2.1</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr> </table><br/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</font></td> <td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate intrinsic value in the table was calculated based on the difference between the estimated fair market value of the Company&#x2019;s stock and the exercise price of the underlying options. The estimated stock values used in the calculation were $1.73 and $1.66 per share for the year ended December 31, 2020 and the three months ended March 31, 2021, respectively.</font></td></tr> </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Restricted Stock Units</i></b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes restricted stock unit activity for the three months ended March 31, 2021:</p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number &#xa0;of<br/> Units</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average<br/> Grant-Date Fair<br/> Value Per Unit</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-indent: -9pt; padding-left: 9pt">Outstanding as of December 31, 2020</td><td style="width: 1%; font-size: 10pt">&#xa0;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 9%; font-size: 10pt; text-align: right">32,072</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 1%; font-size: 10pt">&#xa0;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">4.05</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-indent: -9pt; padding-left: 9pt">Granted</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -9pt; padding-left: 9pt">Vested</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">(667</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1.80</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-indent: -9pt; padding-left: 9pt">Forfeited</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -9pt; padding-left: 9pt">Outstanding as of March 31, 2021</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">31,405</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">2.58</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr> </table><br/><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"><tr><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The stock-based compensation expense was recorded as follows:</p><br/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended<br/> March 31,</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Research and development</td><td style="width: 1%; font-size: 10pt">&#xa0;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">2</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 1%; font-size: 10pt">&#xa0;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">3</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Selling, general and administrative</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">153</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">148</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total stock-based compensation expense</td><td style="font-size: 10pt; padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">155</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">151</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">&#xa0;</td></tr> </table><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The allocation between research and development and selling, general and administrative expense was based on the department and services performed by the employee or non-employee.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At March 31, 2021, the total compensation cost related to restricted stock units and unvested options not yet recognized was $629, which will be recognized over a weighted average period of 34 months, assuming the employees and non-employee<b>s</b> complete their service period required for vesting.</p><br/> 800000 50000 850000 122279 Options granted under the 2018 Plan generally vest immediately, or ratably over a two- to 36-month period coinciding with their respective service periods. P5Y 419061 1.94 1.73 1.66 629000 34 months <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 86%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</font></td> <td style="width: 1%">&#xa0;</td> <td style="width: 1%">&#xa0;</td> <td style="width: 9%; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96.2</font></td> <td style="width: 2%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</font></td> <td style="width: 1%">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected dividend yield</font></td> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#x2014;</font></td> <td>&#xa0;</td> <td>&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (in years)</font></td> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</font></td> <td>&#xa0;</td> <td>&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</font></td> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#xa0;0.26</font></td> <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</font></td> <td>&#xa0;</td></tr> </table> 0.962 P5Y 0.0026 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number&#xa0;of<br/> Options</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price&#xa0;Per<br/> Share</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> Term<br/> (years)</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Aggregate<br/> Intrinsic<br/> Value (1)</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt">Outstanding at December 31, 2020</td><td style="width: 1%; font-size: 10pt">&#xa0;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 9%; font-size: 10pt; text-align: right">496,471</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 1%; font-size: 10pt">&#xa0;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">8.63</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 1%; font-size: 10pt">&#xa0;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 9%; font-size: 10pt; text-align: right">3.9</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 1%; font-size: 10pt">&#xa0;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">&#x2014;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt">Granted</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">12,756</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1.84</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">4.8</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Exercised</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt">Forfeited</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">(2,375</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.5pt">Expired</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">&#x2014;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right">&#x2014;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right">&#x2014;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right">&#x2014;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; padding-bottom: 4pt">Outstanding at March 31, 2021</td><td style="font-size: 10pt; padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">&#xa0;</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">506,852</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">$</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: right">8.15</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: right">2.3</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">$</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: right">&#x2014;</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Exercisable at March 31, 2021</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">228,481</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">14.45</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">2.1</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr> </table> 496471 8.63 P3Y328D 12756 1.84 P4Y292D 2375 506852 8.15 P2Y109D 228481 14.45 P2Y36D <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number &#xa0;of<br/> Units</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average<br/> Grant-Date Fair<br/> Value Per Unit</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-indent: -9pt; padding-left: 9pt">Outstanding as of December 31, 2020</td><td style="width: 1%; font-size: 10pt">&#xa0;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 9%; font-size: 10pt; text-align: right">32,072</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 1%; font-size: 10pt">&#xa0;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">4.05</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-indent: -9pt; padding-left: 9pt">Granted</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -9pt; padding-left: 9pt">Vested</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">(667</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1.80</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-indent: -9pt; padding-left: 9pt">Forfeited</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#x2014;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -9pt; padding-left: 9pt">Outstanding as of March 31, 2021</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">31,405</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">2.58</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr> </table> 32072 4.05 667 1.80 31405 2.58 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended<br/> March 31,</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom"> <td>&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Research and development</td><td style="width: 1%; font-size: 10pt">&#xa0;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">2</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 1%; font-size: 10pt">&#xa0;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">3</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Selling, general and administrative</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">153</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&#xa0;</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">148</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total stock-based compensation expense</td><td style="font-size: 10pt; padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">155</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">151</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">&#xa0;</td></tr> </table> 153000 148000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 12 - Commitments and Contingencies</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Legal Proceedings</i>&#xa0;</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company may be subject to legal proceedings and claims arising from contracts or other matters from time to time in the ordinary course of business. Management is not aware of any pending or threatened litigation where the ultimate disposition or resolution could have a material adverse effect on its financial position, results of operations or liquidity.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Lease Commitments</i></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2012, the Company entered into an operating lease for its then corporate headquarters in Flagstaff, Arizona, which expired in December 2019. In December 2019, we extended the lease for only the manufacturing facilities located in Flagstaff, Arizona, occupying a total of 7,632 square feet of space. The lease for these manufacturing facilities expired in December 2020.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 16, 2016, we leased an additional 1,954 square feet of research and development space, also in Flagstaff. This lease expired on November 15, 2018 but was extended for an additional 24 months, through November 2020. A subsequent amendment to the lease allows for the Company to cancel the lease at any time through the lease term with 30 days&#x2019; notice. The Company provided a 30-day cancellation notice effective February 2020.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 1, 2019, we entered into a lease for our corporate headquarters in Phoenix, Arizona where we lease and occupy approximately 5,529 square feet of office space. This lease expires in November 2024.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 1, 2020, we entered into a lease for our manufacturing and research facility in Phoenix, Arizona where we occupy approximately 5,105 square feet of manufacturing and warehouse space. This lease expires on November 30, 2024.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that our existing facilities are adequate and meet our current needs for business, manufacturing and research.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rent expense was $54 and $69 for the three months ended March 31, 2021 and 2020, respectively. The future minimum lease payments under non-cancellable operating lease and future minimum finance lease payments as of March 31, 2021 are follows:</p><br/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Years Ending December 31,</b></font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Finance</b></font><br/> <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Leases</b></font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating</b></font><br/> <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease</b></font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</font></td> <td style="width: 1%">&#xa0;</td> <td style="width: 1%">&#xa0;</td> <td style="text-align: right; width: 9%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</font></td> <td style="width: 1%">&#xa0;</td> <td style="width: 1%">&#xa0;</td> <td style="width: 1%">&#xa0;</td> <td style="text-align: right; width: 9%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">142</font></td> <td style="width: 1%">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</font></td> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</font></td> <td>&#xa0;</td> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">194</font></td> <td>&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</font></td> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</font></td> <td>&#xa0;</td> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">198</font></td> <td>&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186</font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total minimum lease payments</font></td> <td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</font></td> <td style="border-bottom: Black 4pt double; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</font></td> <td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</font></td> <td style="border-bottom: Black 4pt double; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">720</font></td> <td style="padding-bottom: 4pt">&#xa0;</td></tr> </table><br/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Finance </b></font><br/> <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Leases</b></font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 88%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: amounts representing interest (ranging from 11.43% to 14.68%)</font></td> <td style="width: 1%">&#xa0;</td> <td style="width: 1%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</font></td> <td style="width: 1%">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of minimum lease payments</font></td> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</font></td> <td>&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: current installments under finance lease obligations</font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total long-term portion</font></td> <td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</font></td> <td style="border-bottom: Black 4pt double; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</font></td> <td style="padding-bottom: 4pt">&#xa0;</td></tr> </table><br/> 7632 1954 This lease expired on November 15, 2018 but was extended for an additional 24 months, through November 2020. we entered into a lease for our corporate headquarters in Phoenix, Arizona where we lease and occupy approximately 5,529 square feet of office space. This lease expires in November 2024. we entered into a lease for our manufacturing and research facility in Phoenix, Arizona where we occupy approximately 5,105 square feet of manufacturing and warehouse space. This lease expires on November 30, 2024. 54000 69000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Years Ending December 31,</b></font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Finance</b></font><br/> <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Leases</b></font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating</b></font><br/> <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease</b></font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</font></td> <td style="width: 1%">&#xa0;</td> <td style="width: 1%">&#xa0;</td> <td style="text-align: right; width: 9%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</font></td> <td style="width: 1%">&#xa0;</td> <td style="width: 1%">&#xa0;</td> <td style="width: 1%">&#xa0;</td> <td style="text-align: right; width: 9%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">142</font></td> <td style="width: 1%">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</font></td> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</font></td> <td>&#xa0;</td> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">194</font></td> <td>&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</font></td> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</font></td> <td>&#xa0;</td> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">198</font></td> <td>&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186</font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total minimum lease payments</font></td> <td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</font></td> <td style="border-bottom: Black 4pt double; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</font></td> <td style="padding-bottom: 4pt">&#xa0;</td> <td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</font></td> <td style="border-bottom: Black 4pt double; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">720</font></td> <td style="padding-bottom: 4pt">&#xa0;</td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1.5pt">&#xa0;</td> <td style="padding-bottom: 1.5pt">&#xa0;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Finance </b></font><br/> <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Leases</b></font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 88%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: amounts representing interest (ranging from 11.43% to 14.68%)</font></td> <td style="width: 1%">&#xa0;</td> <td style="width: 1%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</font></td> <td style="width: 1%">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of minimum lease payments</font></td> <td>&#xa0;</td> <td>&#xa0;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</font></td> <td>&#xa0;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: current installments under finance lease obligations</font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid">&#xa0;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</font></td> <td style="padding-bottom: 1.5pt">&#xa0;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total long-term portion</font></td> <td style="padding-bottom: 4pt">&#xa0;</td> <td style="border-bottom: Black 4pt double"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</font></td> <td style="border-bottom: Black 4pt double; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</font></td> <td style="padding-bottom: 4pt">&#xa0;</td></tr> </table> 43000 142000 28000 194000 198000 186000 71000 720000 5000 66000 52000 14000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 13 - Subsequent Events</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>[Share Issuances for Services&#xa0;</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 8, 2021, the Company issued 667 shares of common stock for service for restricted stock units that vested on that date.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 29, 2021, the Company net issued 20,284 shares of common stock for service for the net settlement of restricted stock units that vested on that date.&#xa0;The shares of common stock withheld were used to satisfy required withholding tax liability in connection with the vesting of shares.]</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>COVID-19</b></p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The travel and other restrictions that began in March 2020 in response to the COVID-19 global pandemic have resulted in a significant slowdown in our field studies and sales efforts. We were able to resume some projects by mid-year 2020, however, we still have delays on certain projects that might remain on hold until certain government restrictions are lifted. These continued delays have impacted our results of operations and could impact our results in future quarters. In addition, extended stay at home orders and other social distancing initiatives continue to severely limit our ability to communicate with current and potential commercial customers. The COVID-19 pandemic is also placing a significant budgetary burden on federal, state and local governments, which may impede or delay their ability to purchase our products.</p><br/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has evaluated subsequent events from the balance sheet date through May 14, 2021, the date at which the financial statements were issued, and determined that there were no other items that require adjustment to or disclosure in the financial statements.&#xa0;</p><br/> 667 20284 EX-101.SCH 7 snes-20210331.xsd XBRL SCHEMA FILE 001 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Statements of Operations and Comprehensive Loss (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Organization and Description of Business link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Credit Risk link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Prepaid Expenses link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Property and Equipment link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Accrued Expenses link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Borrowings link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Common Stock Warrants and Common Stock Warrant Liability link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Stockholders’ Deficit link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Stock-based Compensation link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Prepaid Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Property and Equipment (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Borrowings (Tables) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Common Stock Warrants and Common Stock Warrant Liability (Tables) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Stock-based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Organization and Description of Business (Details) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of inventory link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of employee stock-based compensation expense link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of outstanding potentially dilutive securities calculation of diluted loss per share attributable to common stockholders link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Credit Risk (Details) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Prepaid Expenses (Details) - Schedule of prepaid expenses link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Property and Equipment (Details) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Property and Equipment (Details) - Schedule of property and equipment link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Accrued Expenses (Details) - Schedule of accrued expenses link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Borrowings (Details) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Borrowings (Details) - Schedule of capital lease obligations link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Common Stock Warrants and Common Stock Warrant Liability (Details) link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Common Stock Warrants and Common Stock Warrant Liability (Details) - Schedule of common stock warrant activity link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Stockholders’ Deficit (Details) link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - Stock-based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - Stock-based Compensation (Details) - Schedule of fair value of options granted link:presentationLink link:definitionLink link:calculationLink 045 - Disclosure - Stock-based Compensation (Details) - Schedule of stock option activity link:presentationLink link:definitionLink link:calculationLink 046 - Disclosure - Stock-based Compensation (Details) - Schedule of summarizes restricted stock unit activity link:presentationLink link:definitionLink link:calculationLink 047 - Disclosure - Stock-based Compensation (Details) - Schedule of stock-based compensation expense link:presentationLink link:definitionLink link:calculationLink 048 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 049 - Disclosure - Commitments and Contingencies (Details) - Schedule of future minimum lease payments under non-cancellable operating lease and future minimum capital lease payments link:presentationLink link:definitionLink link:calculationLink 050 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 snes-20210331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 snes-20210331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 snes-20210331_lab.xml XBRL LABEL FILE EX-101.PRE 11 snes-20210331_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Document And Entity Information - shares
3 Months Ended
Mar. 31, 2021
May 14, 2021
Document Information Line Items    
Entity Registrant Name SenesTech, Inc.  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   12,184,997
Amendment Flag false  
Entity Central Index Key 0001680378  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Mar. 31, 2021  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q1  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company false  
Entity Ex Transition Period true  
Entity Incorporation, State or Country Code DE  
Entity File Number 001-37941  
Entity Interactive Data Current Yes  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash $ 15,165 $ 3,643
Accounts receivable trade, net 27 25
Prepaid expenses 360 178
Inventory 905 945
Deposits 26 28
Total current assets 16,483 4,819
Right to use asset-operating leases 627 665
Property and equipment, net 528 538
Total assets 17,638 6,022
Current liabilities:    
Short-term debt 79 98
Accounts payable 175 404
Accrued expenses 238 292
Total current liabilities 492 794
Long-term debt, net 662 673
Operating lease liability 636 671
Total liabilities 1,790 2,138
Commitments and contingencies (See note 12)
Stockholders’ equity:    
Common stock, $0.001 par value, 100,000,000 shares authorized, 12,164,046 and 5,099,512 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively 12 5
Additional paid-in capital 121,897 108,119
Accumulated deficit (106,061) (104,240)
Total stockholders’ equity 15,848 3,884
Total liabilities and stockholders’ equity $ 17,638 $ 6,022
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Balance Sheets (Parentheticals) - $ / shares
Mar. 31, 2021
Dec. 31, 2020
Statement of Financial Position [Abstract]    
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, authorized 100,000,000 100,000,000
Common stock, issued 12,164,046 5,099,512
Common stock, outstanding 12,164,046 5,099,512
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenue:    
Sales $ 88 $ 37
Cost of sales 50 22
Gross profit 38 15
Operating expenses:    
Research and development 455 296
Selling, general and administrative 1,422 2,045
Total operating expenses 1,877 2,341
Net operating loss (1,839) (2,326)
Other income (expense):    
Interest income 2 2
Interest expense (5) (8)
Other income 21 15
Total other income 18 9
Net loss and comprehensive loss (1,821) (2,317)
Deemed dividend-warrant price protection-revaluation adjustment   414
Net loss attributable to common shareholders $ (1,821) $ (2,731)
Weighted average common shares outstanding - basic and fully diluted (in Shares) 8,137,038 1,611,304
Net loss per common share - basic and fully diluted (in Dollars per share) $ (0.22) $ (1.69)
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 1 $ 98,433 $ (95,867) $ 2,567
Balance (in Shares) at Dec. 31, 2019 1,414,671      
Stock based compensation 151 151
Issuance of common stock, sold for cash, net $ 1 1,707 1,708
Issuance of common stock, sold for cash, net (in Shares) 353,872      
Issuance of common stock upon exercise of warrants 238 238
Issuance of common stock upon exercise of warrants (in Shares) 51,414      
Issuance costs of common stock issuances   (273)   (273)
Issuance of common stock for fractional shares-20-1 reverse split
Issuance of common stock for fractional shares-20-1 reverse split (in Shares) 24      
Warrant antidilution price protection adjustment   414   414
Net loss (2,731) (2,731)
Balance at Mar. 31, 2020 $ 2 100,670 (98,598) 2,074
Balance (in Shares) at Mar. 31, 2020 1,819,981      
Balance at Dec. 31, 2020 $ 5 108,119 (104,240) 3,884
Balance (in Shares) at Dec. 31, 2020 5,099,512      
Stock based compensation 155 155
Issuance of common stock, sold for cash, net $ 6 12,586 12,592
Issuance of common stock, sold for cash, net (in Shares) 6,163,854      
Issuance of common stock upon exercise of warrants $ 1 1,208 1,209
Issuance of common stock upon exercise of warrants (in Shares) 900,680      
Issuance costs of common stock issuances   (171)   (171)
Net loss (1,821) (1,821)
Balance at Mar. 31, 2021 $ 12 $ 121,897 $ (106,061) $ 15,848
Balance (in Shares) at Mar. 31, 2021 12,164,046      
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (1,821) $ (2,317)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 73 77
Stock-based compensation 155 151
Gain on sale of equipment   (15)
(Increase) decrease in current assets:    
Accounts receivable - trade (2) 4
Accounts receivable - other   123
Other assets 5 9
Prepaid expenses (182) (40)
Inventory 40 18
Increase (decrease) in current liabilities:    
Accounts payable (229) 474
Accrued expenses (54) (355)
Net cash used in operating activities (2,015) (1,871)
CASH FLOWS FROM INVESTING ACTIVITIES    
Cash received on sale of property and equipment   40
Purchase of property and equipment (63)  
Net cash provided by (used in) investing activities (63) 40
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from the issuance of common stock, net 12,421 1,435
Repayments of notes payable (17) (14)
Repayments of finance lease obligations (13) (34)
Proceeds from the exercise of warrants 1,209  
Net cash provided by financing activities 13,600 1,387
NET CHANGE IN CASH 11,522 (444)
CASH AT BEGINNING OF PERIOD 3,643 1,936
CASH AT END OF PERIOD 15,165 1,492
SUPPLEMENTAL INFORMATION:    
Interest paid 5 8
Income taxes paid
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Forgiveness of accrual in warrant exercise   238
Deemed dividend   $ 414
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Organization and Description of Business
3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Organization and Description of Business

Note 1 - Organization and Description of Business


SenesTech, Inc. (referred to in this report as “SenesTech,” the “Company,” “we” or “us”) has developed and is commercializing a global, proprietary technology for managing animal pest populations, initially rat populations, through fertility control.


Although there are myriad tools available to control rat populations, most rely on some form of lethal method to achieve effectiveness. Each of these solutions is inherently limited by rat species’ resilience and survival mechanisms as well as their extraordinary rate of reproduction. ContraPest®, our initial product, is unique in the pest control industry in attacking the reproductive systems of both male and female rats, which our field data shows results in a sustained reduction of the rat population.


Rats have plagued humanity throughout history. They pose significant threats to the environment and to the health and food security of many communities. In addition, rodents cause extensive product loss and damage through consumption and contamination. Rats also cause significant damage to critical infrastructure by burrowing beneath foundations and gnawing on electrical wiring, insulation, fire proofing systems, electronics and computer equipment.


The most prevalent solution to rat infestations is the use of increasingly powerful rodenticides. Although these solutions provide short term results, there are growing concerns about secondary exposure and bioaccumulation of rodenticides in the environment, as well as concerns about rodenticides that have no antidotes. The pest management industry and Pest Management Professionals (“PMPs”) are being asked for new solutions that are both effective and less toxic. Our goal is to provide customers with not only a solution to combat their most difficult rat problems, but also offer an effective, non-lethal option to serve customers that are looking to decrease or remove the amount of rodenticide used in their pest control programs.


ContraPest is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (“VCD”) and triptolide. ContraPest limits reproduction of male and female rats beginning with the first breeding cycle following consumption. ContraPest is being marketed for use in controlling Norway and roof rat populations.


SenesTech began the registration process with the United States Environmental Protection Agency (the “EPA”) for ContraPest on August 23, 2015. On August 2, 2016, the EPA granted an unconditional registration for ContraPest as a Restricted Use Product (“RUP”), due to the need for applicator expertise for deployment. On October 18, 2018, the EPA approved the removal of the RUP designation. We believe ContraPest is the first and only non-lethal, fertility control product approved by the EPA for the management of rodent populations.


In addition to the EPA registration of ContraPest in the United States, ContraPest must obtain registration from the various state regulatory agencies prior to selling in each state. We have received registration for ContraPest in all 50 states and the District of Columbia, 48 of which have approved the removal of the RUP designation.


We expect to continue to pursue regulatory approvals and amendments to the existing U.S. registration for ContraPest to broaden the marketability and use of ContraPest, and if ContraPest begins to generate sufficient revenue, regulatory approvals for additional jurisdictions beyond the United States. In certain cases, our EPA and state registrations require completion of testing and certifications even though we have received approval for the product or its labelling. We continue to seek to comply with these requirements.


The Company also continues to research and develop enhancements to ContraPest that align with our target verticals and other potential fertility control options for additional species. 


We were formed in July 2004 and incorporated in the state of Nevada. The Company subsequently reincorporated in the state of Delaware in November 2015. Our corporate headquarters and manufacturing site are in Phoenix, Arizona. On December 8, 2016, we went public and are currently traded on Nasdaq under the symbol SNES.


On February 4, 2020, we amended our amended and restated certificate of incorporation to effect a 1-for-20 reverse split of our issued and outstanding shares of our common stock. The accompanying condensed financial statements and notes thereto give retrospective effect to the reverse stock split for all periods presented. All issued and outstanding common stock, options and warrants exercisable for common stock, restricted stock units, preferred stock conversions to common stock and per share amounts contained in our condensed financial statements have been retrospectively adjusted.


Going Concern


Our financial statements as of March 31, 2021, December 31, 2020 and March 31, 2020 have been prepared under the assumption that we will continue as a going concern. Our independent registered public accounting firm included in its opinion for the years ended December 31, 2020 and 2019 an explanatory paragraph referring to our net loss from operations and net capital deficiency and expressing substantial doubt in our ability to continue as a going concern without additional capital becoming available. If we encounter continued issues or delays in the commercialization of ContraPest, our prior losses and expected future losses could have an adverse effect on our financial condition and negatively impact our ability to fund continued operations, obtain additional financing in the future and continue as a going concern. There are no assurances that such financing, if necessary, will be available to us at all or will be available in sufficient amounts or on reasonable terms. Our financial statements do not include any adjustments that may result from the outcome of this uncertainty. If we are unable to generate additional funds in the future through additional financings, sales of our products, licensing fees, royalty payments or from other sources or transactions, we will exhaust our resources and will be unable to continue operations.


Liquidity and Capital Resources


Since our inception, we have sustained significant operating losses in the course of our research and development and commercialization activities and expect such losses to continue for the near future. We have generated limited revenue to date from product sales, research grants and licensing fees received under our former license agreement. We have primarily funded our operations to date through the sale of equity securities, including convertible preferred stock, common stock and warrants to purchase common stock. See Note 10 for a description of our public equity sales.


We have also raised capital through debt financing, consisting primarily of convertible notes and government loan programs, and, to a lesser extent, payments received in connection with product sales, research grants and licensing fees.


Through March 31, 2021, we received net proceeds of $89.3 million from our sales of common stock, preferred stock and warrant exercises and issuance of convertible and other promissory notes, an aggregate of $1.7 million from licensing fees and an aggregate of $1.0 million in net product sales. As of March 31, 2021, we had an accumulated deficit of $106.1 million and cash and cash equivalents of $15.2 million.


Our ultimate success depends upon the outcome of a combination of factors, including: (i) successful commercialization of ContraPest and maintaining and obtaining regulatory approval of our products and product candidates; (ii) market acceptance, commercial viability and profitability of ContraPest and other products; (iii) the ability to market our products and establish an effective sales force and marketing infrastructure to generate significant revenue; (iv) the success of our research and development; (v) the ability to retain and attract key personnel to develop, operate and grow our business; and (vi) our ability to meet our working capital needs.


Based upon our current operating plan, we expect that cash and cash equivalents at March 31, 2021, in combination with anticipated revenue and any additional sales of our equity securities, will be sufficient to fund our current operations for at least the next 12 months. We have evaluated and will continue to evaluate our operating expenses and will concentrate our resources toward the successful commercialization of ContraPest in the United States. However, if anticipated revenue targets and margin targets are not achieved or expenses are more than we have budgeted, we may need to raise additional financing before that time. If we need more financing and we are unable to raise necessary capital through the sale of our securities, we may be required to take other measures that could impair our ability to be successful and operate as a going concern. In any event, we may require additional capital in order to fund our operating losses and research and development activities before we become profitable and may opportunistically raise capital. We may never achieve profitability or generate positive cash flows, and unless and until we do, we will continue to need to raise capital through equity or debt financing. If such equity or debt financing is not available at adequate levels or on acceptable terms, we may need to delay, limit or terminate commercialization and development efforts or discontinue operations.


Basis of Presentation


The accompanying unaudited condensed financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. In the Company’s opinion, the unaudited condensed financial statements include all material adjustments, all of which are of a normal and recurring nature, necessary to present fairly the Company’s financial position as of March 31, 2021, the Company’s operating results for the three months ended March 31, 2021 and 2020, and the Company’s cash flows for the three months ended March 31, 2021 and 2020. The accompanying financial information as of December 31, 2020 is derived from audited financial statements. Interim results are not necessarily indicative of results for a full year. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 29, 2021. All amounts shown in these financial statements and accompanying notes are in thousands, except percentages and per share and share amounts. 


XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2 - Summary of Significant Accounting Policies


Use of Estimates


The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and classification of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The significant estimates in the Company’s financial statements include the valuation of preferred stock, if issued, common stock and related warrants, and other stock-based awards. Actual results could differ from such estimates.


Reclassifications


Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no material impact on net earnings, financial position or cash flows.


Cash and Cash Equivalents


The Company considers money market fund investments to be cash equivalents. The Company had cash equivalents in the form of money market fund investment of $7,000 and $1,500 at March 31, 2021 and December 31, 2020, respectively, included in cash as reported.


Accounts Receivable-Trade


Accounts receivable-trade consist primarily of receivables from customers. The Company provides an allowance for doubtful trade receivables equal to the estimated uncollectible amounts. That estimate is based on historical collection experience, current economic and market conditions and a review of the current status of each customer’s trade accounts receivable. The allowance for doubtful trade receivables was $0 at March 31, 2021 and December 31, 2020.


Inventories


Inventories are stated at the lower of cost or market value, using the first-in, first-out convention. Inventories consist of raw materials, work in progress and finished goods. Raw materials are stocked to reduce the risk of impact on manufacturing for potential supply interruptions due to the COVID-19 pandemic or long lead times on certain ingredients.


Components of inventory are:


   March 31,   December 31, 
   2021   2020 
Raw materials  $935   $950 
Work in progress   4    24 
Finished goods   89    94 
Total inventory   1,028    1,068 
Less:          
Reserve for obsolete   (123)   (123)
Total net inventory  $905   $945 

Prepaid Expenses


Prepaid expenses consist primarily of payments made for director and officer insurance, director compensation, rent, legal and inventory purchase deposits and seminar fees to be expensed in the current year.


Property and Equipment


Property and equipment are stated at cost less accumulated depreciation. Equipment held under finance leases are stated at the present value of minimum lease payments less accumulated amortization.


Depreciation on property and equipment is computed using the straight-line method over the estimated useful lives of the respective assets. The cost of leasehold improvements is amortized over the life of the improvement or the term of the lease, whichever is shorter. Equipment held under finance leases is amortized over the shorter of the lease term or estimated useful life of the asset. The Company incurs repair and maintenance costs on its major equipment, which are expensed as incurred.


Impairment of Long-Lived Assets


Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require long-lived assets or asset groups to be tested for possible impairment, the Company compares the undiscounted cash flows expected to be generated from the use of the asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment charge is recognized to the extent that the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques, such as discounted cash flow models and the use of third-party independent appraisals. The Company has not recorded an impairment of long-lived assets since its inception.


Revenue Recognition


Effective January 1, 2018, the Company adopted Accounting Standards Codification (“ASC”) 606 — Revenue from Contracts with Customers (“ASC 606”). Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.


The Company recognizes revenue when product is shipped at a fixed selling price on payment terms of 30 to 120 days from invoicing. The Company recognizes other revenue earned from pilot studies, consulting and implementation services upon the performance of specific services under the respective service contract.


The Company derives revenue primarily from commercial sales of products, net of discounts and promotions, as well as consulting and implementation services provided in conjunction with our product deployments. 


Research and Development


Research and development costs are expensed as incurred. Research and development expenses primarily consist of salaries and benefits for research and development employees, stock-based compensation, consulting fees, lab supplies, costs incurred related to conducting scientific trials and field studies, regulatory compliance costs, and manufacturing costs associated with process improvement. Research and development expenses include an allocation of facilities related costs, including depreciation of research and development equipment.


Stock-based Compensation


Stock based awards, consisting of stock options and restricted stock units expected to be settled in shares of the Company’s common stock, are recorded as equity awards. The grant date fair value of these awards is measured using the Black-Scholes option pricing model for stock options and grant date market value for restricted stock units. The Company expenses the grant date fair value of its stock options on a straight-line basis over their respective vesting periods.


The stock-based compensation expense recorded for the three months ended March 31, 2021 and 2020, is as follows:


   Three Months Ended
March 31,
 
   2021   2020 
Research and development  $2   $3 
Selling, general and administrative   153    148 
Total stock-based compensation expense  $155   $151 

See Note 11 for additional discussion on stock-based compensation.


Income Taxes


The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements and tax bases of assets and liabilities and net operating loss carryforwards using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period that includes the enactment date.


The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized. These deferred tax assets are subject to periodic assessments as to recoverability and if it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recorded which would increase the provision for income taxes. In making such determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations.


The Company applies a more-likely-than-not recognition threshold for all tax uncertainties. Only those benefits that have a greater than fifty percent likelihood of being sustained upon examination by the taxing authorities are recognized. Based on its evaluation, the Company has concluded there are no significant uncertain tax positions requiring recognition in its financial statements.


The Company recognizes interest and/or penalties related to uncertain tax positions in income tax expense. There are no uncertain tax positions as of March 31, 2021 or December 31, 2020 and as such, no interest or penalties were recorded in income tax expense.


Comprehensive Loss


Net loss and comprehensive loss were the same for all periods presented; therefore, a separate statement of comprehensive loss is not included in the accompanying financial statements.


Loss Per Share Attributable to Common Stockholders


Basic loss per share attributable to common stockholders is calculated by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share attributable to common stockholders is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury stock and if-converted methods. For purposes of the computation of diluted loss per share attributable to common stockholders, common stock purchase warrants, and common stock options are considered to be potentially dilutive securities but have been excluded from the calculation of diluted loss per share attributable to common stockholders because their effect would be anti-dilutive given the net loss reported for the three months ended March 31, 2021 and 2020. Therefore, basic and diluted loss per share attributable to common stockholders are the same for each period presented.


The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted loss per share attributable to common stockholders (in common stock equivalent shares):


   March 31, 
   2021   2020 
Common stock purchase warrants   4,553,733    812,963 
Restricted stock units   31,405    5,877 
Common stock options   506,852    136,239 
Total   5,091,990    955,079 

Adoption of New Accounting Standard:


In August 2018, the FASB issued ASU 2018-15 Accounting for Implementation Costs Related to Cloud Computing or Hosting Arrangements, authoritative guidance intended to address a customer’s accounting for implementation costs incurred in a cloud computing arrangement that is a service contract. This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires presentation of the capitalized implementation costs in the statement of financial position and in the statement of cash flows in the same line item that a prepayment for the fees of the associated hosting arrangement would be presented, and the expense related to the capitalized implementation costs to be presented in the same line item in the statement of operations as the fees associated with the hosting element (service) of the arrangement. This guidance was effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods, with early adoption permitted. Effective January 1, 2020, the Company adopted the guidance and determined there was no applicability to the Company at this time and as such, there was no impact on our financial position, results of operations, or cash flows.


Other than the item noted above, there have been no new accounting pronouncements not yet effective or adopted in the current year that we believe have a significant impact, or potential significant impact, to our unaudited condensed interim financial statements.


XML 20 R9.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurements

Note 3 - Fair Value Measurements


The Company issued common stock warrants to purchase shares of common stock in June of 2015 (see Note 9 - Common Stock Warrants and Common Stock Warrant Liability) that expired in June of 2020. These warrants contained a cash settlement provision that resulted in a common stock warrant liability that was revalued at the end of each reporting period.


We valued these warrant derivatives at fair value. The accounting guidance for fair value, among other things, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The framework for measuring fair value consists of a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows: 


Level 1—Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;


Level 2—Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and


Level 3—Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.


An asset’s or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.


Assets and liabilities measured at fair value are based on one or more of the following three valuation techniques:


  A. Market approach: Prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.
     
  B. Cost approach: Amount that would be required to replace the service capacity of an asset (replacement cost).
     
  C. Income approach: Techniques to convert future amounts to a single present amount based upon market expectations, including present value techniques, option-pricing and excess earnings models.

The Company’s common stock warrant liabilities are classified as Level 3 because there is limited activity or less transparency around the inputs to valuation.


Financial Instruments Not Carried at Fair Value


The carrying amounts of the Company’s financial instruments, including accounts payable and accrued liabilities, approximate fair value due to their short maturities. The estimated fair value of the convertible notes and other notes, not recorded at fair value, are recorded at cost or amortized cost which was deemed to estimate fair value.


XML 21 R10.htm IDEA: XBRL DOCUMENT v3.21.1
Credit Risk
3 Months Ended
Mar. 31, 2021
Risks and Uncertainties [Abstract]  
Credit Risk

Note 4 - Credit Risk


The Company is potentially subject to concentrations of credit risk in its accounts receivable. Credit risk with respect to receivables is limited due to the number of companies comprising the Company’s customer base, however the Company did identify a potentially uncollectable account and at December 31, 2019 and maintained a reserve for this receivable balance of $123. At December 31, 2020, the account was deemed uncollectable and offset against the reserve. The Company did not have any potentially uncollectable account at March 31, 2021 or December 31, 2020 and therefore, did not record a reserve for uncollectable accounts at March 31, 2021 or December 31, 2020. The Company does not require collateral or other securities to support its accounts receivable.


XML 22 R11.htm IDEA: XBRL DOCUMENT v3.21.1
Prepaid Expenses
3 Months Ended
Mar. 31, 2021
Prepaid Expenses Disclosure [Abstract]  
Prepaid Expenses

Note 5 - Prepaid Expenses


Prepaid expenses consist of the following:


   March 31,   December 31, 
   2021   2020 
Director, officer and other insurance  $181   $18 
NASDAQ fees   33    - 
Legal retainer   25    25 
Marketing programs and conferences   73    106 
Professional services retainer   12    8 
Rent   18    18 
Engineering, software licenses and other   18    3 
Total prepaid expenses  $360   $178 

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.21.1
Property and Equipment
3 Months Ended
Mar. 31, 2021
Property, Plant and Equipment [Abstract]  
Property and Equipment

Note 6 - Property and Equipment


Property and equipment, net consist of the following:


   Useful  March 31,   December 31, 
   Life  2021   2020 
Research and development equipment  5 years  $1,420   $1,397 
Office and computer equipment (1)  3 years   749    733 
Autos  5 years   54    54 
Furniture and fixtures  7 years   41    41 
Leasehold improvements  *   102    283 
Construction in progress      36    115 
       2,402    2,623 
Less accumulated depreciation and amortization      (1,874)   (2,085)
Total     $528   $538 

* Shorter of lease term or estimated useful life
   
(1)

In the three months ended March 31, 2021, the Company received net proceeds of less than $1 in the sale of research and development equipment resulting in gains on the sale of these assets of less than $1. In the three months ended March 31, 2020, the Company received net proceeds of $40 in the sale of research and development equipment and office and computer equipment, resulting in a gain on the sale of these assets of $15.


Depreciation and amortization expense was approximately $73 and $77 for the three months ended March 31, 2021 and 2020, respectively.


XML 24 R13.htm IDEA: XBRL DOCUMENT v3.21.1
Accrued Expenses
3 Months Ended
Mar. 31, 2021
Payables and Accruals [Abstract]  
Accrued Expenses

Note 7 - Accrued Expenses


Accrued expenses consist of the following:


   March 31,   December 31, 
   2021   2020 
Compensation and related benefits  $209   $218 
Board Compensation   5    3 
Personal property and franchise tax   8    57 
Other   16    14 
Total accrued expenses  $238   $292 

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.21.1
Borrowings
3 Months Ended
Mar. 31, 2021
Debt Disclosure [Abstract]  
Borrowings

Note 8 - Borrowings


A summary of the Company’s borrowings, including finance lease obligations, is as follows:


   March 31,   December 31, 
   2021   2020 
Short-term debt:        
Current portion of long-term debt   79    98 
Total short-term debt  $79   $98 
Long-term debt:          
Finance lease obligations  $66   $79 
Other promissory notes   675    692 
Total   741    771 
Less: current portion of long-term debt   (79)   (98)
Total long-term debt  $662   $673 

Finance Lease Obligations 


Finance lease obligations at March 31, 2021 are for computer and lab equipment leased through GreatAmerica Financial Services and ENGS Commercial Finance Co. These finance leases expire at various dates through April 2022 and carry interest rates ranging from 11.4% to 18.3%.


Other Promissory Notes


Also included in the table above are notes payable to Direct Capital, M2 Financing and Fidelity Capital, all for the financing of fixed assets. These notes expire at various dates through June 2022 and carry interest rates ranging from 13.1% to 13.3%.


Also included in the table above is a loan agreement payable to BMO Harris Bank National Association as the lender in an aggregate principal amount of $645,700 pursuant to the Paycheck Protection Program (the “PPP”) under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The loan is evidenced by a promissory note dated April 15, 2020 and matures April 15, 2022. The loan bears interest at a rate of 1.00% per annum and contains customary events of default including, among other things, payment defaults. The loan closed and was funded April 20, 2020. Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of loans granted under the PPP. The loan is subject to forgiveness to the extent proceeds are used for qualifying expenses, including certain payroll, utility, rent and mortgage interest expenses. No assurance is provided that the Company will obtain forgiveness of the loan in whole or in part.


Pursuant to amendments to the CARES Act, as long as the Company submits its application for loan forgiveness within ten months after the expiration of the applicable covered period, the Company will not be required to make any payments until the forgiveness amount is remitted to the lender by the SBA. The Company applied for forgiveness in February 2021. We cannot guarantee that the PPP loan will be forgiven. In the event the PPP loan is not forgiven in whole or in part, the lender is responsible for notifying the Company of the date on which the Company’s first repayment is due.


XML 26 R15.htm IDEA: XBRL DOCUMENT v3.21.1
Common Stock Warrants and Common Stock Warrant Liability
3 Months Ended
Mar. 31, 2021
Warrants Note Disclosure [Abstract]  
Common Stock Warrants and Common Stock Warrant Liability

Note 9 - Common Stock Warrants and Common Stock Warrant Liability


The table summarizes the common stock warrant activity as of March 31, 2021 as follows:


      Term  Exercise   Balance               Balance               Balance 
Issue Date  Warrant Type  Date  Price   December 31, 2019   Issued   Exercised   Expired   December 31, 2020   Issued   Exercised   Expired   March 31, 2021 
                                               
2016 and prior  Various  Various-2020/2021   Various    17,059    -    (9,375)   (7,684)   -    -    -    -    - 
                                                         
November 21,2017  Common Stock Offering Warrants  November 21, 2022  $1.3659(1)   143,501    -         -    143,501    -    -    -    143,501 
                                                         
November 21,2017  Dealer Manager Warrants  November 21, 2022  $30.00    47,250    -    (47,250)   -    -    -    -    -    - 
                                                         
June 20,2018  Warrant Reissue  December 20, 2023  $36.40    56,696    -    -    -    56,696    -    -    -    56,696 
                                                         
August 13,2018  Rights Offering Warrants  July 25, 2023  $23.00    202,943    -    -    -    202,943    -    -    -    202,943 
                                                         
August 13,2018  Dealer Manager Warrants  August 13, 2023  $34.50    13,393    -    -    -    13,393    -    -    -    13,393 
                                                         
July 16,2019  Dealer Manager Warrants  July 11, 2024  $33.75    8,334    -    -    -    8,334    -    -    -    8,334 
                                                         
January 28,2020  Registered Direct Offering  July 28,2025  $9.00    -    177,500    -    -    177,500    -    -    -    177,500 
                                                         
January 28,2020  Dealer Manager Warrants  July 28,2025  $10.00    -    13,315    -    -    13,315    -    -    -    13,315 
                                                         
March 6,2020  Registered Direct Offering  September 8,2025  $2.88    -    176,372    (176,372)   -    -    -    -    -    - 
                                                         
March 6,2020  Dealer Manager Warrants  March 4,2025  $3.76    -    13,228    -    -    13,228    -    -    -    13,228 
                                                         
April 21,2020  Dealer Manager Warrants  April 21,2025  $3.97    -    118,073    -    -    118,073    -    -    -    118,073 
                                                         
April 24,2020  Registered Direct Offering  April 24,2025  $3.05    -    1,574,308    (1,524,308)   -    50,000    -    -    -    50,000 
                                                         
October 26, 2020  Private Warrant Inducement  April 27,2026  $1.73    -    1,700,680              1,700,680    -    (700,680)   -    1,000,000 
                                                         
October 26, 2020  Dealer Manager Warrants  April 27,2026  $2.16    -    85,034              85,034    -    -    -    85,034 
                                                         
February 2, 2021  Private Placement Agreement  August 2,2026  $2.216    -    -    -    -    -    2,194,427              2,194,427 
                                                         
February 2, 2021  Dealer Manager Warrants  August 2,2026  $2.848    -    -    -    -    -    329,164              329,164 
                                                         
March 23, 2021  Dealer Manager Warrants  March 23, 2026  $2.50    -    -    -    -    -    148,125              148,125 
                                                         
               489,176                   2,582,697                   4,553,733 

(1) The initial exercise price of these warrants was $30.00 per share. Pursuant to antidilution price adjustment protection contained within these warrants, the initial exercise price of these warrants was adjusted downward to $29.40 on July 24, 2018, the record date of the Right’s Offering and downward to $19.00 per share on August 13, 2018. These warrants were further adjusted downward from $19.00 to $7.13 and to $2.1122 on January 28, 2020 and March 4, 2020, respectively, in connection with separate Registered Direct Offerings. These warrants were further adjusted downward from $2.1122 to $1.3659 on October 26, 2020 in connection with a Registered Direct Offering.  These warrants are subject to further adjustment pursuant to antidilution price adjustment protection.

Outstanding Warrants


As of March 31, 2021, we had 4,553,733 shares of common stock issuable upon exercise of outstanding common stock warrants, at a weighted-average exercise price of $3.98603 per share.


On November 21, 2017, the Company issued a total of 232,875 detachable common stock warrants issued with the second public offering of 293,000 shares of its common stock at $20.00 per share. The common stock warrant is exercisable until five years from the date of grant. The common shares of the Company’s stock and detachable warrants exist independently as separate securities. As such, the Company estimated the fair value of the common stock warrants, exercisable at $30.00 per share, to be $661 using a lattice model based on the following significant inputs: common stock price of $20.00; comparable company volatility of 73.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 1.87%. The initial exercise price of these warrants was $30.00 per share, which adjusted downward to $29.40 on July 24, 2018, the record date of the Right’s Offering and downward to $19.00 per share on August 13, 2018, the date of the Rights Offering, pursuant to antidilution price adjustment protection contained within these warrants. The exercise price of the warrants was adjusted downward to $7.13 on January 28, 2020 in connection with a private placement of common stock. Per guidance of ASC 260, the Company recorded a deemed dividend of $285 on the 143,501 unexercised warrants that contained this antidilution price adjustment protection provision and was calculated as the difference between the fair value of the warrants immediately prior to downward exercise price adjustment and immediately after the adjustment using a Black Scholes model based on the following significant inputs: on January 28, 2020, common stock price of $7.90; comparable company volatility of 73.8%; remaining term 2.82 years; dividend yield of 0% and risk-free interest rate of 1.45%.


The exercise price of the warrants was adjusted downward to $2.1122 on March 4, 2020 in connection with a private placement of common stock. Per guidance of ASC 260, the Company recorded a deemed dividend of $129 on the 143,501 unexercised warrants that contained this antidilution price adjustment protection provision and was calculated as the difference between the fair value of the warrants immediately prior to downward exercise price adjustment and immediately after the adjustment using a Black Scholes model based on the following significant inputs: on March 4, 2020, common stock price of $2.88; comparable company volatility of 74.5%; remaining term 2.71 years; dividend yield of 0% and risk-free interest rate of 0.68%.


The exercise price of the warrants was adjusted downward to $1.3659 on October 26, 2020 in connection with an inducement offering of common stock. Per guidance of ASC 260, the Company recorded a deemed dividend of $22 on the 143,501 unexercised warrants that contained this antidilution price adjustment protection provision and was calculated as the difference between the fair value of the warrants immediately prior to downward exercise price adjustment and immediately after the adjustment using a Black Scholes model based on the following significant inputs: On October 26, 2020, common stock price of $1.47; comparable company volatility of 96.5%; remaining term 2.08 years; dividend yield of 0% and risk-free interest rate of 0.18%.


On June 20, 2018, the Company entered into an agreement with a holder of 56,696 of the November 2017 warrants to exercise its original warrant representing 56,696 shares of common stock for cash at the $30.00 exercise price for gross proceeds of $1.7 million and the Company issued to holder a new warrant to purchase 56,696 shares of common stock at an exercise price of $36.40 per share. The new warrant did not contain the antidilution price adjustment protection that was contained within the exercised warrants. In June 2018, the Company recorded stock compensation expense of $1,700 representing the fair value of the of 56,696 inducement warrants issued. The Company estimated the fair value of the common stock warrants, exercisable at $36.40 per share, to be $1,700 using a Black Scholes model based on the following significant inputs: common stock price of $42.20; comparable company volatility of 72.6%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.8%. Also, in June 2018, an additional 17,088 of the November 8, 2017 warrants that were in the money at the time of exercise, were exercised for gross proceeds of $513.


On August 13, 2018, in connection with a Rights Offering of 267,853 shares of its common stock, the Company issued 267,853 warrants to purchase shares of its common stock at an exercise price of $23.00 per share. The Company estimated the fair value of the common stock warrants, exercisable at $23.00 per share, to be $3,600 using a Monte Carlo model based on the following significant inputs: common stock price of $18.80; comparable company volatility of 159.0%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.77%.


In connection with the closing of the Rights Offering, the Company issued a warrant to purchase 13,393 shares of common stock to Maxim Partners LLC, an affiliate of the dealer-manager of the Rights Offering. The Company estimated the fair value of the common stock warrants, exercisable at $34.50 per share, to be $169 using a using a Monte Carlo model based on the following significant inputs: common stock price of $18.80; comparable company volatility of 159.0%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.77%.


Common Stock Warrant Issued to Underwriter of Common Stock Offering


In July 2019, the Company issued to H.C. Wainwright & Co., as placement agent, a warrant to purchase 8,334 shares of common stock at an exercise price of $33.75 per share as consideration for providing services in connection with a common stock offering in July 2019. The warrant was fully vested and exercisable on the date of issuance. The common stock warrant is exercisable until five years from the date of grant. The Company estimated the fair value of the common stock warrants, exercisable at $33.75 per share, to be $127 using a lattice model based on the following significant inputs: common stock price of $26.80; comparable company volatility of 133.3%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.07%.


Common Stock Warrants Issued in January and March 2020 Private Placements


In January and March 2020, in separate private placements concurrent with registered direct offerings (collectively, the “2020 Registered Direct Offerings”) of shares of the Company’s common stock, the Company also issued warrants to purchase an aggregate of up to 353,872 shares of common stock to certain institutional and accredited investors that participated in the 2020 Registered Direct Offerings (the “2020 Warrants”). The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”) and Rule 506(b) of Regulation D promulgated thereunder. Terms used but not otherwise defined herein will have the meanings given them in the warrants, attached as Exhibit 4.1 to our Form 8-K filed on January 28, 2020, and our Form 8-K filed on March 6, 2020.


The warrants issued in January 2020 to purchase 177,500 shares of common stock have an exercise price of $9.00 per share, are exercisable after July 28, 2020 and will expire July 28, 2025. The Company estimated the fair value of the common stock warrants, exercisable at $9.00 per share, to be $813 using a Black Scholes model based on the following significant inputs: common stock price of $7.90; comparable company volatility of 73.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 1.53%.


The warrants issued in March 2020 to purchase 176,372 shares of common stock have an exercise price of $2.88 per share, are immediately exercisable and will expire September 8, 2025. The Company estimated the fair value of the common stock warrants, exercisable at $2.88 per share, to be $242 using a Black Scholes model based on the following significant inputs: common stock price of $2.35; comparable company volatility of 74.8%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.39%.


For so long as the 2020 Warrants remain outstanding, the exercise price and number of shares of common stock issuable upon exercise of the warrants are subject to adjustment as follows: (a) upon payment of a stock dividend or other distribution on a class or series of shares common stock, not including shares issued under this warrant; (b) upon subdivision (by stock spilt, stock dividend, recapitalization, or otherwise) or combination (by reverse stock split or otherwise) of shares of common stock; or (c) upon the issuance of any shares of capital stock by reclassification of shares of the common stock.


In the event that the Company declares or makes any dividend or other distribution of its assets to holders of its common stock, each 2020 Warrant holder will be entitled to participate in such distribution to the same extent that such holder would have participated therein if the holder had held the number of shares of common stock acquirable upon exercise of the 2020 Warrant.


In the event of a Fundamental Transaction, as described in the 2020 Warrants and generally including the sale, transfer or other disposition of all or substantially all of our properties or assets; our consolidation or merger with or into another person or reorganization; a recapitalization, reorganization or reclassification in which our common stock is converted into other securities, cash or property; or any acquisition of our outstanding common stock that results in any person or group becoming the beneficial owner of 50% of the voting power represented by our outstanding common stock, then the holders of the 2020 Warrants will be entitled to receive upon exercise of such warrants the kind and amount of securities, cash, assets or other property that the holders would have received had they exercised the 2020 Warrants immediately prior to such Fundamental Transaction. Subject to certain limitations, in the event of a Fundamental Transaction the 2020 Warrant holder may at its option require the Company or any Successor Entity to purchase such warrant from the holder by paying to the holder an amount of cash equal to the Black Scholes Value of the remaining unexercised portion of the 2020 Warrant on the date of the consummation of the Fundamental Transaction.


Any time that the Company grants, issues, or sells any securities pro rata to all of the record holders of the common stock (the “2020 Purchase Right”), each holder of 2020 Warrants will be entitled to acquire the aggregate amount of securities that the holder could have acquired if the holder had held the number of shares of common stock acquirable upon exercise of the applicable 2020 Warrant. However, to the extent that an exercise of a 2020 Purchase Right would exceed the Beneficial Ownership Limitation (defined below), then to such extent the 2020 Purchase Right will be held in abeyance until such time, if ever, that complete exercise of the 2020 Purchase Right would not exceed the Beneficial Ownership Limitation.


After the Initial Exercisability Date (as defined in the 2020 Warrants), the 2020 Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise notice accompanied by payment in full for the number of shares of our common stock purchased upon such exercise. If, at the time a holder exercises the 2020 Warrant (but not sooner than six months following the date of such warrant), a registration statement registering the issuance of the shares of common stock underlying the 2020 Warrants under the Securities Act is not then effective or available, nor is any current prospectus thereto available, and an exemption from registration under the Securities Act is not available for the issuance of such shares, then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the number of shares of common stock determined according to a formula set forth in the 2020 Warrant.


Limitations on Exercise. A holder (together with its affiliates) may not exercise any portion of the 2020 Warrants to the extent that the holder would own more than 4.99% of the outstanding common stock after exercise (the “Beneficial Ownership Limitation”), except that upon at least 61 days’ prior notice from the holder to us, the holder may increase the Beneficial Ownership Limitation up to 9.99% of the number of shares of our common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the 2020 Warrants. No fractional shares of common stock will be issued in connection with the exercise of a 2020 Warrant. In lieu of fractional shares, we will either pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price or round up to the next whole share.


Except as otherwise provided in the 2020 Warrants or by virtue of such holder’s ownership of shares of our common stock, the holders of the 2020 Warrants do not have the rights or privileges of holders of our common stock, including any voting rights, unless and until they exercise such warrants.


Common Stock Warrants Issued in April 2020 Public Offering


On April 24, 2020, in connection with a previously announced public offering of 145,586 Class A Units and 1,428,722 Class B Units, the Company issued warrants to purchase 1,574,308 shares of common stock to the participants in the public offering and have an exercise price of $3.05 per share (the “April 2020 Warrants”). These warrants are immediately exercisable and will expire April 24, 2025.


The Common Stock, Pre-Funded Warrants and Warrants sold in this Public Offering were offered and sold pursuant to a registration statement on Form S-1 (File No. 333-236302) initially filed with the SEC on February 7, 2020, as amended (“Registration Statement”), which was declared effective by the SEC on February 14, 2020. The Post-Effective Amendment No. 2 to the Registration Statement was declared effective by the SEC on April 21, 2020.


The Company estimated the fair value of the common stock warrants, exercisable at $3.05 per share, to be $2,402 using a Black Scholes model based on the following significant inputs: common stock price of $2.40; comparable company volatility of 87.9%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 0.18%.


Common Stock Warrants Issued to Placement Agent in 2020 Registered Direct Offerings and Private Placement


In connection with the separate private placements concurrent with registered direct offerings of shares of the Company’s common stock in January and March 2020, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, a warrant to purchase 13,228 shares of common stock and a warrant to purchase 13,313 shares of common stock. The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. These warrants have substantially similar terms as the 2020 Warrants described above, except that the placement agent warrant issued in January 2020 has an exercise price of $10.00 per share, and the placement agent warrant issued in March 2020 has an exercise price of $3.7563 per share.


The Company estimated the fair value of the common stock warrants issued in January, with an exercise price of $10.00 per share, to be $58 using a Black Scholes model based on the following significant inputs: common stock price of $7.90; comparable company volatility of 73.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 1.53%.


The Company estimated the fair value of the common stock warrants issued in March, with an exercise price of $3.7563 per share, to be $17 using a Black Scholes model based on the following significant inputs: common stock price of $2.35; comparable company volatility of 74.8%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.39%.


In connection with the public offering of 145,586 Class A Units and 1,428,722 Class B Units on April 24, 2020, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, warrants to purchase 118,073 shares of common stock. The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. These warrants have substantially similar terms as the April 2020 Warrants described above, except that the placement agent warrant issued has an exercise price of $3.97 per share.


The Company estimated the fair value of the common stock warrants issued in April, with an exercise price of $3.97 per share, to be $167 using a Black Scholes model based on the following significant inputs: common stock price of $2.40; comparable company volatility of 87.9%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%.


Common Stock Warrants Issued in October 2020 Private Warrant Inducement


In October 2020, in connection with an inducement agreement with an existing accredited investor to exercise 1,700,680 outstanding warrants (the “Original Warrants”) to purchase an equal number of shares of the Company’s common stock, the Company issued new unregistered warrants to purchase up to an aggregate of 1,700,680 shares of common stock at an exercise price of $1.725 per share. The warrants issued were immediately exercisable with an exercise period of five and one-half years from the date of issuance. The Original Warrants were issued on March 6, 2020 and on April 24, 2020. Pursuant to the Letter Agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. The Company estimated the fair value of the common stock warrants, exercisable at $1.725 per share, to be $1,806 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%.


In connection with the private warrant inducement in October 2020 of 1,700,680 shares of the Company’s common warrants, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, warrants to purchase 85,034 shares of common stock. These warrants have substantially similar terms as the 2020 Warrants described above, except that the placement agent warrant issued in October 2020 has an exercise price of $2.156 per share.


The Company estimated the fair value of these common stock warrants, with an exercise price of $2.156 per share, to be $86 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%.


Common Stock Warrants Issued in February 2021 Private Placement Agreement


In February 2021, in connection with a private placement agreement with certain institutional and accredited investors, the Company issued common stock warrants to purchase up to an aggregate of 2,194,427 shares of common stock at an exercise price of $2.216 per share. The warrants were exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The warrant holder may not exercise any portion of such holder’s warrants to the extent that the holder, together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding shares of common stock immediately after exercise, except that upon at least 61 days’ prior notice from the holder to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise. The Company estimated the fair value of the common stock warrants, exercisable at $2.216 per share, to be $3,052 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%.


 Common Stock Warrants Issued to Placement Agent in February 2021 Private Placement Agreement


In connection with the private placement in February 2021, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, warrants to purchase up to 329,164 shares of Common Stock with an exercise price of $2.8481 per share. The warrants are exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.8481 per share, to be $435 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%.


Common Stock Warrants Issued to Placement Agent in March 2021 Registered Direct Offering


On March 23, 2021, the Company consummated a registered direct offering with certain institutional investors and issued an aggregate of 1,975,000 shares of the Company’s common stock, par value $0.001 per share at a purchase price of $2.00 per share for gross proceeds to the Company of approximately $3.95 million, before deducting fees payable to the placement agent and other estimated offering expenses payable by the Company. The 1,975,000 shares of Common Stock sold in the Offering were offered and sold pursuant to a prospectus, dated August 24, 2018, and a prospectus supplement, dated March 22, 2021, in connection with a takedown from the Company’s shelf registration statement on Form S-3 (File No. 333-225712).


In connection with the registered direct offering in March 2021, the Company issued to H.C. Wainwright & Co., LLC, as the placement agent, warrants to purchase up to 148,125 shares of Common Stock. The Placement Agent Warrants will be exercisable commencing six months following the date of issuance, expire five years following the date of sale and have an exercise price per share of $2.50 per share. The Placement Agent Warrants, and the shares of Common Stock issuable upon exercise thereof, will be issued in reliance on the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Regulation D promulgated thereunder. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.50 per share, to be $181 using a Black Scholes model based on the following significant inputs: common stock price of $1.76; comparable company volatility of 100.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 0.31%.


Deemed Dividend Adjustment-Warrant Modified Terms Revaluation


On March 3, 2020, the Company issued an aggregate of 51,414 common shares in a cashless exercise of 56,625 warrants issued in December 2016 and November 2017. Consideration for the exercise of these warrants was the full settlement of an outstanding litigation reserve of $238.


On October 26, 2020, in connection with the private warrant inducement with an existing accredited investor to exercise 1,700,680 Original Warrants, the Company agreed to modify the terms of the Original Warrants that were originally issued on March 6, 2020 and on April 24, 2020. Pursuant to the agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725.


Per recent proposed guidance of ASC 260, the Company determined that this was an exchange of the existing 1,700,680 warrants that were affected and the difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was a cost of raising capital and was recorded as a reduction of equity. The difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was calculated as $237, using a Black Scholes model based on the following significant inputs: On October 26, 2020: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 4.5-4.8 years; dividend yield of 0% and risk-free interest rate of 0.18%.


XML 27 R16.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders’ Deficit
3 Months Ended
Mar. 31, 2021
Stockholders' Equity Note [Abstract]  
Stockholders’ Deficit

Note 10 - Stockholders’ Deficit


Capital Stock


The Company was organized under the laws of the state of Nevada on July 27, 2004 and was subsequently reincorporated under the laws of the state of Delaware on November 10, 2015. In connection with the reincorporation, as approved by the stockholders, the Company changed its authorized capital stock to consist of (i) 100 million shares of common stock, $.001 par value, and (ii) 2 million shares of preferred stock, $0.001 par value, designated as Series A convertible preferred stock. In December 2015, the Company amended its Certificate of Incorporation to change its authorized capital stock to provide for 15 million authorized shares of preferred stock of which 7,515,000 was designated as Series B convertible preferred stock, par value $.001 per share.


Prior to November 10, 2015, the Company’s authorized capital stock consisted of 100 million shares of common stock, $.001 par value, and 10 million shares of preferred stock, $.001 par value.


Common Stock


The Company had 12,164,046 and 5,099,512 shares of common stock issued and outstanding as of March 31, 2021 and December 31, 2020, respectively.


During the three months ended March 31, 2021, the Company issued 7,064,534 shares of common stock as follows:


  an aggregate of 4,388,854 shares in connection with a private placement offering and exercise of pre-funded warrants issued in connection with the offering, generating net proceeds to the Company in February 2021 of approximately $8,898, as further described below; 
     
  an aggregate of 1,975,000 shares in connection with a registered direct offering generating net proceeds to the Company in March 2021 of approximately $3,523, as further described below; and
     
  an aggregate of 700,680 shares in connection with the exercise of common stock warrants, generating net proceeds to the Company in March 2020 of approximately $1,209, as further described below.
     

Public Offerings and Registered Direct Offerings


On February 2, 2021, the Company consummated a private placement agreement with certain institutional and accredited investors and issued an aggregate of 3,968,854 shares of its common stock, par value $0.001 per share at a purchase price of $2.2785 per share, pre-funded warrants to purchase up to an aggregate of 420,000 shares of common stock at a purchase price of $2.2775 per pre-funded warrant and associated warrants to purchase up to an aggregate of 2,194,427 shares of common stock, for gross proceeds of approximately $10.0 million, prior to deducting placement agent fees and offering expenses. At March 29, 2021, all 420,000 pre-funded shares had been distributed. In connection with the offering, we issued the placement agent warrants to purchase up to 329,164 shares of Common Stock with an exercise price of $2.8481 per share.


On March 23, 2021, the Company consummated a registered direct offering with certain institutional investors and issued an aggregate of 1,975,000 shares of the Company’s common stock, par value $0.001 per share at a purchase price of $2.00 per share for gross proceeds to the Company of approximately $3.95 million, pursuant to a prospectus, dated August 24, 2018, and a prospectus supplement, dated March 22, 2021, in connection with a takedown from the Company’s shelf registration statement on Form S-3 (File No. 333-225712).


In connection with the offering, we issued the placement agent warrants to purchase up to 148,125 shares of Common Stock at an exercise price per share of $2.50 per share.


On March 19, 2021, the Company issued an aggregate of 700,680 shares of commons stock for the exercise of certain warrants. The net proceeds to the Company for these exercises was $1,209.


XML 28 R17.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-based Compensation
3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Stock-based Compensation

Note 11 - Stock-based Compensation


On June 12, 2018, the Company’s stockholders approved the 2018 Equity Incentive Plan (the “2018 Plan”) to replace the Company’s 2015 Equity Incentive Plan (the “2015 Plan”). On July 8, 2020, the Company’s stockholders approved an amendment to the 2018 Plan to increase the number of shares of common stock available for issuance under the 2018 Plan by 800,000 shares from 50,000 to 850,000. In addition, up to 122,279 shares of our common stock previously reserved for issuance under the 2015 Plan are available for issuance under the 2018 Plan to the extent such shares were available for issuance under the 2015 Plan as of June 12, 2018 or thereafter cease to be subject to awards outstanding under the 2015 Plan, such as by expiration, cancellation, or forfeiture of such awards.


Stock options are generally issued with a per share exercise price equal to no less than fair market value of our common stock at the date of grant. Options granted under the 2018 Plan generally vest immediately, or ratably over a two- to 36-month period coinciding with their respective service periods. Options under the 2018 Plan generally have a term of five years. Certain stock option awards provide for accelerated vesting upon a change in control.


As of March 31, 2021, the Company had 419,061 shares of common stock available for issuance under the 2018 Plan.


The Company measures the fair value of stock options with service-based vesting criteria to employees, directors and consultants on the date of grant using the Black-Scholes option pricing model. The Black-Scholes valuation model requires the Company to make certain estimates and assumptions, including assumptions related to the expected price volatility of the Company’s stock, the period during which the options will be outstanding, the rate of return on risk-free investments, and the expected dividend yield for the Company’s stock.


The weighted-average assumptions used in the Black-Scholes option-pricing model used to calculate the fair value of options granted during the three months ended March 31, 2021 were as follows:


Expected volatility     96.2 %  
Expected dividend yield        
Expected term (in years)     5    
Risk-free interest rate      0.26 %  

The weighted average grant date fair value of options granted during the three months ended March 31, 2021 was $1.94 per share, as per the table above.


Due to the Company’s limited operating history and lack of company-specific historical or implied volatility, the expected volatility assumption was determined based on historical volatilities from traded options of biotech companies of comparable size and stability, whose share prices are publicly available. The expected term of options granted to employees is calculated based on the mid-point between the vesting date and the end of the contractual term according to the simplified method as described in SEC Staff Accounting Bulletin 110 because the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term due to the limited period of time its awards have been outstanding. For non-employee options, the expected term of options granted is the contractual term of the options. The risk-free interest rate is determined by reference to the implied yields of U.S. Treasury securities with a remaining term equal to the expected term assumed at the time of grant. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts. The Company has not paid and does not intend to pay dividends.


The following table summarizes the stock option activity, for both equity plans, for the periods indicated as follows: 


   Number of
Options
   Weighted
Average
Exercise
Price Per
Share
   Weighted
Average
Remaining
Contractual
Term
(years)
   Aggregate
Intrinsic
Value (1)
 
Outstanding at December 31, 2020   496,471   $8.63    3.9   $ 
Granted   12,756   $1.84    4.8   $ 
Exercised      $       $ 
Forfeited   (2,375)  $       $ 
Expired      $       $ 
Outstanding at March 31, 2021   506,852   $8.15    2.3   $ 
Exercisable at March 31, 2021   228,481   $14.45    2.1   $ 

(1) The aggregate intrinsic value in the table was calculated based on the difference between the estimated fair market value of the Company’s stock and the exercise price of the underlying options. The estimated stock values used in the calculation were $1.73 and $1.66 per share for the year ended December 31, 2020 and the three months ended March 31, 2021, respectively.

Restricted Stock Units


The following table summarizes restricted stock unit activity for the three months ended March 31, 2021:


   Number  of
Units
   Weighted Average
Grant-Date Fair
Value Per Unit
 
Outstanding as of December 31, 2020   32,072   $4.05 
Granted      $ 
Vested   (667)  $1.80 
Forfeited      $ 
Outstanding as of March 31, 2021   31,405   $2.58 

22

The stock-based compensation expense was recorded as follows:


   Three Months Ended
March 31,
 
   2021   2020 
Research and development  $2   $3 
Selling, general and administrative   153    148 
Total stock-based compensation expense  $155   $151 

The allocation between research and development and selling, general and administrative expense was based on the department and services performed by the employee or non-employee.


At March 31, 2021, the total compensation cost related to restricted stock units and unvested options not yet recognized was $629, which will be recognized over a weighted average period of 34 months, assuming the employees and non-employees complete their service period required for vesting.


XML 29 R18.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 12 - Commitments and Contingencies


Legal Proceedings 


The Company may be subject to legal proceedings and claims arising from contracts or other matters from time to time in the ordinary course of business. Management is not aware of any pending or threatened litigation where the ultimate disposition or resolution could have a material adverse effect on its financial position, results of operations or liquidity.


Lease Commitments


In February 2012, the Company entered into an operating lease for its then corporate headquarters in Flagstaff, Arizona, which expired in December 2019. In December 2019, we extended the lease for only the manufacturing facilities located in Flagstaff, Arizona, occupying a total of 7,632 square feet of space. The lease for these manufacturing facilities expired in December 2020.


On November 16, 2016, we leased an additional 1,954 square feet of research and development space, also in Flagstaff. This lease expired on November 15, 2018 but was extended for an additional 24 months, through November 2020. A subsequent amendment to the lease allows for the Company to cancel the lease at any time through the lease term with 30 days’ notice. The Company provided a 30-day cancellation notice effective February 2020.


On December 1, 2019, we entered into a lease for our corporate headquarters in Phoenix, Arizona where we lease and occupy approximately 5,529 square feet of office space. This lease expires in November 2024.


On August 1, 2020, we entered into a lease for our manufacturing and research facility in Phoenix, Arizona where we occupy approximately 5,105 square feet of manufacturing and warehouse space. This lease expires on November 30, 2024.


We believe that our existing facilities are adequate and meet our current needs for business, manufacturing and research.


Rent expense was $54 and $69 for the three months ended March 31, 2021 and 2020, respectively. The future minimum lease payments under non-cancellable operating lease and future minimum finance lease payments as of March 31, 2021 are follows:


Years Ending December 31,   Finance
Leases
    Operating
Lease
 
2021     43       142  
2022     28       194  
2023     -       198  
2024     -       186  
Total minimum lease payments   $ 71     $ 720  

    Finance
Leases
 
Less: amounts representing interest (ranging from 11.43% to 14.68%)   $ 5  
Present value of minimum lease payments     66  
Less: current installments under finance lease obligations     52  
Total long-term portion   $ 14  

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.21.1
Subsequent Events
3 Months Ended
Mar. 31, 2021
Subsequent Events [Abstract]  
Subsequent Events

Note 13 - Subsequent Events


[Share Issuances for Services 


On April 8, 2021, the Company issued 667 shares of common stock for service for restricted stock units that vested on that date.


On April 29, 2021, the Company net issued 20,284 shares of common stock for service for the net settlement of restricted stock units that vested on that date. The shares of common stock withheld were used to satisfy required withholding tax liability in connection with the vesting of shares.]


COVID-19


The travel and other restrictions that began in March 2020 in response to the COVID-19 global pandemic have resulted in a significant slowdown in our field studies and sales efforts. We were able to resume some projects by mid-year 2020, however, we still have delays on certain projects that might remain on hold until certain government restrictions are lifted. These continued delays have impacted our results of operations and could impact our results in future quarters. In addition, extended stay at home orders and other social distancing initiatives continue to severely limit our ability to communicate with current and potential commercial customers. The COVID-19 pandemic is also placing a significant budgetary burden on federal, state and local governments, which may impede or delay their ability to purchase our products.


The Company has evaluated subsequent events from the balance sheet date through May 14, 2021, the date at which the financial statements were issued, and determined that there were no other items that require adjustment to or disclosure in the financial statements. 


XML 31 R20.htm IDEA: XBRL DOCUMENT v3.21.1
Accounting Policies, by Policy (Policies)
3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Use of Estimates

Use of Estimates


The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and classification of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The significant estimates in the Company’s financial statements include the valuation of preferred stock, if issued, common stock and related warrants, and other stock-based awards. Actual results could differ from such estimates.

Reclassifications

Reclassifications


Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no material impact on net earnings, financial position or cash flows.

Cash and Cash Equivalents

Cash and Cash Equivalents


The Company considers money market fund investments to be cash equivalents. The Company had cash equivalents in the form of money market fund investment of $7,000 and $1,500 at March 31, 2021 and December 31, 2020, respectively, included in cash as reported.

Accounts Receivable-Trade

Accounts Receivable-Trade


Accounts receivable-trade consist primarily of receivables from customers. The Company provides an allowance for doubtful trade receivables equal to the estimated uncollectible amounts. That estimate is based on historical collection experience, current economic and market conditions and a review of the current status of each customer’s trade accounts receivable. The allowance for doubtful trade receivables was $0 at March 31, 2021 and December 31, 2020.

Inventories

Inventories


Inventories are stated at the lower of cost or market value, using the first-in, first-out convention. Inventories consist of raw materials, work in progress and finished goods. Raw materials are stocked to reduce the risk of impact on manufacturing for potential supply interruptions due to the COVID-19 pandemic or long lead times on certain ingredients.


Components of inventory are:


   March 31,   December 31, 
   2021   2020 
Raw materials  $935   $950 
Work in progress   4    24 
Finished goods   89    94 
Total inventory   1,028    1,068 
Less:          
Reserve for obsolete   (123)   (123)
Total net inventory  $905   $945 
Prepaid Expenses

Prepaid Expenses


Prepaid expenses consist primarily of payments made for director and officer insurance, director compensation, rent, legal and inventory purchase deposits and seminar fees to be expensed in the current year.

Property and Equipment

Property and Equipment


Property and equipment are stated at cost less accumulated depreciation. Equipment held under finance leases are stated at the present value of minimum lease payments less accumulated amortization.


Depreciation on property and equipment is computed using the straight-line method over the estimated useful lives of the respective assets. The cost of leasehold improvements is amortized over the life of the improvement or the term of the lease, whichever is shorter. Equipment held under finance leases is amortized over the shorter of the lease term or estimated useful life of the asset. The Company incurs repair and maintenance costs on its major equipment, which are expensed as incurred.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets


Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require long-lived assets or asset groups to be tested for possible impairment, the Company compares the undiscounted cash flows expected to be generated from the use of the asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment charge is recognized to the extent that the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques, such as discounted cash flow models and the use of third-party independent appraisals. The Company has not recorded an impairment of long-lived assets since its inception.

Revenue Recognition

Revenue Recognition


Effective January 1, 2018, the Company adopted Accounting Standards Codification (“ASC”) 606 — Revenue from Contracts with Customers (“ASC 606”). Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.


The Company recognizes revenue when product is shipped at a fixed selling price on payment terms of 30 to 120 days from invoicing. The Company recognizes other revenue earned from pilot studies, consulting and implementation services upon the performance of specific services under the respective service contract.


The Company derives revenue primarily from commercial sales of products, net of discounts and promotions, as well as consulting and implementation services provided in conjunction with our product deployments.

Research and Development

Research and Development


Research and development costs are expensed as incurred. Research and development expenses primarily consist of salaries and benefits for research and development employees, stock-based compensation, consulting fees, lab supplies, costs incurred related to conducting scientific trials and field studies, regulatory compliance costs, and manufacturing costs associated with process improvement. Research and development expenses include an allocation of facilities related costs, including depreciation of research and development equipment.

Stock-based Compensation

Stock-based Compensation


Stock based awards, consisting of stock options and restricted stock units expected to be settled in shares of the Company’s common stock, are recorded as equity awards. The grant date fair value of these awards is measured using the Black-Scholes option pricing model for stock options and grant date market value for restricted stock units. The Company expenses the grant date fair value of its stock options on a straight-line basis over their respective vesting periods.


The stock-based compensation expense recorded for the three months ended March 31, 2021 and 2020, is as follows:


   Three Months Ended
March 31,
 
   2021   2020 
Research and development  $2   $3 
Selling, general and administrative   153    148 
Total stock-based compensation expense  $155   $151 

See Note 11 for additional discussion on stock-based compensation.

Income Taxes

Income Taxes


The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements and tax bases of assets and liabilities and net operating loss carryforwards using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period that includes the enactment date.


The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized. These deferred tax assets are subject to periodic assessments as to recoverability and if it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recorded which would increase the provision for income taxes. In making such determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations.


The Company applies a more-likely-than-not recognition threshold for all tax uncertainties. Only those benefits that have a greater than fifty percent likelihood of being sustained upon examination by the taxing authorities are recognized. Based on its evaluation, the Company has concluded there are no significant uncertain tax positions requiring recognition in its financial statements.


The Company recognizes interest and/or penalties related to uncertain tax positions in income tax expense. There are no uncertain tax positions as of March 31, 2021 or December 31, 2020 and as such, no interest or penalties were recorded in income tax expense.

Comprehensive Loss

Comprehensive Loss


Net loss and comprehensive loss were the same for all periods presented; therefore, a separate statement of comprehensive loss is not included in the accompanying financial statements.

Loss Per Share Attributable to Common Stockholders

Loss Per Share Attributable to Common Stockholders


Basic loss per share attributable to common stockholders is calculated by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share attributable to common stockholders is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares and potentially dilutive securities outstanding for the period determined using the treasury stock and if-converted methods. For purposes of the computation of diluted loss per share attributable to common stockholders, common stock purchase warrants, and common stock options are considered to be potentially dilutive securities but have been excluded from the calculation of diluted loss per share attributable to common stockholders because their effect would be anti-dilutive given the net loss reported for the three months ended March 31, 2021 and 2020. Therefore, basic and diluted loss per share attributable to common stockholders are the same for each period presented.


The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted loss per share attributable to common stockholders (in common stock equivalent shares):


   March 31, 
   2021   2020 
Common stock purchase warrants   4,553,733    812,963 
Restricted stock units   31,405    5,877 
Common stock options   506,852    136,239 
Total   5,091,990    955,079 
Adoption of New Accounting Standards:

Adoption of New Accounting Standard:


In August 2018, the FASB issued ASU 2018-15 Accounting for Implementation Costs Related to Cloud Computing or Hosting Arrangements, authoritative guidance intended to address a customer’s accounting for implementation costs incurred in a cloud computing arrangement that is a service contract. This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The guidance also requires presentation of the capitalized implementation costs in the statement of financial position and in the statement of cash flows in the same line item that a prepayment for the fees of the associated hosting arrangement would be presented, and the expense related to the capitalized implementation costs to be presented in the same line item in the statement of operations as the fees associated with the hosting element (service) of the arrangement. This guidance was effective for annual periods beginning after December 15, 2019, including interim periods within those annual periods, with early adoption permitted. Effective January 1, 2020, the Company adopted the guidance and determined there was no applicability to the Company at this time and as such, there was no impact on our financial position, results of operations, or cash flows.


Other than the item noted above, there have been no new accounting pronouncements not yet effective or adopted in the current year that we believe have a significant impact, or potential significant impact, to our unaudited condensed interim financial statements.

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Schedule of inventory
   March 31,   December 31, 
   2021   2020 
Raw materials  $935   $950 
Work in progress   4    24 
Finished goods   89    94 
Total inventory   1,028    1,068 
Less:          
Reserve for obsolete   (123)   (123)
Total net inventory  $905   $945 
Schedule of employee stock-based compensation expense
   Three Months Ended
March 31,
 
   2021   2020 
Research and development  $2   $3 
Selling, general and administrative   153    148 
Total stock-based compensation expense  $155   $151 
Schedule of outstanding potentially dilutive securities calculation of diluted loss per share attributable to common stockholders
   March 31, 
   2021   2020 
Common stock purchase warrants   4,553,733    812,963 
Restricted stock units   31,405    5,877 
Common stock options   506,852    136,239 
Total   5,091,990    955,079 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.21.1
Prepaid Expenses (Tables)
3 Months Ended
Mar. 31, 2021
Prepaid Expenses Disclosure [Abstract]  
Schedule of prepaid expenses
   March 31,   December 31, 
   2021   2020 
Director, officer and other insurance  $181   $18 
NASDAQ fees   33    - 
Legal retainer   25    25 
Marketing programs and conferences   73    106 
Professional services retainer   12    8 
Rent   18    18 
Engineering, software licenses and other   18    3 
Total prepaid expenses  $360   $178 
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Property and Equipment (Tables)
3 Months Ended
Mar. 31, 2021
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment
   Useful  March 31,   December 31, 
   Life  2021   2020 
Research and development equipment  5 years  $1,420   $1,397 
Office and computer equipment (1)  3 years   749    733 
Autos  5 years   54    54 
Furniture and fixtures  7 years   41    41 
Leasehold improvements  *   102    283 
Construction in progress      36    115 
       2,402    2,623 
Less accumulated depreciation and amortization      (1,874)   (2,085)
Total     $528   $538 
* Shorter of lease term or estimated useful life
   
(1)

In the three months ended March 31, 2021, the Company received net proceeds of less than $1 in the sale of research and development equipment resulting in gains on the sale of these assets of less than $1. In the three months ended March 31, 2020, the Company received net proceeds of $40 in the sale of research and development equipment and office and computer equipment, resulting in a gain on the sale of these assets of $15.

XML 35 R24.htm IDEA: XBRL DOCUMENT v3.21.1
Accrued Expenses (Tables)
3 Months Ended
Mar. 31, 2021
Payables and Accruals [Abstract]  
Schedule of accrued expenses
   March 31,   December 31, 
   2021   2020 
Compensation and related benefits  $209   $218 
Board Compensation   5    3 
Personal property and franchise tax   8    57 
Other   16    14 
Total accrued expenses  $238   $292 
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.21.1
Borrowings (Tables)
3 Months Ended
Mar. 31, 2021
Debt Disclosure [Abstract]  
Schedule of capital lease obligations
   March 31,   December 31, 
   2021   2020 
Short-term debt:        
Current portion of long-term debt   79    98 
Total short-term debt  $79   $98 
Long-term debt:          
Finance lease obligations  $66   $79 
Other promissory notes   675    692 
Total   741    771 
Less: current portion of long-term debt   (79)   (98)
Total long-term debt  $662   $673 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.21.1
Common Stock Warrants and Common Stock Warrant Liability (Tables)
3 Months Ended
Mar. 31, 2021
Warrants Note Disclosure [Abstract]  
Schedule of common stock warrant activity
      Term  Exercise   Balance               Balance               Balance 
Issue Date  Warrant Type  Date  Price   December 31, 2019   Issued   Exercised   Expired   December 31, 2020   Issued   Exercised   Expired   March 31, 2021 
                                               
2016 and prior  Various  Various-2020/2021   Various    17,059    -    (9,375)   (7,684)   -    -    -    -    - 
                                                         
November 21,2017  Common Stock Offering Warrants  November 21, 2022  $1.3659(1)   143,501    -         -    143,501    -    -    -    143,501 
                                                         
November 21,2017  Dealer Manager Warrants  November 21, 2022  $30.00    47,250    -    (47,250)   -    -    -    -    -    - 
                                                         
June 20,2018  Warrant Reissue  December 20, 2023  $36.40    56,696    -    -    -    56,696    -    -    -    56,696 
                                                         
August 13,2018  Rights Offering Warrants  July 25, 2023  $23.00    202,943    -    -    -    202,943    -    -    -    202,943 
                                                         
August 13,2018  Dealer Manager Warrants  August 13, 2023  $34.50    13,393    -    -    -    13,393    -    -    -    13,393 
                                                         
July 16,2019  Dealer Manager Warrants  July 11, 2024  $33.75    8,334    -    -    -    8,334    -    -    -    8,334 
                                                         
January 28,2020  Registered Direct Offering  July 28,2025  $9.00    -    177,500    -    -    177,500    -    -    -    177,500 
                                                         
January 28,2020  Dealer Manager Warrants  July 28,2025  $10.00    -    13,315    -    -    13,315    -    -    -    13,315 
                                                         
March 6,2020  Registered Direct Offering  September 8,2025  $2.88    -    176,372    (176,372)   -    -    -    -    -    - 
                                                         
March 6,2020  Dealer Manager Warrants  March 4,2025  $3.76    -    13,228    -    -    13,228    -    -    -    13,228 
                                                         
April 21,2020  Dealer Manager Warrants  April 21,2025  $3.97    -    118,073    -    -    118,073    -    -    -    118,073 
                                                         
April 24,2020  Registered Direct Offering  April 24,2025  $3.05    -    1,574,308    (1,524,308)   -    50,000    -    -    -    50,000 
                                                         
October 26, 2020  Private Warrant Inducement  April 27,2026  $1.73    -    1,700,680              1,700,680    -    (700,680)   -    1,000,000 
                                                         
October 26, 2020  Dealer Manager Warrants  April 27,2026  $2.16    -    85,034              85,034    -    -    -    85,034 
                                                         
February 2, 2021  Private Placement Agreement  August 2,2026  $2.216    -    -    -    -    -    2,194,427              2,194,427 
                                                         
February 2, 2021  Dealer Manager Warrants  August 2,2026  $2.848    -    -    -    -    -    329,164              329,164 
                                                         
March 23, 2021  Dealer Manager Warrants  March 23, 2026  $2.50    -    -    -    -    -    148,125              148,125 
                                                         
               489,176                   2,582,697                   4,553,733 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of fair value of options granted
Expected volatility     96.2 %  
Expected dividend yield        
Expected term (in years)     5    
Risk-free interest rate      0.26 %  
Schedule of stock option activity
   Number of
Options
   Weighted
Average
Exercise
Price Per
Share
   Weighted
Average
Remaining
Contractual
Term
(years)
   Aggregate
Intrinsic
Value (1)
 
Outstanding at December 31, 2020   496,471   $8.63    3.9   $ 
Granted   12,756   $1.84    4.8   $ 
Exercised      $       $ 
Forfeited   (2,375)  $       $ 
Expired      $       $ 
Outstanding at March 31, 2021   506,852   $8.15    2.3   $ 
Exercisable at March 31, 2021   228,481   $14.45    2.1   $ 
Schedule of summarizes restricted stock unit activity
   Number  of
Units
   Weighted Average
Grant-Date Fair
Value Per Unit
 
Outstanding as of December 31, 2020   32,072   $4.05 
Granted      $ 
Vested   (667)  $1.80 
Forfeited      $ 
Outstanding as of March 31, 2021   31,405   $2.58 
Schedule of stock-based compensation expense
   Three Months Ended
March 31,
 
   2021   2020 
Research and development  $2   $3 
Selling, general and administrative   153    148 
Total stock-based compensation expense  $155   $151 
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingencies (Tables)
3 Months Ended
Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Schedule of future minimum lease payments under non-cancellable operating lease and future minimum capital lease payments
Years Ending December 31,   Finance
Leases
    Operating
Lease
 
2021     43       142  
2022     28       194  
2023     -       198  
2024     -       186  
Total minimum lease payments   $ 71     $ 720  
    Finance
Leases
 
Less: amounts representing interest (ranging from 11.43% to 14.68%)   $ 5  
Present value of minimum lease payments     66  
Less: current installments under finance lease obligations     52  
Total long-term portion   $ 14  
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.1
Organization and Description of Business (Details)
$ in Millions
3 Months Ended
Mar. 31, 2021
USD ($)
Accounting Policies [Abstract]  
Net proceeds received $ 89.3
Proceeds from licensing fees 1.7
Proceeds from product sales 1.0
Accumulated deficit 106.1
Cash and cash equivalents $ 15.2
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies (Details) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Accounting Policies [Abstract]    
Money market fund $ 7,000 $ 1,500
Allowance for doubtful trade receivables $ 0  
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies (Details) - Schedule of inventory - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Schedule of inventory [Abstract]    
Raw materials $ 935 $ 950
Work in progress 4 24
Finished goods 89 94
Total inventory 1,028 1,068
Reserve for obsolete (123) (123)
Total net inventory $ 905 $ 945
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies (Details) - Schedule of employee stock-based compensation expense - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense $ 155 $ 151
Research and development [Member]    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense 2 3
General and administrative [Member]    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense $ 153 $ 148
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies (Details) - Schedule of outstanding potentially dilutive securities calculation of diluted loss per share attributable to common stockholders - shares
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 5,091,990 955,079
Common Stock Purchase Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 4,553,733 812,963
Restricted Stock Units [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 31,405 5,877
Common Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 506,852 136,239
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.21.1
Credit Risk (Details)
$ in Thousands
Dec. 31, 2019
USD ($)
Risks and Uncertainties [Abstract]  
Credit risk receivable $ 123
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Prepaid Expenses (Details) - Schedule of prepaid expenses - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Schedule of prepaid expenses [Abstract]    
Director, officer and other insurance $ 181 $ 18
NASDAQ fees 33  
Legal retainer 25 25
Marketing programs and conferences 73 106
Professional services retainer 12 8
Rent 18 18
Engineering, software licenses and other 18 3
Total prepaid expenses $ 360 $ 178
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.21.1
Property and Equipment (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Property, Plant and Equipment [Abstract]    
Sale of research and development equipment $ 1  
Sale of assets 1  
Net proceeds   $ 40
Net proceeds of sale properties   15
Depreciation and amortization expense $ 73 $ 77
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.21.1
Property and Equipment (Details) - Schedule of property and equipment - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 2,402 $ 2,623
Less accumulated depreciation and amortization (1,874) (2,085)
Total $ 528 538
Research and development equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, useful life 5 years  
Property, plant and equipment, gross $ 1,420 1,397
Office and computer equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, useful life [1] 3 years  
Property, plant and equipment, gross [1] $ 749 733
Autos [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, useful life 5 years  
Property, plant and equipment, gross $ 54 54
Furniture and fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, useful life 7 years  
Property, plant and equipment, gross $ 41 41
Leasehold improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, useful life [2]  
Property, plant and equipment, gross [2] $ 102 283
Construction in Progress [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 36 $ 115
[1] In the three months ended March 31, 2021, the Company received net proceeds of less than $1 in the sale of research and development equipment resulting in gains on the sale of these assets of less than $1. In the three months ended March 31, 2020, the Company received net proceeds of $40 in the sale of research and development equipment and office and computer equipment, resulting in a gain on the sale of these assets of $15.
[2] Shorter of lease term or estimated useful life
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.21.1
Accrued Expenses (Details) - Schedule of accrued expenses - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Schedule of accrued expenses [Abstract]    
Compensation and related benefits $ 209 $ 218
Board Compensation 5 3
Personal property and franchise tax 8 57
Other 16 14
Total accrued expenses $ 238 $ 292
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.21.1
Borrowings (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2021
USD ($)
Borrowings (Details) [Line Items]  
Interest rate on borrowings 1.00%
Description of borrowings expiration period The loan is evidenced by a promissory note dated April 15, 2020 and matures April 15, 2022.
Principal amount (in Dollars) $ 645,700
Other Promissory Notes [Member]  
Borrowings (Details) [Line Items]  
Description of borrowings expiration period These notes expire at various dates through June 2022 and carry interest rates ranging from 13.1% to 13.3%.
Minimum [Member] | Finance Lease Obligations [Member]  
Borrowings (Details) [Line Items]  
Interest rate on borrowings 11.40%
Minimum [Member] | Other Promissory Notes [Member]  
Borrowings (Details) [Line Items]  
Interest rate on borrowings 13.10%
Maximum [Member] | Finance Lease Obligations [Member]  
Borrowings (Details) [Line Items]  
Interest rate on borrowings 18.30%
Maximum [Member] | Other Promissory Notes [Member]  
Borrowings (Details) [Line Items]  
Interest rate on borrowings 13.30%
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.21.1
Borrowings (Details) - Schedule of capital lease obligations - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Short-term debt:    
Current portion of long-term debt $ 79 $ 98
Total short-term debt 79 98
Long-term debt:    
Finance lease obligations 66 79
Other promissory notes 675 692
Total 741 771
Less: current portion of long-term debt (79) (98)
Total long-term debt $ 662 $ 673
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.21.1
Common Stock Warrants and Common Stock Warrant Liability (Details) - USD ($)
1 Months Ended 3 Months Ended
Mar. 04, 2020
Mar. 03, 2020
Aug. 13, 2018
Mar. 23, 2021
Feb. 28, 2021
Oct. 31, 2020
Oct. 26, 2020
Apr. 24, 2020
Mar. 31, 2020
Jan. 31, 2020
Jan. 28, 2020
Jul. 31, 2019
Jun. 30, 2018
Jun. 20, 2018
Nov. 21, 2017
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Warrants, description                               The initial exercise price of these warrants was $30.00 per share. Pursuant to antidilution price adjustment protection contained within these warrants, the initial exercise price of these warrants was adjusted downward to $29.40 on July 24, 2018, the record date of the Right’s Offering and downward to $19.00 per share on August 13, 2018. These warrants were further adjusted downward from $19.00 to $7.13 and to $2.1122 on January 28, 2020 and March 4, 2020, respectively, in connection with separate Registered Direct Offerings. These warrants were further adjusted downward from $2.1122 to $1.3659 on October 26, 2020 in connection with a Registered Direct Offering.    
Common stock offering warrants issued, value (in Shares)                       5       4,553,733    
Weighted-average exercise price (in Dollars per share)                               $ 3.98603    
Number of warrant purchased (in Shares)                           56,696        
Risk free interest rate 0.68%           0.18%       1.45%              
Common stock warrants issued, description                               The initial exercise price of these warrants was $30.00 per share, which adjusted downward to $29.40 on July 24, 2018, the record date of the Right’s Offering and downward to $19.00 per share on August 13, 2018, the date of the Rights Offering, pursuant to antidilution price adjustment protection contained within these warrants.    
Deemed dividend (in Dollars)                               $ 285,000    
Unexercised warrants (in Shares)                               143,501    
Share price (in Dollars per share)                               $ 1.66   $ 1.73
Stock compensation expense (in Dollars)                               $ 155,000 $ 151,000  
Common stock, par value (in Dollars per share)                               $ 0.001   $ 0.001
Common Stock Offering Warrants Issued [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Common stock offering warrants issued, value (in Shares)                             232,875      
Number of warrant purchased (in Shares)                         56,696 56,696        
Common stock per share (in Dollars per share)                         $ 42.20   $ 20.00      
Warrant term                             5 years      
Exercise price (in Dollars per share)     $ 19.00                   $ 36.40 $ 36.40 $ 30.00      
Fair value of common stock warrant (in Dollars)                             $ 661,000      
Per share price (in Dollars per share)                             $ 20.00      
Expected volatility rate                     73.80%   72.60%   73.80%      
Expected term                     2 years 299 days   5 years   5 years      
Expected dividend rate                     0.00%   0.00%   0.00%      
Risk free interest rate                         2.80%   1.87%      
Share price (in Dollars per share)                     $ 7.90              
Stock compensation expense (in Dollars)                         $ 1,700,000          
Fair value adjustment of warrants (in Dollars)                         $ 1,700,000          
Common Stock Warrant Issued to Underwriter of Common Stock Offering [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Common stock per share (in Dollars per share)           $ 2.156                        
Exercise price (in Dollars per share)                     $ 7.13              
Expected volatility rate 74.50%           96.50%                      
Expected term 2 years 259 days           2 years 29 days                      
Expected dividend rate 0.00%           0.00%                      
Deemed dividend (in Dollars) $ 129,000           $ 22                      
Share price (in Dollars per share) $ 2.88           $ 1.47                      
Warrants exercise price (in Dollars per share) $ 2.1122           $ 1.3659                      
Unexercised warrants (in Shares) 143,501           143,501                      
November 2017 warrants [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Common stock offering warrants issued, value (in Shares)                           56,696        
Common stock per share (in Dollars per share)                           $ 30.00        
Gross proceeds (in Dollars)                           $ 1,700,000        
New Warrants November 8, 2017 [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Number of warrant purchased (in Shares)                         17,088          
Gross proceeds (in Dollars)                         $ 513,000          
Right Offering [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Warrants, description     In connection with the closing of the Rights Offering, the Company issued a warrant to purchase 13,393 shares of common stock to Maxim Partners LLC, an affiliate of the dealer-manager of the Rights Offering. The Company estimated the fair value of the common stock warrants, exercisable at $34.50 per share, to be $169 using a using a Monte Carlo model based on the following significant inputs: common stock price of $18.80; comparable company volatility of 159.0%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 2.77%.                              
Common stock offering warrants issued, value (in Shares)     267,853                              
Common stock per share (in Dollars per share)     $ 18.80                              
Exercise price (in Dollars per share)     $ 23.00                              
Fair value of common stock warrant (in Dollars)     $ 3,600,000                              
Expected volatility rate     159.00%                              
Expected term     5 years                              
Expected dividend rate     0.00%                              
Risk free interest rate     2.77%                              
Share price (in Dollars per share)     $ 23.00                              
Purchase of warrants shares (in Shares)     267,853                              
Common Stock Warrants Issued to Placement Agent in 2020 Registered Direct Offerings and Private Placement [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Exercise price (in Dollars per share)               $ 3.97                    
Expected dividend rate                       0.00%            
Risk free interest rate                       2.07%            
Description of method used                   The Company estimated the fair value of the common stock warrants issued in January, with an exercise price of $10.00 per share, to be $58 using a Black Scholes model based on the following significant inputs: common stock price of $7.90; comparable company volatility of 73.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 1.53%. The Company estimated the fair value of the common stock warrants issued in March, with an exercise price of $3.7563 per share, to be $17 using a Black Scholes model based on the following significant inputs: common stock price of $2.35; comparable company volatility of 74.8%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.39%. In connection with the public offering of 145,586 Class A Units and 1,428,722 Class B Units on April 24, 2020, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, warrants to purchase 118,073 shares of common stock. The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. These warrants have substantially similar terms as the April 2020 Warrants described above, except that the placement agent warrant issued has an exercise price of $3.97 per share. The Company estimated the fair value of the common stock warrants issued in April, with an exercise price of $3.97 per share, to be $167 using a Black Scholes model based on the following significant inputs: common stock price of $2.40; comparable company volatility of 87.9%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued in October 2020 Private Warrant Inducement In October 2020, in connection with an inducement agreement with an existing accredited investor to exercise 1,700,680 outstanding warrants (the “Original Warrants”) to purchase an equal number of shares of the Company’s common stock, the Company issued new unregistered warrants to purchase up to an aggregate of 1,700,680 shares of common stock at an exercise price of $1.725 per share. The warrants issued were immediately exercisable with an exercise period of five and one-half years from the date of issuance. The Original Warrants were issued on March 6, 2020 and on April 24, 2020. Pursuant to the Letter Agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. The Company estimated the fair value of the common stock warrants, exercisable at $1.725 per share, to be $1,806 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. In connection with the private warrant inducement in October 2020 of 1,700,680 shares of the Company’s common warrants, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, warrants to purchase 85,034 shares of common stock. These warrants have substantially similar terms as the 2020 Warrants described above, except that the placement agent warrant issued in October 2020 has an exercise price of $2.156 per share. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.156 per share, to be $86 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued in February 2021 Private Placement Agreement In February 2021, in connection with a private placement agreement with certain institutional and accredited investors, the Company issued common stock warrants to purchase up to an aggregate of 2,194,427 shares of common stock at an exercise price of $2.216 per share. The warrants were exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The warrant holder may not exercise any portion of such holder’s warrants to the extent that the holder, together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding shares of common stock immediately after exercise, except that upon at least 61 days’ prior notice from the holder to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise. The Company estimated the fair value of the common stock warrants, exercisable at $2.216 per share, to be $3,052 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued to Placement Agent in February 2021 Private Placement Agreement In connection with the private placement in February 2021, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, warrants to purchase up to 329,164 shares of Common Stock with an exercise price of $2.8481 per share. The warrants are exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.8481 per share, to be $435 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued to Placement Agent in March 2021 Registered Direct Offering On March 23, 2021, the Company consummated a registered direct offering with certain institutional investors and issued an aggregate of 1,975,000 shares of the Company’s common stock, par value $0.001 per share at a purchase price of $2.00 per share for gross proceeds to the Company of approximately $3.95 million, before deducting fees payable to the placement agent and other estimated offering expenses payable by the Company. The 1,975,000 shares of Common Stock sold in the Offering were offered and sold pursuant to a prospectus, dated August 24, 2018, and a prospectus supplement, dated March 22, 2021, in connection with a takedown from the Company’s shelf registration statement on Form S-3 (File No. 333-225712). In connection with the registered direct offering in March 2021, the Company issued to H.C. Wainwright & Co., LLC, as the placement agent, warrants to purchase up to 148,125 shares of Common Stock. The Placement Agent Warrants will be exercisable commencing six months following the date of issuance, expire five years following the date of sale and have an exercise price per share of $2.50 per share. The Placement Agent Warrants, and the shares of Common Stock issuable upon exercise thereof, will be issued in reliance on the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Regulation D promulgated thereunder. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.50 per share, to be $181 using a Black Scholes model based on the following significant inputs: common stock price of $1.76; comparable company volatility of 100.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 0.31%. Deemed Dividend Adjustment-Warrant Modified Terms Revaluation On March 3, 2020, the Company issued an aggregate of 51,414 common shares in a cashless exercise of 56,625 warrants issued in December 2016 and November 2017. Consideration for the exercise of these warrants was the full settlement of an outstanding litigation reserve of $238. On October 26, 2020, in connection with the private warrant inducement with an existing accredited investor to exercise 1,700,680 Original Warrants, the Company agreed to modify the terms of the Original Warrants that were originally issued on March 6, 2020 and on April 24, 2020. Pursuant to the agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. Per recent proposed guidance of ASC 260, the Company determined that this was an exchange of the existing 1,700,680 warrants that were affected and the difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was a cost of raising capital and was recorded as a reduction of equity. The difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was calculated as $237, using a Black Scholes model based on the following significant inputs: On October 26, 2020: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 4.5-4.8 years; dividend yield of 0% and risk-free interest rate of 0.18%.           The Company estimated the fair value of the common stock warrants issued in April, with an exercise price of $3.97 per share, to be $167 using a Black Scholes model based on the following significant inputs: common stock price of $2.40; comparable company volatility of 87.9%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued in October 2020 Private Warrant Inducement In October 2020, in connection with an inducement agreement with an existing accredited investor to exercise 1,700,680 outstanding warrants (the “Original Warrants”) to purchase an equal number of shares of the Company’s common stock, the Company issued new unregistered warrants to purchase up to an aggregate of 1,700,680 shares of common stock at an exercise price of $1.725 per share. The warrants issued were immediately exercisable with an exercise period of five and one-half years from the date of issuance. The Original Warrants were issued on March 6, 2020 and on April 24, 2020. Pursuant to the Letter Agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. The Company estimated the fair value of the common stock warrants, exercisable at $1.725 per share, to be $1,806 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. In connection with the private warrant inducement in October 2020 of 1,700,680 shares of the Company’s common warrants, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, warrants to purchase 85,034 shares of common stock. These warrants have substantially similar terms as the 2020 Warrants described above, except that the placement agent warrant issued in October 2020 has an exercise price of $2.156 per share. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.156 per share, to be $86 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued in February 2021 Private Placement Agreement In February 2021, in connection with a private placement agreement with certain institutional and accredited investors, the Company issued common stock warrants to purchase up to an aggregate of 2,194,427 shares of common stock at an exercise price of $2.216 per share. The warrants were exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The warrant holder may not exercise any portion of such holder’s warrants to the extent that the holder, together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding shares of common stock immediately after exercise, except that upon at least 61 days’ prior notice from the holder to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise. The Company estimated the fair value of the common stock warrants, exercisable at $2.216 per share, to be $3,052 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued to Placement Agent in February 2021 Private Placement Agreement In connection with the private placement in February 2021, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, warrants to purchase up to 329,164 shares of Common Stock with an exercise price of $2.8481 per share. The warrants are exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.8481 per share, to be $435 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued to Placement Agent in March 2021 Registered Direct Offering On March 23, 2021, the Company consummated a registered direct offering with certain institutional investors and issued an aggregate of 1,975,000 shares of the Company’s common stock, par value $0.001 per share at a purchase price of $2.00 per share for gross proceeds to the Company of approximately $3.95 million, before deducting fees payable to the placement agent and other estimated offering expenses payable by the Company. The 1,975,000 shares of Common Stock sold in the Offering were offered and sold pursuant to a prospectus, dated August 24, 2018, and a prospectus supplement, dated March 22, 2021, in connection with a takedown from the Company’s shelf registration statement on Form S-3 (File No. 333-225712). In connection with the registered direct offering in March 2021, the Company issued to H.C. Wainwright & Co., LLC, as the placement agent, warrants to purchase up to 148,125 shares of Common Stock. The Placement Agent Warrants will be exercisable commencing six months following the date of issuance, expire five years following the date of sale and have an exercise price per share of $2.50 per share. The Placement Agent Warrants, and the shares of Common Stock issuable upon exercise thereof, will be issued in reliance on the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Regulation D promulgated thereunder. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.50 per share, to be $181 using a Black Scholes model based on the following significant inputs: common stock price of $1.76; comparable company volatility of 100.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 0.31%. Deemed Dividend Adjustment-Warrant Modified Terms Revaluation On March 3, 2020, the Company issued an aggregate of 51,414 common shares in a cashless exercise of 56,625 warrants issued in December 2016 and November 2017. Consideration for the exercise of these warrants was the full settlement of an outstanding litigation reserve of $238. On October 26, 2020, in connection with the private warrant inducement with an existing accredited investor to exercise 1,700,680 Original Warrants, the Company agreed to modify the terms of the Original Warrants that were originally issued on March 6, 2020 and on April 24, 2020. Pursuant to the agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. Per recent proposed guidance of ASC 260, the Company determined that this was an exchange of the existing 1,700,680 warrants that were affected and the difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was a cost of raising capital and was recorded as a reduction of equity. The difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was calculated as $237, using a Black Scholes model based on the following significant inputs: On October 26, 2020: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 4.5-4.8 years; dividend yield of 0% and risk-free interest rate of 0.18%.    
Common Stock Warrants Issued in January and March 2020 Private Placements [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Common stock offering warrants issued, value (in Shares)                   353,872                
Number of warrant purchased (in Shares)                 176,372 177,500             176,372  
Exercise price (in Dollars per share)                 $ 2.88 $ 9.00             $ 2.88  
Expected volatility rate                 74.80% 73.80%                
Expected term                 5 years 6 months 5 years                
Expected dividend rate                 0.00% 0.00%                
Risk free interest rate                 0.39% 1.53%                
Limitations on Exercise, description                               A holder (together with its affiliates) may not exercise any portion of the 2020 Warrants to the extent that the holder would own more than 4.99% of the outstanding common stock after exercise (the “Beneficial Ownership Limitation”), except that upon at least 61 days’ prior notice from the holder to us, the holder may increase the Beneficial Ownership Limitation up to 9.99% of the number of shares of our common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the 2020 Warrants.    
Common Stock Warrants Issued in April 2020 Public Offering [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Number of warrant purchased (in Shares)               1,574,308                    
Exercise price (in Dollars per share)               $ 3.05                    
Expected volatility rate                               87.90%    
Expected term                               5 years    
Expected dividend rate                               0.00%    
Risk free interest rate                               0.18%    
Warrant expire date               Apr. 24, 2025                    
Common Stock Warrants Issued to Placement Agent in October 2020 Inducement Offering [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Warrants, description                               In connection with the separate private placements concurrent with registered direct offerings of shares of the Company’s common stock in January and March 2020, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, a warrant to purchase 13,228 shares of common stock and a warrant to purchase 13,313 shares of common stock. The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. These warrants have substantially similar terms as the 2020 Warrants described above, except that the placement agent warrant issued in January 2020 has an exercise price of $10.00 per share, and the placement agent warrant issued in March 2020 has an exercise price of $3.7563 per share. The Company estimated the fair value of the common stock warrants issued in January, with an exercise price of $10.00 per share, to be $58 using a Black Scholes model based on the following significant inputs: common stock price of $7.90; comparable company volatility of 73.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 1.53%. The Company estimated the fair value of the common stock warrants issued in March, with an exercise price of $3.7563 per share, to be $17 using a Black Scholes model based on the following significant inputs: common stock price of $2.35; comparable company volatility of 74.8%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.39%. In connection with the public offering of 145,586 Class A Units and 1,428,722 Class B Units on April 24, 2020, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, warrants to purchase 118,073 shares of common stock. The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder.    
Common stock per share (in Dollars per share)           $ 1.47                        
Fair value of common stock warrant (in Dollars)           $ 86,000                        
Expected volatility rate           96.50%                        
Expected term           5 years 6 months                        
Expected dividend rate           0.00%                        
Risk free interest rate           0.18%                        
Fair value adjustment of warrants (in Dollars)             $ 237,000                      
Purchase of warrants shares (in Shares)           1,700,680 1,700,680                      
Description of method used                                 The Company estimated the fair value of the common stock warrants issued in March, with an exercise price of $3.7563 per share, to be $17 using a Black Scholes model based on the following significant inputs: common stock price of $2.35; comparable company volatility of 74.8%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.39%. In connection with the public offering of 145,586 Class A Units and 1,428,722 Class B Units on April 24, 2020, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, warrants to purchase 118,073 shares of common stock. The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. These warrants have substantially similar terms as the April 2020 Warrants described above, except that the placement agent warrant issued has an exercise price of $3.97 per share. The Company estimated the fair value of the common stock warrants issued in April, with an exercise price of $3.97 per share, to be $167 using a Black Scholes model based on the following significant inputs: common stock price of $2.40; comparable company volatility of 87.9%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued in October 2020 Private Warrant Inducement In October 2020, in connection with an inducement agreement with an existing accredited investor to exercise 1,700,680 outstanding warrants (the “Original Warrants”) to purchase an equal number of shares of the Company’s common stock, the Company issued new unregistered warrants to purchase up to an aggregate of 1,700,680 shares of common stock at an exercise price of $1.725 per share. The warrants issued were immediately exercisable with an exercise period of five and one-half years from the date of issuance. The Original Warrants were issued on March 6, 2020 and on April 24, 2020. Pursuant to the Letter Agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. The Company estimated the fair value of the common stock warrants, exercisable at $1.725 per share, to be $1,806 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. In connection with the private warrant inducement in October 2020 of 1,700,680 shares of the Company’s common warrants, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, warrants to purchase 85,034 shares of common stock. These warrants have substantially similar terms as the 2020 Warrants described above, except that the placement agent warrant issued in October 2020 has an exercise price of $2.156 per share. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.156 per share, to be $86 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued in February 2021 Private Placement Agreement In February 2021, in connection with a private placement agreement with certain institutional and accredited investors, the Company issued common stock warrants to purchase up to an aggregate of 2,194,427 shares of common stock at an exercise price of $2.216 per share. The warrants were exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The warrant holder may not exercise any portion of such holder’s warrants to the extent that the holder, together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding shares of common stock immediately after exercise, except that upon at least 61 days’ prior notice from the holder to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise. The Company estimated the fair value of the common stock warrants, exercisable at $2.216 per share, to be $3,052 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued to Placement Agent in February 2021 Private Placement Agreement In connection with the private placement in February 2021, the Company issued to H.C. Wainwright & Co., LLC, as placement agent, warrants to purchase up to 329,164 shares of Common Stock with an exercise price of $2.8481 per share. The warrants are exercisable immediately and have an exercise period of five and one-half years from the date of issuance. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.8481 per share, to be $435 using a Black Scholes model based on the following significant inputs: common stock price of $1.93; comparable company volatility of 95.6%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%. Common Stock Warrants Issued to Placement Agent in March 2021 Registered Direct Offering On March 23, 2021, the Company consummated a registered direct offering with certain institutional investors and issued an aggregate of 1,975,000 shares of the Company’s common stock, par value $0.001 per share at a purchase price of $2.00 per share for gross proceeds to the Company of approximately $3.95 million, before deducting fees payable to the placement agent and other estimated offering expenses payable by the Company. The 1,975,000 shares of Common Stock sold in the Offering were offered and sold pursuant to a prospectus, dated August 24, 2018, and a prospectus supplement, dated March 22, 2021, in connection with a takedown from the Company’s shelf registration statement on Form S-3 (File No. 333-225712). In connection with the registered direct offering in March 2021, the Company issued to H.C. Wainwright & Co., LLC, as the placement agent, warrants to purchase up to 148,125 shares of Common Stock. The Placement Agent Warrants will be exercisable commencing six months following the date of issuance, expire five years following the date of sale and have an exercise price per share of $2.50 per share. The Placement Agent Warrants, and the shares of Common Stock issuable upon exercise thereof, will be issued in reliance on the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Regulation D promulgated thereunder. The Company estimated the fair value of these common stock warrants, with an exercise price of $2.50 per share, to be $181 using a Black Scholes model based on the following significant inputs: common stock price of $1.76; comparable company volatility of 100.8%; remaining term 5 years; dividend yield of 0% and risk-free interest rate of 0.31%. Deemed Dividend Adjustment-Warrant Modified Terms Revaluation On March 3, 2020, the Company issued an aggregate of 51,414 common shares in a cashless exercise of 56,625 warrants issued in December 2016 and November 2017. Consideration for the exercise of these warrants was the full settlement of an outstanding litigation reserve of $238. On October 26, 2020, in connection with the private warrant inducement with an existing accredited investor to exercise 1,700,680 Original Warrants, the Company agreed to modify the terms of the Original Warrants that were originally issued on March 6, 2020 and on April 24, 2020. Pursuant to the agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. Per recent proposed guidance of ASC 260, the Company determined that this was an exchange of the existing 1,700,680 warrants that were affected and the difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was a cost of raising capital and was recorded as a reduction of equity. The difference between the fair value of the warrants immediately prior to modification of terms and immediately after the adjustment was calculated as $237, using a Black Scholes model based on the following significant inputs: On October 26, 2020: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 4.5-4.8 years; dividend yield of 0% and risk-free interest rate of 0.18%.  
Common Stock Warrants Issued in October 2020 Private Warrant Inducement [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Warrants, description           The Original Warrants were issued on March 6, 2020 and on April 24, 2020. Pursuant to the Letter Agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725. The Company estimated the fair value of the common stock warrants, exercisable at $1.725 per share, to be $1,806 using a Black Scholes model based on the following significant inputs: common stock price of $1.47; comparable company volatility of 96.5%; remaining term 5.5 years; dividend yield of 0% and risk-free interest rate of 0.18%.                        
Warrant term           5 years                        
Exercise price (in Dollars per share)           $ 1.725                        
Purchase of warrants shares (in Shares)           1,700,680                        
Exercise outstanding warrants (in Shares)           1,700,680                        
Common Stock Warrants Issued in February 2021 Private Placement Agreement [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Warrants, description                               The warrant holder may not exercise any portion of such holder’s warrants to the extent that the holder, together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding shares of common stock immediately after exercise, except that upon at least 61 days’ prior notice from the holder to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number of shares of common stock outstanding immediately after giving effect to the exercise.    
Common stock per share (in Dollars per share)                               $ 1.93    
Exercise price (in Dollars per share)         $ 2.216                     $ 2.216    
Expected volatility rate                               95.60%    
Expected term                               5 years 6 months    
Expected dividend rate                               0.00%    
Risk free interest rate                               0.18%    
Fair value adjustment of warrants (in Dollars)                               $ 3,052,000    
Purchase of warrants shares (in Shares)         2,194,427                          
Common Stock Warrants Issued to Placement Agent in February 2021 Private Placement Agreement [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Common stock per share (in Dollars per share)                               $ 1.93    
Exercise price (in Dollars per share)                               $ 2.8481    
Expected volatility rate                               95.60%    
Expected term                               5 years 6 months    
Expected dividend rate                               0.00%    
Risk free interest rate                               0.18%    
Fair value adjustment of warrants (in Dollars)                               $ 435,000    
Common Stock Warrants Issued to Placement Agent in March 2021 Registered Direct Offering [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Common stock offering warrants issued, value (in Shares)       1,975,000                            
Warrant term                               5 years    
Exercise price (in Dollars per share)                               $ 2.50    
Per share price (in Dollars per share)                               $ 2.50    
Expected volatility rate                               100.80%    
Expected term                               5 years    
Expected dividend rate                               0.00%    
Risk free interest rate                               0.31%    
Share price (in Dollars per share)       $ 2.00                       $ 1.76    
Stock compensation expense (in Dollars)                               $ 181,000    
Purchase of warrants shares (in Shares)                               148,125    
Common stock, par value (in Dollars per share)       $ 0.001                            
Deducting fees payable (in Dollars)       $ 3,950,000                            
Common stock sold (in Shares)       1,975,000                            
Deemed Dividend Adjustment-Warrant Modified Terms Revaluation [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Warrants, description   the Company issued an aggregate of 51,414 common shares in a cashless exercise of 56,625 warrants issued in December 2016 and November 2017. Consideration for the exercise of these warrants was the full settlement of an outstanding litigation reserve of $238.         the Company agreed to modify the terms of the Original Warrants that were originally issued on March 6, 2020 and on April 24, 2020. Pursuant to the agreement, the per share exercise price of the Original Warrants were reduced from $2.88 and $3.05, respectively, to $1.725.                      
Common stock per share (in Dollars per share)             $ 1.47                      
Expected volatility rate             96.50%                      
Expected dividend rate             0.00%                      
Risk free interest rate             0.18%                      
Exercise outstanding warrants (in Shares)             1,700,680                      
Deemed Dividend Adjustment-Warrant Modified Terms Revaluation [Member] | Minimum [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Expected term             4 years 6 months                      
Deemed Dividend Adjustment-Warrant Modified Terms Revaluation [Member] | Maximum [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Expected term             8 years                      
H.C. Wainwright & Co., LLC [Member] | Common Stock Warrant Issued to Underwriter of Common Stock Offering [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Number of warrant purchased (in Shares)                       8,334            
Common stock per share (in Dollars per share)                       $ 33.75            
Exercise price (in Dollars per share)                       $ 33.75            
Fair value of common stock warrant (in Dollars)                       $ 127,000            
Share price (in Dollars per share)                       $ 26.80            
H.C. Wainwright & Co., LLC [Member] | Common Stock Warrants Issued to Placement Agent in 2020 Registered Direct Offerings and Private Placement [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Number of warrant purchased (in Shares)               118,073                    
Expected volatility rate                       133.30%            
Expected term                       5 years            
H.C. Wainwright & Co., LLC [Member] | Common Stock Warrants Issued to Placement Agent in October 2020 Inducement Offering [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Exercise price (in Dollars per share)           $ 2.156                        
Purchase of warrants shares (in Shares)           85,034                        
H.C. Wainwright & Co., LLC [Member] | Common Stock Warrants Issued in February 2021 Private Placement Agreement [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Exercise price (in Dollars per share)         $ 2.8481                          
H.C. Wainwright & Co., LLC [Member] | Common Stock Warrants Issued to Placement Agent in February 2021 Private Placement Agreement [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Purchase of warrants shares (in Shares)         329,164                          
Public Offering [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Number of warrant purchased (in Shares)                             293,000      
Common Class A [Member] | Common Stock Warrants Issued to Placement Agent in 2020 Registered Direct Offerings and Private Placement [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Common stock offering warrants issued, value (in Shares)               145,586                    
Common Class A [Member] | Common Stock Warrants Issued in April 2020 Public Offering [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Common stock offering warrants issued, value (in Shares)               145,586                    
Common Class B [Member] | Common Stock Warrants Issued to Placement Agent in 2020 Registered Direct Offerings and Private Placement [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Common stock offering warrants issued, value (in Shares)               1,428,722                    
Common Class B [Member] | Common Stock Warrants Issued in April 2020 Public Offering [Member]                                    
Common Stock Warrants and Common Stock Warrant Liability (Details) [Line Items]                                    
Common stock offering warrants issued, value (in Shares)               1,428,722                    
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.21.1
Common Stock Warrants and Common Stock Warrant Liability (Details) - Schedule of common stock warrant activity - shares
3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Class of Warrant or Right [Line Items]      
Outstanding at beginning 2,582,697   489,176
Outstanding at ending 4,553,733 2,582,697  
Various [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     2016 and prior
Expiration Date     Various-2020/2021
Exercise price     Various
Outstanding at beginning     17,059
Warrants Exercised   (9,375)  
Warrants Expired (7,684)  
Common Stock Offering Warrants [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     November 21,2017
Expiration Date     November 21, 2022
Exercise price [1]     $1.3659
Outstanding at beginning 143,501   143,501
Warrants issued  
Warrants Exercised    
Outstanding at ending 143,501 143,501  
Dealer Manager Warrants [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     November 21,2017
Expiration Date     November 21, 2022
Exercise price     $30.00
Outstanding at beginning     47,250
Warrants Exercised   (47,250)  
Warrant Reissue [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     June 20,2018
Expiration Date     December 20, 2023
Exercise price     $36.40
Outstanding at beginning 56,696   56,696
Warrants issued  
Warrants Exercised  
Warrants Expired  
Outstanding at ending 56,696 56,696  
Rights Offering Warrants [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     August 13,2018
Expiration Date     July 25, 2023
Exercise price     $23.00
Outstanding at beginning 202,943   202,943
Warrants issued  
Warrants Exercised  
Warrants Expired  
Outstanding at ending 202,943 202,943  
Dealer Manager Warrants [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     August 13,2018
Expiration Date     August 13, 2023
Exercise price     $34.50
Outstanding at beginning 13,393   13,393
Warrants issued  
Warrants Exercised  
Warrants Expired  
Outstanding at ending 13,393 13,393  
Dealer Manager Warrants [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     July 16,2019
Expiration Date     July 11, 2024
Exercise price     $33.75
Outstanding at beginning 8,334   8,334
Warrants issued  
Warrants Exercised  
Warrants Expired  
Outstanding at ending 8,334 8,334  
Registered Direct Offering [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     January 28,2020
Expiration Date     July 28,2025
Exercise price     $9.00
Outstanding at beginning 177,500  
Warrants issued 177,500  
Warrants Exercised  
Warrants Expired  
Outstanding at ending 177,500 177,500  
Dealer Manager Warrants [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     January 28,2020
Expiration Date     July 28,2025
Exercise price     $10.00
Outstanding at beginning 13,315  
Warrants issued 13,315  
Warrants Exercised  
Warrants Expired  
Outstanding at ending 13,315 13,315  
Registered Direct Offering [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     March 6,2020
Expiration Date     September 8,2025
Exercise price     $2.88
Outstanding at beginning  
Warrants issued 176,372  
Warrants Exercised (176,372)  
Warrants Expired  
Outstanding at ending  
Dealer Manager Warrants [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     March 6,2020
Expiration Date     March 4,2025
Exercise price     $3.76
Outstanding at beginning 13,228  
Warrants issued 13,228  
Warrants Exercised  
Warrants Expired  
Outstanding at ending 13,228 13,228  
Dealer Manager Warrants [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     April 21,2020
Expiration Date     April 21,2025
Exercise price     $3.97
Outstanding at beginning 118,073  
Warrants issued 118,073  
Warrants Exercised  
Warrants Expired  
Outstanding at ending 118,073 118,073  
Registered Direct Offering [Member[      
Class of Warrant or Right [Line Items]      
Issue Date     April 24,2020
Expiration Date     April 24,2025
Exercise price     $3.05
Outstanding at beginning 50,000  
Warrants issued 1,574,308  
Warrants Exercised (1,524,308)  
Warrants Expired  
Outstanding at ending 50,000 50,000  
Private Warrant Inducement [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     October 26, 2020
Expiration Date     April 27,2026
Exercise price     $1.73
Outstanding at beginning 1,700,680  
Warrants issued 1,700,680  
Warrants Exercised (700,680)    
Warrants Expired    
Outstanding at ending 1,000,000 1,700,680  
Dealer Manager Warrants [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     October 26, 2020
Expiration Date     April 27,2026
Exercise price     $2.16
Outstanding at beginning 85,034  
Warrants issued 85,034  
Warrants Exercised    
Warrants Expired    
Outstanding at ending 85,034 85,034  
Private Placement Agreement [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     February 2, 2021
Expiration Date     August 2,2026
Exercise price     $2.216
Outstanding at beginning  
Warrants issued 2,194,427  
Warrants Exercised    
Warrants Expired    
Outstanding at ending 2,194,427  
Dealer Manager Warrants [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     February 2, 2021
Expiration Date     August 2,2026
Exercise price     $2.848
Outstanding at beginning  
Warrants issued 329,164  
Warrants Exercised    
Warrants Expired    
Outstanding at ending 329,164  
Dealer Manager Warrants [Member]      
Class of Warrant or Right [Line Items]      
Issue Date     March 23, 2021
Expiration Date     March 23, 2026
Exercise price     $2.50
Outstanding at beginning  
Warrants issued 148,125  
Warrants Exercised    
Warrants Expired    
Outstanding at ending 148,125  
[1] The initial exercise price of these warrants was $30.00 per share. Pursuant to antidilution price adjustment protection contained within these warrants, the initial exercise price of these warrants was adjusted downward to $29.40 on July 24, 2018, the record date of the Right’s Offering and downward to $19.00 per share on August 13, 2018. These warrants were further adjusted downward from $19.00 to $7.13 and to $2.1122 on January 28, 2020 and March 4, 2020, respectively, in connection with separate Registered Direct Offerings. These warrants were further adjusted downward from $2.1122 to $1.3659 on October 26, 2020 in connection with a Registered Direct Offering. These warrants are subject to further adjustment pursuant to antidilution price adjustment protection.
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders’ Deficit (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended
Feb. 02, 2021
Nov. 10, 2015
Mar. 29, 2021
Mar. 23, 2021
Mar. 19, 2021
Feb. 28, 2021
Mar. 31, 2020
Mar. 31, 2021
Dec. 31, 2020
Dec. 31, 2018
Jun. 20, 2018
Dec. 31, 2015
Stockholders’ Deficit (Details) [Line Items]                        
Common stock, authorized               100,000,000 100,000,000      
Common stock, par value (in Dollars per share)               $ 0.001 $ 0.001      
Preferred stock, authorized                       15,000,000
Capital stock, description   the Company’s authorized capital stock consisted of 100 million shares of common stock, $.001 par value, and 10 million shares of preferred stock, $.001 par value.                    
Common stock, shares, issued               12,164,046 5,099,512      
Common Stock, Shares, Outstanding               12,164,046 5,099,512      
Shares issued in connection with exercise of warrants                     56,696  
Warrant to purchase shares               4,553,733 2,582,697 489,176    
Aggregate shares of common stock         700,680              
Registered direct offering, description       the Company consummated a registered direct offering with certain institutional investors and issued an aggregate of 1,975,000 shares of the Company’s common stock, par value $0.001 per share at a purchase price of $2.00 per share for gross proceeds to the Company of approximately $3.95 million, pursuant to a prospectus, dated August 24, 2018, and a prospectus supplement, dated March 22, 2021, in connection with a takedown from the Company’s shelf registration statement on Form S-3 (File No. 333-225712).                
Net proceeds (in Dollars)         $ 1,209              
Placement Agent Warrants [Member]                        
Stockholders’ Deficit (Details) [Line Items]                        
Shares issued in connection with exercise of warrants               148,125        
Exercise price per share (in Dollars per share)               $ 2.50        
Private Placement [Member]                        
Stockholders’ Deficit (Details) [Line Items]                        
Common stock, par value (in Dollars per share) $ 0.001                      
Shares issued in connection with exercise of warrants 2,194,427                      
Warrant to purchase shares 3,968,854                      
Purchase price per share (in Dollars per share) $ 2.2785                      
Aggregate shares of common stock 420,000                      
Purchase price of pre- funded warrants (in Dollars per share) $ 2.2775                      
Gross proceeds (in Dollars) $ 10,000                      
Exercise price per share, description     all 420,000 pre-funded shares had been distributed. In connection with the offering, we issued the placement agent warrants to purchase up to 329,164 shares of Common Stock with an exercise price of $2.8481 per share.                  
Common Stock [Member]                        
Stockholders’ Deficit (Details) [Line Items]                        
Common stock, authorized   100,000,000                    
Common stock, par value (in Dollars per share)   $ 1                    
Common stock, shares, issued               7,064,534        
Shares issued in connection with registered direct offering           4,388,854   1,975,000        
Sale of Stock, Consideration Received on Transaction (in Dollars)           $ 8,898   $ 3,523        
Shares issued in connection with exercise of warrants             700,680          
Proceeds from warrants (in Dollars)             $ 1,209          
Series A Preferred Stock [Member]                        
Stockholders’ Deficit (Details) [Line Items]                        
Preferred stock, authorized   2,000,000                    
Preferred stock, par value (in Dollars per share)   $ 0.001                    
Series B Preferred Stock [Member]                        
Stockholders’ Deficit (Details) [Line Items]                        
Preferred stock, authorized                       7,515,000
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Jun. 12, 2018
Mar. 31, 2021
Dec. 31, 2020
Stock-based Compensation (Details) [Line Items]      
Service period, description   Options granted under the 2018 Plan generally vest immediately, or ratably over a two- to 36-month period coinciding with their respective service periods.  
Stock options term   5 years  
Weighted average grant date fair value of options granted (in Dollars per share)   $ 1.94  
Share price (in Dollars per share)   $ 1.66 $ 1.73
Weighted average grant date   34 months  
Minimum [Member]      
Stock-based Compensation (Details) [Line Items]      
Number of shares authorized 50,000    
Maximum [Member]      
Stock-based Compensation (Details) [Line Items]      
Number of shares authorized 850,000    
Restricted Stock Units [Member]      
Stock-based Compensation (Details) [Line Items]      
Compensation cost not yet recognized (in Dollars)   $ 629  
Equity Incentive Plan 2018 [Member]      
Stock-based Compensation (Details) [Line Items]      
Number of shares authorized 800,000    
Number of additional shares authorized 122,279    
Common stock available for issuance   419,061  
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-based Compensation (Details) - Schedule of fair value of options granted - Employee [Member]
3 Months Ended
Mar. 31, 2021
Stock-based Compensation (Details) - Schedule of fair value of options granted [Line Items]  
Expected volatility 96.20%
Expected dividend yield
Expected term (in years) 5 years
Risk-free interest rate 0.26%
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-based Compensation (Details) - Schedule of stock option activity
3 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Schedule of stock option activity [Abstract]  
Number of Options, Outstanding at December 31, 2020 (in Shares) | shares 496,471
Weighted Average Exercise Price Per Share, Outstanding at December 31, 2020 $ 8.63
Weighted Average Remaining Contractual Term (years), Outstanding at December 31, 2020 3 years 328 days
Aggregate Intrinsic Value, Outstanding at December 31, 2020 (in Dollars) | $ [1]
Number of Options, Granted (in Shares) | shares 12,756
Weighted Average Exercise Price Per Share, Granted $ 1.84
Weighted Average Remaining Contractual Term (years), Granted 4 years 292 days
Aggregate Intrinsic Value, Granted [1]
Number of Options, Exercised (in Shares) | shares
Weighted Average Exercise Price Per Share, Exercised
Exercised (in Dollars) | $ [1]
Aggregate Intrinsic Value, Exercised (in Dollars) | $ [1]
Number of Options, Forfeited (in Shares) | shares (2,375)
Weighted Average Exercise Price Per Share, Forfeited
Weighted Average Remaining Contractual Term (years), Forfeited [1]
Aggregate Intrinsic Value, Forfeited [1]
Number of Options, Expired (in Shares) | shares
Weighted Average Exercise Price Per Share, Expired
Weighted Average Remaining Contractual Term (years), Expired [1]
Aggregate Intrinsic Value, Exercised, Expired [1]
Number of Options, Outstanding at March 31, 2021 (in Shares) | shares 506,852
Weighted Average Exercise Price Per Share, Outstanding at March 31, 2021 $ 8.15
Weighted Average Remaining Contractual Term (years), Outstanding at March 31, 2021 2 years 109 days
Aggregate Intrinsic Value, Outstanding at March 31, 2021 (in Dollars) | $ [1]
Number of Options, Outstanding, Exercisable at March 31, 2021 (in Shares) | shares 228,481
Weighted Average Exercise Price Per Share, Exercisable at March 31, 2021 $ 14.45
Weighted Average Remaining Contractual Term (years), Exercisable at March 31, 2021 2 years 36 days
Aggregate Intrinsic Value, Outstanding, Exercisable at March 31, 2021 (in Dollars) | $ [1]
[1] The aggregate intrinsic value in the table was calculated based on the difference between the estimated fair market value of the Company’s stock and the exercise price of the underlying options. The estimated stock values used in the calculation were $1.73 and $1.66 per share for the year ended December 31, 2020 and the three months ended March 31, 2021, respectively.
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-based Compensation (Details) - Schedule of summarizes restricted stock unit activity - Restricted Stock [Member]
3 Months Ended
Mar. 31, 2021
$ / shares
shares
Stock-based Compensation (Details) - Schedule of summarizes restricted stock unit activity [Line Items]  
Number of Units, Outstanding beginning | shares 32,072
Weighted Average Grant-Date Fair Value Per Unit, Outstanding beginning | $ / shares $ 4.05
Number of Units, Granted | shares
Weighted Average Grant-Date Fair Value Per Unit, Granted | $ / shares
Number of Units, Vested | shares (667)
Weighted Average Grant-Date Fair Value Per Unit, Vested | $ / shares $ 1.80
Number of Units, Forfeited | shares
Weighted Average Grant-Date Fair Value Per Unit, Forfeited | $ / shares
Number of Units, Outstanding ending | shares 31,405
Weighted Average Grant-Date Fair Value Per Unit, Outstanding ending | $ / shares $ 2.58
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-based Compensation (Details) - Schedule of stock-based compensation expense - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Stock-based Compensation (Details) - Schedule of stock-based compensation expense [Line Items]    
Total stock-based compensation expense $ 155 $ 151
Research and Development Expense [Member]    
Stock-based Compensation (Details) - Schedule of stock-based compensation expense [Line Items]    
Total stock-based compensation expense 2 3
General and Administrative Expense [Member]    
Stock-based Compensation (Details) - Schedule of stock-based compensation expense [Line Items]    
Total stock-based compensation expense $ 153 $ 148
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingencies (Details)
$ in Thousands
1 Months Ended 3 Months Ended
Aug. 01, 2020
Dec. 02, 2019
Nov. 16, 2016
ft²
Mar. 31, 2021
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2019
ft²
Commitments and Contingencies (Details) [Line Items]            
Area square feet           7,632
Lease commitments extended, description we entered into a lease for our manufacturing and research facility in Phoenix, Arizona where we occupy approximately 5,105 square feet of manufacturing and warehouse space. This lease expires on November 30, 2024. we entered into a lease for our corporate headquarters in Phoenix, Arizona where we lease and occupy approximately 5,529 square feet of office space. This lease expires in November 2024.        
Rent expense | $       $ 54 $ 69  
Research and Development Equipment [Member]            
Commitments and Contingencies (Details) [Line Items]            
Area square feet     1,954      
Lease commitments extended, description     This lease expired on November 15, 2018 but was extended for an additional 24 months, through November 2020.      
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingencies (Details) - Schedule of future minimum lease payments under non-cancellable operating lease and future minimum capital lease payments
$ in Thousands
Mar. 31, 2021
USD ($)
Schedule of future minimum lease payments under non-cancellable operating lease and future minimum capital lease payments [Abstract]  
2021 Finance leases $ 43
2021 Operating leases 142
2022 Finance leases 28
2022 Operating leases 194
2023 Finance leases
2023 Operating leases 198
2024 Finance leases
2024 Operating leases 186
Total minimum lease payments of Finance leases 71
Total minimum lease payments of Operating leases 720
Less: amounts representing interest (ranging from 11.43% to 14.68%) 5
Present value of minimum lease payments 66
Less: current installments under finance lease obligations 52
Total long-term portion $ 14
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.21.1
Subsequent Events (Details) - Subsequent Event [Member] - shares
1 Months Ended
Apr. 29, 2021
Apr. 08, 2021
Subsequent Events (Details) [Line Items]    
Common stock shares   667
Institutional Investors [Member]    
Subsequent Events (Details) [Line Items]    
Number of common stock issued 20,284  
EXCEL 63 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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�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end XML 64 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 65 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 66 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 262 360 1 true 66 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://senestech.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Balance Sheets Sheet http://senestech.com/role/ConsolidatedBalanceSheet Condensed Balance Sheets Statements 2 false false R3.htm 002 - Statement - Condensed Balance Sheets (Parentheticals) Sheet http://senestech.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://senestech.com/role/ConsolidatedIncomeStatement Condensed Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) Sheet http://senestech.com/role/ShareholdersEquityType2or3 Condensed Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://senestech.com/role/ConsolidatedCashFlow Condensed Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Organization and Description of Business Sheet http://senestech.com/role/OrganizationandDescriptionofBusiness Organization and Description of Business Notes 7 false false R8.htm 007 - Disclosure - Summary of Significant Accounting Policies Sheet http://senestech.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Fair Value Measurements Sheet http://senestech.com/role/FairValueMeasurements Fair Value Measurements Notes 9 false false R10.htm 009 - Disclosure - Credit Risk Sheet http://senestech.com/role/CreditRisk Credit Risk Notes 10 false false R11.htm 010 - Disclosure - Prepaid Expenses Sheet http://senestech.com/role/PrepaidExpenses Prepaid Expenses Notes 11 false false R12.htm 011 - Disclosure - Property and Equipment Sheet http://senestech.com/role/PropertyandEquipment Property and Equipment Notes 12 false false R13.htm 012 - Disclosure - Accrued Expenses Sheet http://senestech.com/role/AccruedExpenses Accrued Expenses Notes 13 false false R14.htm 013 - Disclosure - Borrowings Sheet http://senestech.com/role/Borrowings Borrowings Notes 14 false false R15.htm 014 - Disclosure - Common Stock Warrants and Common Stock Warrant Liability Sheet http://senestech.com/role/CommonStockWarrantsandCommonStockWarrantLiability Common Stock Warrants and Common Stock Warrant Liability Notes 15 false false R16.htm 015 - Disclosure - Stockholders??? Deficit Sheet http://senestech.com/role/StockholdersDeficit Stockholders??? Deficit Notes 16 false false R17.htm 016 - Disclosure - Stock-based Compensation Sheet http://senestech.com/role/StockbasedCompensation Stock-based Compensation Notes 17 false false R18.htm 017 - Disclosure - Commitments and Contingencies Sheet http://senestech.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 18 false false R19.htm 018 - Disclosure - Subsequent Events Sheet http://senestech.com/role/SubsequentEvents Subsequent Events Notes 19 false false R20.htm 019 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://senestech.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://senestech.com/role/SummaryofSignificantAccountingPolicies 20 false false R21.htm 020 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://senestech.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://senestech.com/role/SummaryofSignificantAccountingPolicies 21 false false R22.htm 021 - Disclosure - Prepaid Expenses (Tables) Sheet http://senestech.com/role/PrepaidExpensesTables Prepaid Expenses (Tables) Tables http://senestech.com/role/PrepaidExpenses 22 false false R23.htm 022 - Disclosure - Property and Equipment (Tables) Sheet http://senestech.com/role/PropertyandEquipmentTables Property and Equipment (Tables) Tables http://senestech.com/role/PropertyandEquipment 23 false false R24.htm 023 - Disclosure - Accrued Expenses (Tables) Sheet http://senestech.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://senestech.com/role/AccruedExpenses 24 false false R25.htm 024 - Disclosure - Borrowings (Tables) Sheet http://senestech.com/role/BorrowingsTables Borrowings (Tables) Tables http://senestech.com/role/Borrowings 25 false false R26.htm 025 - Disclosure - Common Stock Warrants and Common Stock Warrant Liability (Tables) Sheet http://senestech.com/role/CommonStockWarrantsandCommonStockWarrantLiabilityTables Common Stock Warrants and Common Stock Warrant Liability (Tables) Tables http://senestech.com/role/CommonStockWarrantsandCommonStockWarrantLiability 26 false false R27.htm 026 - Disclosure - Stock-based Compensation (Tables) Sheet http://senestech.com/role/StockbasedCompensationTables Stock-based Compensation (Tables) Tables http://senestech.com/role/StockbasedCompensation 27 false false R28.htm 027 - Disclosure - Commitments and Contingencies (Tables) Sheet http://senestech.com/role/CommitmentsandContingenciesTables Commitments and Contingencies (Tables) Tables http://senestech.com/role/CommitmentsandContingencies 28 false false R29.htm 028 - Disclosure - Organization and Description of Business (Details) Sheet http://senestech.com/role/OrganizationandDescriptionofBusinessDetails Organization and Description of Business (Details) Details http://senestech.com/role/OrganizationandDescriptionofBusiness 29 false false R30.htm 029 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://senestech.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://senestech.com/role/SummaryofSignificantAccountingPoliciesTables 30 false false R31.htm 030 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of inventory Sheet http://senestech.com/role/ScheduleofinventoryTable Summary of Significant Accounting Policies (Details) - Schedule of inventory Details http://senestech.com/role/SummaryofSignificantAccountingPoliciesTables 31 false false R32.htm 031 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of employee stock-based compensation expense Sheet http://senestech.com/role/ScheduleofemployeestockbasedcompensationexpenseTable Summary of Significant Accounting Policies (Details) - Schedule of employee stock-based compensation expense Details http://senestech.com/role/SummaryofSignificantAccountingPoliciesTables 32 false false R33.htm 032 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of outstanding potentially dilutive securities calculation of diluted loss per share attributable to common stockholders Sheet http://senestech.com/role/ScheduleofoutstandingpotentiallydilutivesecuritiescalculationofdilutedlosspershareattributabletocommonstockholdersTable Summary of Significant Accounting Policies (Details) - Schedule of outstanding potentially dilutive securities calculation of diluted loss per share attributable to common stockholders Details http://senestech.com/role/SummaryofSignificantAccountingPoliciesTables 33 false false R34.htm 033 - Disclosure - Credit Risk (Details) Sheet http://senestech.com/role/CreditRiskDetails Credit Risk (Details) Details http://senestech.com/role/CreditRisk 34 false false R35.htm 034 - Disclosure - Prepaid Expenses (Details) - Schedule of prepaid expenses Sheet http://senestech.com/role/ScheduleofprepaidexpensesTable Prepaid Expenses (Details) - Schedule of prepaid expenses Details http://senestech.com/role/PrepaidExpensesTables 35 false false R36.htm 035 - Disclosure - Property and Equipment (Details) Sheet http://senestech.com/role/PropertyandEquipmentDetails Property and Equipment (Details) Details http://senestech.com/role/PropertyandEquipmentTables 36 false false R37.htm 036 - Disclosure - Property and Equipment (Details) - Schedule of property and equipment Sheet http://senestech.com/role/ScheduleofpropertyandequipmentTable Property and Equipment (Details) - Schedule of property and equipment Details http://senestech.com/role/PropertyandEquipmentTables 37 false false R38.htm 037 - Disclosure - Accrued Expenses (Details) - Schedule of accrued expenses Sheet http://senestech.com/role/ScheduleofaccruedexpensesTable Accrued Expenses (Details) - Schedule of accrued expenses Details http://senestech.com/role/AccruedExpensesTables 38 false false R39.htm 038 - Disclosure - Borrowings (Details) Sheet http://senestech.com/role/BorrowingsDetails Borrowings (Details) Details http://senestech.com/role/BorrowingsTables 39 false false R40.htm 039 - Disclosure - Borrowings (Details) - Schedule of capital lease obligations Sheet http://senestech.com/role/ScheduleofcapitalleaseobligationsTable Borrowings (Details) - Schedule of capital lease obligations Details http://senestech.com/role/BorrowingsTables 40 false false R41.htm 040 - Disclosure - Common Stock Warrants and Common Stock Warrant Liability (Details) Sheet http://senestech.com/role/CommonStockWarrantsandCommonStockWarrantLiabilityDetails Common Stock Warrants and Common Stock Warrant Liability (Details) Details http://senestech.com/role/CommonStockWarrantsandCommonStockWarrantLiabilityTables 41 false false R42.htm 041 - Disclosure - Common Stock Warrants and Common Stock Warrant Liability (Details) - Schedule of common stock warrant activity Sheet http://senestech.com/role/ScheduleofcommonstockwarrantactivityTable Common Stock Warrants and Common Stock Warrant Liability (Details) - Schedule of common stock warrant activity Details http://senestech.com/role/CommonStockWarrantsandCommonStockWarrantLiabilityTables 42 false false R43.htm 042 - Disclosure - Stockholders??? Deficit (Details) Sheet http://senestech.com/role/StockholdersDeficitDetails Stockholders??? Deficit (Details) Details http://senestech.com/role/StockholdersDeficit 43 false false R44.htm 043 - Disclosure - Stock-based Compensation (Details) Sheet http://senestech.com/role/StockbasedCompensationDetails Stock-based Compensation (Details) Details http://senestech.com/role/StockbasedCompensationTables 44 false false R45.htm 044 - Disclosure - Stock-based Compensation (Details) - Schedule of fair value of options granted Sheet http://senestech.com/role/ScheduleoffairvalueofoptionsgrantedTable Stock-based Compensation (Details) - Schedule of fair value of options granted Details http://senestech.com/role/StockbasedCompensationTables 45 false false R46.htm 045 - Disclosure - Stock-based Compensation (Details) - Schedule of stock option activity Sheet http://senestech.com/role/ScheduleofstockoptionactivityTable Stock-based Compensation (Details) - Schedule of stock option activity Details http://senestech.com/role/StockbasedCompensationTables 46 false false R47.htm 046 - Disclosure - Stock-based Compensation (Details) - Schedule of summarizes restricted stock unit activity Sheet http://senestech.com/role/ScheduleofsummarizesrestrictedstockunitactivityTable Stock-based Compensation (Details) - Schedule of summarizes restricted stock unit activity Details http://senestech.com/role/StockbasedCompensationTables 47 false false R48.htm 047 - Disclosure - Stock-based Compensation (Details) - Schedule of stock-based compensation expense Sheet http://senestech.com/role/ScheduleofstockbasedcompensationexpenseTable Stock-based Compensation (Details) - Schedule of stock-based compensation expense Details http://senestech.com/role/StockbasedCompensationTables 48 false false R49.htm 048 - Disclosure - Commitments and Contingencies (Details) Sheet http://senestech.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://senestech.com/role/CommitmentsandContingenciesTables 49 false false R50.htm 049 - Disclosure - Commitments and Contingencies (Details) - Schedule of future minimum lease payments under non-cancellable operating lease and future minimum capital lease payments Sheet http://senestech.com/role/ScheduleoffutureminimumleasepaymentsundernoncancellableoperatingleaseandfutureminimumcapitalleasepaymentsTable Commitments and Contingencies (Details) - Schedule of future minimum lease payments under non-cancellable operating lease and future minimum capital lease payments Details http://senestech.com/role/CommitmentsandContingenciesTables 50 false false R51.htm 050 - Disclosure - Subsequent Events (Details) Sheet http://senestech.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://senestech.com/role/SubsequentEvents 51 false false All Reports Book All Reports snes-20210331.xml snes-20210331.xsd snes-20210331_cal.xml snes-20210331_def.xml snes-20210331_lab.xml snes-20210331_pre.xml http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2020-01-31 true true ZIP 68 0001213900-21-026400-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-21-026400-xbrl.zip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

0Z3H]SZ$/RS1>G1P!3G=UBS8WU.)E, M]MJ'CQD:&V>I6*EGO$*,?2[$ZG55'N1(?5C( MM'V"J;>!%Q]@ZH<9O$G#6IYGJO.%H$]@]MH_#408\A[SBR&@& /*08", C=H MFY/EY6>'8V>#92&?:,=+63C1^Y>]DT6&(>N\,9?2]CGT$9DT,Y;1(1WE1P1S M&>=I&&>A/UFGE^F '?N]SOY9U$:(5^5LLTGAQLLAJ#ZGE7'DI\W_ATW*\R2* MO'0.W:"G%-F)MC�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end